The following table presents the amounts reclassified out of AOCI for the three and six months ended ~~March 31,~~June 30, 2013 (dollars in thousands):

The following tables provide information relating to investments in fixed maturity and equity securities by sector as of ~~March 31,~~June 30, 2013 and December 31, 2012 (dollars in thousands):

Other-than-
Estimated temporary
March 31, 2013: Amortized Unrealized Unrealized Fair % of impairments
Cost Gains Losses Value Total in AOCI
Available-for-sale:

Corporate securities
$       11,464,082 $       1,022,512 $ 45,093 $ 12,441,501 55.5 %    $ --
Canadian and Canadian provincial governments
2,681,603 1,261,728 1,133 3,942,198 17.6     --
Residential mortgage-backed securities
1,005,232 75,579 4,041 1,076,770 4.8     (241)
Asset-backed securities
752,280 23,333 19,069 756,544 3.4     (2,259)
Commercial mortgage-backed securities
1,596,659 143,381 41,896 1,698,144 7.6     (5,431)
U.S. government and agencies
299,395 31,938 132 331,201 1.5     --
State and political subdivisions
281,215 37,628 5,746 313,097 1.4     --
Other foreign government, supranational and foreign government-sponsored enterprises
1,758,483 87,306 3,585 1,842,204 8.2     --

Total fixed maturity securities
$ 19,838,949 $ 2,683,405 $         120,695 $       22,401,659           100.0 %    $         (7,931)

Non-redeemable preferred stock
$ 76,179 $ 7,940 $ 8 $ 84,111 38.1 %
Other equity securities
138,088 295 1,829 136,554 61.9

Total equity securities
$ 214,267 $ 8,235 $ 1,837 $ 220,665 100.0 %


											Other-than-
							Estimated				temporary
December 31, 2012:	Amortized		Unrealized		Unrealized		Fair		% of		impairments
	Cost		Gains		Losses		Value		Total		in AOCI
June 30, 2013:													Amortized Cost		Unrealized Gains		Unrealized Losses		Estimated Fair Value		% of Total			Other-than- temporary impairments in AOCI
Available-for-sale:
Corporate securities	$	11,333,431	$	1,085,973	$	39,333	$	12,380,071		55.5 %	$	--	$	11,346,144	$	648,955	$	191,618	$	11,803,481		55.4	%	$	—
Canadian and Canadian provincial governments		2,676,777		1,372,731		174		4,049,334		18.2		--		2,633,388		901,567		9,162		3,525,793		16.6			—
Residential mortgage-backed securities		969,267		76,520		3,723		1,042,064		4.7		(241)		1,015,155		53,581		13,768		1,054,968		5.0			(241	)
Asset-backed securities		700,455		19,898		28,798		691,555		3.1		(2,259)		789,849		18,998		18,537		790,310		3.7			(2,259	)
Commercial mortgage-backed securities		1,608,376		142,369		51,842		1,698,903		7.6		(6,125)		1,564,924		110,294		36,586		1,638,632		7.7			(5,125	)
U.S. government and agencies		231,256		33,958		24		265,190		1.2		--		394,026		21,417		2,453		412,990		1.9			—
State and political subdivisions		270,086		38,058		5,646		302,498		1.4		--		278,148		25,513		11,850		291,811		1.4			—
Other foreign government, supranational and foreign government-sponsored enterprises		1,769,784		94,929		2,714		1,861,999		8.3		--		1,735,687		51,165		20,621		1,766,231		8.3			—

Total fixed maturity securities	$	19,559,432	$	2,864,436	$	132,254	$	22,291,614		100.0 %	$	(8,625)	$	19,757,321	$	1,831,490	$	304,595	$	21,284,216		100.0	%	$	(7,625	)


Non-redeemable preferred stock	$	68,469	$	6,542	$	170	$	74,841		33.6 %			$	85,483	$	6,722	$	1,747	$	90,458		56.4	%
Other equity securities		148,577		416		1,134		147,859		66.4				74,273		—		4,392		69,881		43.6

Total equity securities	$	217,046	$	6,958	$	1,304	$	222,700		100.0 %			$	159,756	$	6,722	$	6,139	$	160,339		100.0	%

The Company enters into various collateral arrangements that require both the pledging and acceptance of fixed maturity securities as collateral. The Company pledged fixed maturity securities as collateral to derivative and reinsurance counterparties with an amortized cost of ~~$25.4~~$32.9 million and $16.9 million, and an estimated fair value of ~~$25.8~~$33.9 million and $17.0 million, as of ~~March 31,~~June 30, 2013 and December 31, 2012 ~~respectively, which~~respectively. The pledged fixed maturity securities are included in fixed maturity securities, available-for-sale in the condensed consolidated balance sheets as of June 30, 2013, and are included in other invested assets in the condensed consolidated balance ~~sheets.~~sheets as of December 31, 2012. Securities with an amortized cost of ~~$8,216.3~~$8,046.9 million and $7,549.0 million, and an estimated fair value of ~~$8,889.9~~$8,377.6 million and $7,913.8 million, as of ~~March 31,~~June 30, 2013 and December 31, 2012, respectively, were held in trust to satisfy collateral requirements under certain third-party reinsurance treaties.

The Company received fixed maturity securities as collateral from derivative and reinsurance counterparties with an estimated fair value of ~~$85.4~~$91.5 million and $95.6 million, as of ~~March 31,~~June 30, 2013 and December 31, 2012, respectively. The collateral is held in separate custodial accounts and is not recorded on the Company’s condensed consolidated balance sheets. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral; however, as of ~~March 31,~~June 30, 2013 and December 31, 2012, none of the collateral had been sold or re-pledged.

As of ~~March 31,~~June 30, 2013, the Company held securities with a fair value of ~~$1,357.9~~$1,231.6 million that were guaranteed or issued by the Canadian province of Ontario and ~~$1,723.9~~$1,516.3 million that were guaranteed or issued by the Canadian province of Quebec, both of which exceeded 10% of total stockholders’ equity. As of December 31, 2012, the Company held securities with a fair value of $1,400.0 million that were guaranteed or issued by the Canadian province of Ontario and $1,785.0 million that were guaranteed or issued by the Canadian province of Quebec, both of which exceeded 10% of total stockholders’ equity.

The amortized cost and estimated fair value of fixed maturity securities available-for-sale at ~~March 31,~~June 30, 2013 are shown by contractual maturity in the table below. Actual maturities can differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Asset and mortgage-backed securities are shown separately in the table below, as they are not due at a single maturity date. At ~~March 31,~~June 30, 2013, the contractual maturities of investments in fixed maturity securities were as follows (dollars in thousands):


	Amortized		Fair
	Cost		Value		Amortized Cost		Fair Value
Available-for-sale:
Due in one year or less	$	348,130	$	352,916	$	426,022	$	432,495
Due after one year through five years		3,716,625		3,917,468		3,613,328		3,773,306
Due after five years through ten years		6,922,683		7,521,433		6,893,971		7,127,743
Due after ten years		5,497,340		7,078,384		5,454,072		6,466,762
Asset and mortgage-backed securities		3,354,171		3,531,458		3,369,928		3,483,910

Total	$	19,838,949	$	22,401,659	$	19,757,321	$	21,284,216

The tables below show the major industry types of the Company’s corporate fixed maturity holdings as of ~~March 31,~~June 30, 2013 and December 31, 2012 (dollars in thousands):


March 31, 2013:			Estimated
	Amortized Cost		Fair Value		% of Total
June 30, 2013:							Amortized Cost		Estimated Fair Value		% of Total
Finance	$	3,693,500	$	3,978,979		32.0 %	$	3,636,121	$	3,770,773		32.0	%
Industrial		5,977,146		6,480,028		52.1		5,914,051		6,138,234		52.0
Utility		1,763,573		1,951,839		15.7		1,768,696		1,867,151		15.8
Other		29,863		30,655		0.2		27,276		27,323		0.2

Total	$	11,464,082	$	12,441,501		100.0 %	$	11,346,144	$	11,803,481		100.0	%


December 31, 2012:			Estimated				Amortized Cost		Estimated Fair Value		% of Total
	Amortized Cost		Fair Value		% of Total
Finance	$	3,619,455	$	3,900,152		31.5 %	$	3,619,455	$	3,900,152		31.5	%
Industrial		5,881,967		6,443,846		52.0		5,881,967		6,443,846		52.0
Utility		1,799,658		2,002,611		16.2		1,799,658		2,002,611		16.2
Other		32,351		33,462		0.3		32,351		33,462		0.3

Total	$	11,333,431	$	12,380,071		100.0 %	$	11,333,431	$	12,380,071		100.0	%

As discussed in Note 2 – “Summary of Significant Accounting Policies” of the 2012 Annual Report, a portion of certain other-than-temporary impairment (“OTTI”) losses on fixed maturity securities are recognized in AOCI. For these securities the net amount recognized in earnings (“credit loss impairments”) represents the difference between the amortized cost of the security and the net present value of its projected future cash flows discounted at the effective interest rate implicit in the debt security prior to impairment. Any remaining difference between the fair value and amortized cost is recognized in AOCI. The following table sets forth the amount of pre-tax credit loss impairments on fixed maturity securities held by the Company as of the dates indicated, for which a portion of the OTTI loss was recognized in AOCI, and the corresponding changes in such amounts (dollars in thousands):


	Three months ended March 31,				Three months ended June 30,
	2013		2012		2013			2012
Balance, beginning of period	$	16,675	$	63,947	$	14,773		$	62,236
Initial impairments - credit loss OTTI recognized on securities not previously impaired		--		1,902		—			60
Additional impairments - credit loss OTTI recognized on securities previously impaired		--		8,720		—			161
Credit loss OTTI previously recognized on securities impaired to fair value during the period		--		(11,381)		(1,449	)		(8,288	)
Credit loss OTTI previously recognized on securities which matured, paid down, prepaid or were sold during the period		(1,902)		(952)		—			(8,266	)

Balance, end of period					$	13,324		$	45,903


					Six months ended June 30,
					2013			2012
Balance, beginning of period					$	16,675		$	63,947
Initial impairments -credit loss OTTI recognized on securities not previously impaired						—			1,962
Additional impairments - credit loss OTTI recognized on securities previously impaired						—			8,881
Credit loss OTTI previously recognized on securities impaired to fair value during the period						(1,449	)		(19,669	)
Credit loss OTTI previously recognized on securities which matured, paid down, prepaid or were sold during the period						(1,902	)		(9,218	)

Balance, end of period	$	14,773	$	62,236	$	13,324		$	45,903

In the third quarter of 2012, the Company began purchasing certain ~~residential mortgage-backed~~structured securities that had experienced deterioration in credit quality since their issuance. Securities acquired with evidence of credit quality deterioration since origination and for which it is probable at the acquisition date that the Company will be unable to collect all contractually required payments are classified as purchased credit impaired securities. For each security, the excess of the cash flows expected to be collected as of the acquisition date over its acquisition date fair value is referred to as the accretable yield and is recognized as net investment income on an effective yield basis. At the date of acquisition, the timing and

amount of the cash flows expected to be collected was determined based on a best estimate using key assumptions, such as interest rates, default rates and prepayment speeds. If subsequently, based on current information and events, it is probable that there is a significant increase in cash flows previously expected to be collected or if actual cash flows are significantly greater than cash flows previously expected to be collected, the accretable yield is adjusted prospectively. The excess of the contractually required payments (including interest) as of the acquisition date over the cash flows expected to be collected as of the acquisition date is referred to as the nonaccretable difference, and this amount is not expected to be realized as net investment income. Decreases in cash flows expected to be collected can result in OTTI.

The following tables present information on the Company’s purchased credit impaired securities, which are included in fixed maturity securities available-for-sale (dollars in thousands):


	March 31, 2013		December 31, 2012		June 30, 2013		December 31, 2012
Outstanding principal and interest balance⁽¹⁾	$	172,800	$	108,831	$	178,911	$	108,831
Carrying value, including accrued interest⁽²⁾	$	134,564	$	84,765	$	132,985	$	84,765

The following table presents information about purchased credit impaired investments acquired during the ~~three~~six months ended ~~March 31,~~June 30, 2013 (dollars in thousands).

The following table presents activity for the accretable yield on purchased credit impaired securities for the three and six months ended ~~March 31,~~June 30, 2013 (dollars in thousands):

The following table presents the total gross unrealized losses for the ~~667~~1,394 and 567 fixed maturity and equity securities as of ~~March 31,~~June 30, 2013 and December 31, 2012, respectively, where the estimated fair value had declined and remained below amortized cost by the indicated amount (dollars in thousands):


	March 31, 2013				December 31, 2012				June 30, 2013				December 31, 2012
	Gross Unrealized Losses		% of Total		Gross Unrealized Losses		% of Total		Gross Unrealized Losses		% of Total		Gross Unrealized Losses		% of Total
Less than 20%	$	66,235		54.1 %	$	54,951		41.2 %	$	267,765		86.2%	$	54,951		41.2%
20% or more for less than six months		--		--		734		0.5		5,629		1.8		734		0.5
20% or more for six months or greater		56,297		45.9		77,873		58.3		37,340		12.0		77,873		58.3

Total	$	122,532		100.0 %	$	133,558		100.0 %	$	310,734		100.0%	$	133,558		100.0%

The Company’s determination of whether a decline in value is other-than-temporary includes analysis of the underlying credit and the extent and duration of a decline in value. The Company’s credit analysis of an investment includes determining whether the issuer is current on its contractual payments, evaluating whether it is probable that the Company will be able to collect all amounts due according to the contractual terms of the security and analyzing the overall ability of the Company to recover the amortized cost of the investment. The Company continues to consider declines in value as a potential indicator of credit deterioration. However, the Company believes that due to fluctuating market conditions and an extended period of economic uncertainty, the extent and duration of a decline in value have become less indicative of when

there has been credit deterioration with respect to a fixed maturity security since it may not have an impact on the ability of the issuer to service all scheduled payments and the Company’s evaluation of the recoverability of all contractual cash flows or the ability to recover an amount at least equal to amortized cost. In the Company’s impairment review process, the duration and severity of an unrealized loss position for equity securities are given greater weight and consideration given the lack of contractual cash flows or deferability features.

The following tables present the estimated fair values and gross unrealized losses, including other-than-temporary impairment losses reported in AOCI, for ~~667~~1,394 and 567 fixed maturity and equity securities that have estimated fair values below amortized cost as of ~~March 31,~~June 30, 2013 and December 31, 2012, respectively (dollars in thousands). These investments are presented by class and grade of security, as well as the length of time the related ~~market~~fair value has remained below amortized cost.


	Less than 12 months				12 months or greater				Total				Less than 12 months				12 months or greater				Total
			Gross				Gross				Gross
December 31, 2012:	Estimated		Unrealized		Estimated		Unrealized		Estimated		Unrealized
	Fair Value		Losses		Fair Value		Losses		Fair Value		Losses
June 30, 2013:													Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses
Investment grade securities:
Corporate securities	$	786,203	$	13,276	$	108,187	$	17,386	$	894,390	$	30,662	$	3,229,715	$	161,032	$	89,098	$	12,531	$	3,318,813	$	173,563
Canadian and Canadian provincial governments		12,349		174		--		--		12,349		174		138,843		9,162		—		—		138,843		9,162

Residential mortgage-backed securities		22,288		97		19,394		3,199		41,682		3,296		210,336		9,553		14,822		2,643		225,158		12,196

Asset-backed securities		59,119		449		96,179		9,508		155,298		9,957		220,912		4,719		51,673		5,567		272,585		10,286

Commercial mortgage-backed securities		89,507		797		29,181		7,974		118,688		8,771		227,712		9,172		18,893		6,455		246,605		15,627

U.S. government and agencies		7,272		24		--		--		7,272		24		191,973		2,344		4,037		109		196,010		2,453

State and political subdivisions		20,602		1,514		11,736		4,132		32,338		5,646		97,877		6,351		11,402		5,499		109,279		11,850

Other foreign government, supranational and foreign government-sponsored enterprises		244,817		1,953		7,435		761		252,252		2,714		657,957		19,787		5,698		721		663,655		20,508


Total investment grade securities		1,242,157		18,284		272,112		42,960		1,514,269		61,244		4,975,325		222,120		195,623		33,525		5,170,948		255,645


Non-investment grade securities:

Corporate securities		181,168		3,170		39,123		5,501		220,291		8,671		366,159		11,452		40,425		6,603		406,584		18,055

Residential mortgage-backed securities		15,199		80		2,633		347		17,832		427		53,715		1,007		2,359		565		56,074		1,572

Asset-backed securities		3,421		26		31,938		18,815		35,359		18,841		25,233		376		30,434		7,875		55,667		8,251

Commercial mortgage-backed securities		3,317		764		68,405		42,307		71,722		43,071		19,324		198		43,879		20,761		63,203		20,959

Other foreign government, supranational and foreign government-sponsored enterprises														952		113		—		—		952		113

Total non-investment grade securities		203,105		4,040		142,099		66,970		345,204		71,010		465,383		13,146		117,097		35,804		582,480		48,950

Total fixed maturity securities	$	1,445,262	$	22,324	$	414,211	$	109,930	$	1,859,473	$	132,254	$	5,440,708	$	235,266	$	312,720	$	69,329	$	5,753,428	$	304,595


Non-redeemable preferred stock	$	5,577	$	52	$	5,679	$	118	$	11,256	$	170	$	30,787	$	1,745	$	1	$	2	$	30,788	$	1,747

Other equity securities		85,374		1,134		--		--		85,374		1,134		69,881		4,392		—		—		69,881		4,392

Total equity securities	$	90,951	$	1,186	$	5,679	$	118	$	96,630	$	1,304	$	100,668	$	6,137	$	1	$	2	$	100,669	$	6,139


													Less than 12 months				12 months or greater				Total
December 31, 2012:													Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses
Investment grade securities:
Corporate securities													$	786,203	$	13,276	$	108,187	$	17,386	$	894,390	$	30,662
Canadian and Canadian provincial governments														12,349		174		—		—		12,349		174
Residential mortgage-backed securities														22,288		97		19,394		3,199		41,682		3,296
Asset-backed securities														59,119		449		96,179		9,508		155,298		9,957
Commercial mortgage-backed securities														89,507		797		29,181		7,974		118,688		8,771
U.S. government and agencies														7,272		24		—		—		7,272		24
State and political subdivisions														20,602		1,514		11,736		4,132		32,338		5,646
Other foreign government, supranational and foreign government-sponsored enterprises														244,817		1,953		7,435		761		252,252		2,714

Total investment grade securities														1,242,157		18,284		272,112		42,960		1,514,269		61,244

Non-investment grade securities:
Corporate securities														181,168		3,170		39,123		5,501		220,291		8,671
Residential mortgage-backed securities														15,199		80		2,633		347		17,832		427
Asset-backed securities														3,421		26		31,938		18,815		35,359		18,841
Commercial mortgage-backed securities														3,317		764		68,405		42,307		71,722		43,071

Total non-investment grade securities														203,105		4,040		142,099		66,970		345,204		71,010

Total fixed maturity securities													$	1,445,262	$	22,324	$	414,211	$	109,930	$	1,859,473	$	132,254

Non-redeemable preferred stock													$	5,577	$	52	$	5,679	$	118	$	11,256	$	170
Other equity securities														85,374		1,134		—		—		85,374		1,134

Total equity securities													$	90,951	$	1,186	$	5,679	$	118	$	96,630	$	1,304

As of ~~March 31,~~June 30, 2013, the Company does not intend to sell these fixed maturity securities and does not believe it is more likely than not that it will be required to sell these fixed maturity securities before the recovery of the fair value up to the current amortized cost of the investment, which may be maturity. As of ~~March 31,~~June 30, 2013, the Company has the ability and intent to hold the equity securities until the recovery of the fair value up to the current cost of the investment. However, unforeseen facts and circumstances may cause the Company to sell fixed maturity and equity securities in the ordinary course of managing its portfolio to meet certain diversification, credit quality, asset-liability management and liquidity guidelines.

Unrealized losses on non-investment grade securities are principally related to asset and mortgage-backed securities and were the result of wider credit spreads resulting from higher risk premiums since the time of initial purchase, largely due to macroeconomic conditions and credit market deterioration, including the impact of lower real estate valuations. As of ~~March 31,~~June 30, 2013 and December 31, 2012, approximately ~~$46.3~~$29.2 million and $61.5 million, respectively, of gross unrealized losses greater than 12 months was associated with non-investment grade asset and mortgage-backed securities. This class of securities was evaluated based on actual and projected collateral losses relative to the securities’ positions in the respective securitization trusts and security specific expectations of cash flows. This evaluation also takes into consideration credit enhancement, measured in terms of (i) subordination from other classes of securities in the trust that are contractually obligated to absorb losses before the class of security the Company owns, and (ii) the expected impact of other structural features embedded in the securitization trust beneficial to the class of securities the Company owns, such as overcollateralization and excess spread.

Major categories of investment income, net of related expenses, consist of the following (dollars in thousands):


	Three months ended March 31,				Three months ended June 30,						Six months ended June 30,
	2013		2012		2013			2012			2013			2012
Fixed maturity securities available-for-sale	$	239,244	$	191,418	$	240,590		$	193,388		$	479,834		$	384,806
Mortgage loans on real estate		28,243		14,965		28,362			16,000			56,605			30,966
Policy loans		17,910		16,783		15,450			16,334			33,360			33,117
Funds withheld at interest		137,259		115,014		159,212			62,992			296,471			178,006
Short-term investments		813		988		422			781			1,235			1,769
Investment receivable						—			36,752			—			36,752
Other invested assets		13,922		11,322		13,379			11,356			27,301			22,679

Investment revenue		437,391		350,490		457,415			337,603			894,806			688,095
Investment expense		12,260		9,550		(13,181	)		(9,269	)		(25,441	)		(18,821	)

Investment income, net of related expenses	$	425,131	$	340,940	$	444,234		$	328,334		$	869,365		$	669,274

Investment related gains (losses), net consist of the following (dollars in thousands):


	Three months ended March 31,				Three months ended June 30,						Six months ended June 30,
	2013		2012		2013			2012			2013			2012
Fixed maturities and equity securities available for sale:
Other-than-temporary impairment losses on fixed maturities	$	(202)	$	(7,607)	$	(9,803	)	$	(1,959	)	$	(10,005	)	$	(9,566	)
Portion of loss recognized in accumulated other comprehensive income (before taxes)		--		(7,221)		(306	)		162			(306	)		(7,059	)

Net other-than-temporary impairment losses on fixed maturities recognized in earnings		(202)		(14,828)		(10,109	)		(1,797	)		(10,311	)		(16,625	)
Impairment losses on equity securities		--		(839)		—			(2,186	)		—			(3,025	)
Gain on investment activity		21,680		22,312		26,845			26,593			48,525			48,905
Loss on investment activity		(11,212)		(7,504)		(6,760	)		(8,918	)		(17,972	)		(16,422	)
Other impairment losses and change in mortgage loan provision		(1,626)		(5,843)		125			1,762			(1,501	)		(4,081	)
Derivatives and other, net		85,731		50,222		38,142			8,347			123,873			58,569

Total investment related gains (losses), net	$	94,371	$	43,520	$	48,243		$	23,801		$	142,614		$	67,321

The net other-than-temporary impairment losses on fixed maturity securities recognized in earnings were ~~$0.2~~$10.1 million and ~~$14.8~~$1.8 million infor the three months ended June 30, 2013 and 2012, and $10.3 million and $16.6 million for the first ~~three~~six months of 2013 and 2012, respectively. The other-than-temporary impairment losses on fixed maturity securities in the second quarter and first six months of 2013 were primarily due to the decision to sell certain subordinated commercial mortgage-backed securities. The other-than-temporary impairments in the first ~~three~~six months of 2012 were primarily due to a decline in value of structured securities with exposure to commercial mortgages and general credit deterioration in select corporate and foreign securities. The increase in derivatives and other in 2013 is primarily due to an increase in the fair value of ~~free-standing~~embedded derivatives.

During the three months ended ~~March 31,~~June 30, 2013 and 2012, the Company sold fixed maturity and equity securities with fair values of ~~$204.3~~$257.6 million and ~~$248.1~~$153.5 million at losses of ~~$11.2~~$6.8 million and ~~$7.5~~$8.9 million, respectively. During the six months ended June 30, 2013 and 2012, the Company sold fixed maturity and equity securities with fair values of $461.9 million and $401.6 million at losses of $18.0 million and $16.4 million, respectively. The Company generally does not engage in short-term buying and selling of securities.

The Company participates in a securities borrowing program whereby securities, which are not reflected on the Company’s condensed consolidated balance sheets, are borrowed from a third party. The Company is required to maintain a minimum of 100% of the ~~market~~fair value of the borrowed securities as collateral, which consists of rights to reinsurance treaty cash flows. The Company had borrowed securities with an amortized cost of $87.5 million as of ~~March 31,~~June 30, 2013 and December 31, 2012, which was equal to the ~~market~~fair value in both periods. The borrowed securities are used to provide collateral under an affiliated reinsurance transaction.

The Company also participates in a repurchase/reverse repurchase program in which securities, reflected as investments on the Company’s condensed consolidated balance sheets, are pledged to a third party. In return, the Company receives securities from the third party with an estimated fair value equal to a minimum of 100% of the securities pledged. The securities received are not reflected on the Company’s condensed consolidated balance sheets. As of ~~March 31,~~June 30, 2013 the Company had pledged securities with an amortized cost of ~~$284.5~~$292.1 million and an estimated fair value of ~~$309.7~~$307.7 million, and in return the Company received securities with an estimated fair value of ~~$343.2~~$338.0 million. As of December 31, 2012 the Company had pledged securities with an amortized cost of $290.2 million and an estimated fair value of $305.9 million, and in return the Company received securities with an estimated fair value of $342.0 million.

Mortgage loans represented approximately 7.5% and 7.0% of the Company’s total investments as of ~~March 31,~~June 30, 2013 and December 31, 2012. The Company makes mortgage loans on income producing properties, such as apartments, retail and office buildings, and light industrial facilities. Loan-to-value ratios at the time of loan approval are 75% or less. The distribution of mortgage loans, gross of valuation allowances, by property type is as follows as of ~~March 31,~~June 30, 2013 and December 31, 2012 (dollars in thousands):


	March 31, 2013				December 31, 2012				June 30, 2013				December 31, 2012
	Recorded		Percentage		Recorded		Percentage		Recorded Investment		% of Total		Recorded Investment		% of Total
Property type:	Investment		of Total		Investment		of Total
Apartment	$	230,762		9.9 %	$	229,266		9.9 %	$	220,117		9.2%	$	229,266		9.9%
Retail		715,036		30.6		669,958		29.0		747,282		31.3		669,958		29.0
Office building		836,332		35.8		825,406		35.7		841,842		35.3		825,406		35.7
Industrial		426,011		18.2		455,682		19.7		450,140		18.9		455,682		19.7
Other commercial		126,974		5.5		131,855		5.7		125,768		5.3		131,855		5.7

Total	$	2,335,115		100.0 %	$	2,312,167		100.0 %	$	2,385,149		100.0%	$	2,312,167		100.0%

As of ~~March 31,~~June 30, 2013 and December 31, 2012, the Company’s mortgage loans, gross of valuation allowances, were distributed throughout the United States as follows (dollars in thousands):


	March 31, 2013				December 31, 2012
	Recorded		Percentage		Recorded		Percentage		June 30, 2013				December 31, 2012
	Investment		of Total		Investment		of Total		Recorded Investment		% of Total		Recorded Investment		% of Total
Pacific	$	597,540		25.6 %	$	593,589		25.7 %	$	636,084		26.7%	$	593,589		25.7%
South Atlantic		483,398		20.7		477,068		20.5		507,010		21.3		477,068		20.5
Mountain		251,406		10.8		233,174		10.1		257,130		10.8		233,174		10.1
Middle Atlantic		286,314		12.3		300,475		13.0		276,799		11.6		300,475		13.0
West North Central		160,203		6.8		168,063		7.3		174,764		7.3		168,063		7.3
East North Central		243,202		10.4		224,122		9.7		222,991		9.2		224,122		9.7
West South Central		160,117		6.9		161,451		7.0		158,666		6.7		161,451		7.0
East South Central		62,323		2.7		62,789		2.7		61,966		2.6		62,789		2.7
New England		90,612		3.8		91,436		4.0		89,739		3.8		91,436		4.0

Total	$	2,335,115		100.0 %	$	2,312,167		100.0 %	$	2,385,149		100.0%	$	2,312,167		100.0%

The maturities of the mortgage loans, gross of valuation allowances, as of ~~March 31,~~June 30, 2013 and December 31, 2012 are as follows (dollars in thousands):


					June 30, 2013				December 31, 2012
	March 31, 2013		December 31, 2012		Recorded Investment		% of Total		Recorded Investment		% of Total
Due within five years	$	1,157,373	$	1,187,387	$	1,066,678		44.7%	$	1,187,387		51.3%
Due after five years through ten years		832,292		776,655		875,596		36.7		776,655		33.6
Due after ten years		345,450		348,125		442,875		18.6		348,125		15.1

Total	$	2,335,115	$	2,312,167	$	2,385,149		100.0%	$	2,312,167		100.0%

Information regarding the Company’s credit quality indicators for its recorded investment in mortgage loans, gross of valuation allowances, as of ~~March 31,~~June 30, 2013 and December 31, 2012 is as follows (dollars in thousands):


					June 30, 2013				December 31, 2012
Internal credit risk grade:	March 31, 2013		December 31, 2012		Recorded Investment		% of Total		Recorded Investment		% of Total
High investment grade	$	1,473,018	$	1,235,605	$	1,475,089		61.8%	$	1,235,605		53.5%
Investment grade		622,794		834,494		694,476		29.1		834,494		36.1
Average		147,650		132,607		127,967		5.4		132,607		5.7
Watch list		62,679		76,463		53,831		2.3		76,463		3.3
In or near default		28,974		32,998		33,786		1.4		32,998		1.4

Total	$	2,335,115	$	2,312,167	$	2,385,149		100.0%	$	2,312,167		100.0%

The age analysis of the Company’s past due recorded investment in mortgage loans, gross of valuation allowances, as of ~~March 31,~~June 30, 2013 and December 31, 2012 is as follows (dollars in thousands):

       March 31, 2013           December 31, 2012

31-60 days past due
   $   6,594    $   7,504

61-90 days past due
   --       --

Greater than 90 days
   8,342    16,886




Total past due
   14,936    24,390

Current
   2,320,179    2,287,777




Total
   $ 2,335,115    $ 2,312,167

The following table presents the recorded investment in mortgage loans, by method of evaluation of credit loss, and the related valuation allowances, by type of credit loss, at (dollars in thousands):


	March 31, 2013		December 31, 2012		June 30, 2013		December 31, 2012
Mortgage loans:
Evaluated individually for credit losses	$	41,167	$	39,956	$	37,617	$	39,956
Evaluated collectively for credit losses		2,293,948		2,272,211		2,347,532		2,272,211

Mortgage loans, gross of valuation allowances		2,335,115		2,312,167		2,385,149		2,312,167


Valuation allowances:
Specific for credit losses		6,008		6,980		4,738		6,980
Non-specifically identified credit losses		3,916		4,600		3,165		4,600

Total valuation allowances		9,924		11,580		7,903		11,580

Mortgage loans, net of valuation allowances	$	2,325,191	$	2,300,587	$	2,377,246	$	2,300,587

Information regarding the Company’s loan valuation allowances for mortgage loans for the three and six months ended ~~March 31,~~June 30, 2013 and 2012 is as follows (dollars in thousands):


	Three Months Ended March 31,				Three months ended June 30,
	2013		2012		2013			2012
Balance, beginning of period	$	11,580	$	11,793	$	9,924		$	14,650
Charge-offs		(852)		(2,193)		(1,296	)		(1,876	)
Provision (release)		(804)		5,050		(725	)		(1,763	)

Balance, end of period	$	9,924	$	14,650	$	7,903		$	11,011


					Six months ended June 30,
					2013			2012
Balance, beginning of period					$	11,580		$	11,793
Charge-offs						(2,148	)		(4,069	)
Provision (release)						(1,529	)		3,287

Balance, end of period					$	7,903		$	11,011

Information regarding the portion of the Company’s mortgage loans that were impaired as of ~~March 31,~~June 30, 2013 and December 31, 2012 is as follows (dollars in thousands):


		Unpaid Principal Balance		Recorded Investment		Related Allowance		Carrying Value			Unpaid Principal Balance		Recorded Investment		Related Allowance		Carrying Value
March 31, 2013:
June 30, 2013:
Impaired mortgage loans with no valuation allowance recorded		$	14,802	$	14,259	$	--	$	14,259		$	16,714	$	16,104	$	—	$	16,104
Impaired mortgage loans with valuation allowance recorded			26,975		26,908		6,008		20,900			21,582		21,513		4,738		16,775

Total impaired mortgage loans		$	41,777	$	41,167	$	6,008	$	35,159		$	38,296	$	37,617	$	4,738	$	32,879


December 31, 2012:
Impaired mortgage loans with no valuation allowance recorded		$	13,039	$	12,496	$	--	$	12,496		$	13,039	$	12,496	$	—	$	12,496
Impaired mortgage loans with valuation allowance recorded			27,527		27,460		6,980		20,480			27,527		27,460		6,980		20,480

Total impaired mortgage loans		$	40,566	$	39,956	$	6,980	$	32,976		$	40,566	$	39,956	$	6,980	$	32,976

The Company’s average investment in impaired mortgage loans and the related interest income are reflected in the table below for the periods indicated (dollars in thousands):	The Company’s average investment in impaired mortgage loans and the related interest income are reflected in the table below for the periods indicated (dollars in thousands):									The Company’s average investment in impaired mortgage loans and the related interest income are reflected in the table below for the periods indicated (dollars in thousands):
		Three Months Ended									Three months ended June 30,
		March 31, 2013				March 31, 2012					2013				2012
		Average Investment⁽¹⁾		Interest Income		Average Investment⁽¹⁾		Interest Income			Average Investment⁽¹⁾		Interest Income		Average Investment⁽¹⁾		Interest Income
Impaired mortgage loans with no valuation allowance recorded		$	13,378	$	135	$	21,571	$	169		$	15,181	$	49	$	10,585	$	28
Impaired mortgage loans with valuation allowance recorded			27,184		240		37,308		308			24,211		294		41,747		410

Total		$	40,562	$	375	$	58,879	$	477		$	39,392	$	343	$	52,332	$	438
							��

											Six months ended June 30,
											2013				2012
											Average Investment⁽¹⁾		Interest Income		Average Investment⁽¹⁾		Interest Income
Impaired mortgage loans with no valuation allowance recorded											$	14,286	$	184	$	17,555	$	197
Impaired mortgage loans with valuation allowance recorded												25,294		534		37,634		718

Total											$	39,580	$	718	$	55,189	$	915

(1) Average recorded investment represents the average loan balances as of the beginning of period and all subsequent quarterly end of period balances.

The Company did not acquire any impaired mortgage loans during the ~~three~~six months ended ~~March 31,~~June 30, 2013 and 2012. The Company had ~~$8.3~~$7.9 million and $16.9 million of mortgage loans, gross of valuation allowances, that were on nonaccrual status at ~~March 31,~~June 30, 2013 and December 31, 2012, respectively.

Policy loans comprised approximately ~~3.8% and~~ 3.9% of the Company’s total investments as of ~~March 31,~~both June 30, 2013 and December 31, 2012, ~~respectively,~~ substantially all of which are associated with one client. These policy loans present no credit risk because the amount of the loan cannot exceed the obligation due to the ceding company upon the death of the insured or surrender of the underlying policy. The provisions of the treaties in force and the underlying policies determine the policy loan interest rates. As policy loans represent premature distributions of policy liabilities, they have the effect of reducing future disintermediation risk. In addition, the Company earns a spread between the interest rate earned on policy loans and the interest rate credited to corresponding liabilities.

Funds withheld at interest comprised approximately ~~17.3%~~18.2% and 17.0% of the Company’s total investments as of ~~March 31,~~June 30, 2013 and December 31, 2012, respectively. As of ~~March 31,~~June 30, 2013 and December 31, 2012, approximately ~~70.2%~~70.8% and 69.7%, respectively, of the Company’s funds withheld at interest balance, net of embedded derivatives, was associated with one client. For reinsurance agreements written on a modified coinsurance basis and certain agreements written on a coinsurance funds withheld basis, assets equal to the net statutory reserves are withheld and legally owned and managed by the ceding company and are reflected as funds withheld at interest on the Company’s condensed consolidated balance sheets. In the event of a ceding company’s insolvency, the Company would need to assert a claim on the assets supporting its reserve liabilities. However, the risk of loss to the Company is mitigated by its ability to offset amounts it owes the ceding company for claims or allowances with amounts owed to the Company from the ceding company. The Company is subject to the investment performance on the withheld assets, although it does not directly control them. These assets are primarily fixed maturity investment securities and pose risks similar to the fixed maturity securities the Company owns. To mitigate this risk, the Company helps set the investment guidelines followed by the ceding company and monitors compliance.

Other invested assets include equity securities, ~~collateral (included in other),~~ limited partnership interests, real estate joint ventures, structured loans, derivative contracts, Federal Home Loan Bank of Des Moines (“FHLB”) common stock (included in other), and real estate held-for-investment (included in other)~~, structured loans and derivative contracts.~~. Other invested assets represented approximately ~~3.4%~~3.3% and 3.5% of the Company’s total investments as of ~~March 31,~~June 30, 2013 and December 31, 2012, respectively. Carrying values of these assets as of ~~March 31,~~June 30, 2013 and December 31, 2012 are as follows (dollars in thousands):

Certain of the Company’s derivatives are subject to enforceable master netting arrangements and reported as a net asset or liability in the condensed consolidated balance sheets. The Company nets all derivatives that are subject to such arrangements.

The Company has elected to include all derivatives, except embedded derivatives, in the tables below, irrespective of whether they are subject to an enforceable master netting arrangement or a similar agreement. See “Securities Borrowing and Other” above for information regarding the Company’s securities borrowing and repurchase/reverse repurchase programs. See Note 5 – “Derivative Instruments” for information regarding the Company’s bifurcated embedded derivatives.

~~The following table provides information relating to the Company’s derivative instruments as of March 31, 2013 and December 31, 2012 (dollars in thousands):~~

            Gross Amounts Not
Offset in the Balance Sheet
      Gross Amounts    Net Amounts          Cash Collateral
      Gross Amounts       Offset in the    Presented in the    Financial    Pledged/
   Recognized       Balance Sheet          Balance Sheet            Instruments         Received       Net Amount
March 31, 2013:

Derivative assets
   $ 175,236    $ (23,475)       $ 151,761    $ (17,664)       $ (126,329)       $ 7,768
Derivative liabilities
   42,079    (23,475)       18,604    (14,118)       (6,250)       (1,764)
December 31, 2012:

Derivative assets
   $ 190,634    $ (22,426)       $ 168,208    $ (22,458)       $ (136,414)       $ 9,336
Derivative liabilities
   54,078    (22,426)       31,652    (1,565)       (27,867)       2,220


	June 30, 2013		December 31, 2012
Equity securities	$	160,339	$	222,700
Limited partnerships and real estate joint ventures		423,790		356,419
Structured loans		245,734		306,497
Derivatives		118,791		168,208
Other		87,155		105,719

Total other invested assets	$	1,035,809	$	1,159,543

Derivatives, except embedded derivatives, are carried on the Company’s condensed consolidated balance sheets in other invested assets or other liabilities, at fair value. Embedded derivative liabilities on modified coinsurance or funds withheld arrangements are included on the condensed consolidated balance sheets with the host contract in funds withheld at interest, at fair value. Embedded derivative liabilities on indexed annuity and variable annuity products are included on the condensed consolidated balance sheets with the host contract in interest-sensitive contract liabilities, at fair value. Embedded derivative assets are included on the condensed consolidated balance sheets in reinsurance ceded receivables. The following table presents the notional amounts and gross fair value of derivative instruments prior to taking into account the netting effects of master netting agreements as of ~~March 31,~~June 30, 2013 and December 31, 2012 (dollars in thousands):


	March 31, 2013						December 31, 2012						June 30, 2013								December 31, 2012
	Notional		Carrying Value/Fair Value				Notional		Carrying Value/Fair Value				Notional Amount			Carrying Value/Fair Value					Notional Amount			Carrying Value/Fair Value
	Amount		Assets		Liabilities		Amount		Assets		Liabilities				Assets			Liabilities			Notional Amount		Assets			Liabilities
Derivatives not designated as hedging instruments:													Notional Amount
Interest rate swaps	$	1,566,403	$	99,860	$	15,642	$	2,195,059	$	123,085	$	17,867	$	1,531,811		$	54,742		$	16,971	$	2,195,059		$	123,085		$	17,867
Interest rate options		240,000		16,054		--		--		--		--		240,000			8,073			—		—			—			—
Financial futures		113,046		--		--		127,877		--		--		110,328			—			—		127,877			—			—
Foreign currency forwards		70,000		--		7,014		74,400		1,017		2,105		83,387			148			9,484		74,400			1,017			2,105
Consumer price index swaps		85,332		945		--		85,135		1,446		--		74,840			234			257		85,135			1,446			—
Credit default swaps		716,700		2,160		5,431		714,000		2,228		5,922		709,700			3,975			6,632		714,000			2,228			5,922
Equity options		812,494		54,791		--		696,776		62,514		--		727,641			61,102			—		696,776			62,514			—
Synthetic guaranteed investment contracts		3,185,035		--		--		2,018,073		--		--		3,469,027			—			—		2,018,073			—			—
Embedded derivatives in:
Modified coinsurance or funds withheld arrangements		--		--		156,189		--		--		243,177		—			—			108,473		—			—			243,177
Indexed annuity products		--		--		769,685		--		--		740,256		—			—			793,586		—			—			740,256
Variable annuity products		--		--		120,791		--		--		172,105		—			—			84,982		—			—			172,105

Total non-hedging derivatives		6,789,010		173,810		1,074,752		5,911,320		190,290		1,181,432		6,946,734			128,274			1,020,385		5,911,320			190,290			1,181,432


Derivatives designated as hedging instruments:
Interest rate swaps		55,098		254		2,273		57,275		344		786		50,349			—			5,058		57,275			344			786
Foreign currency swaps		632,921		1,172		11,719		629,512		--		27,398		729,890			18,298			2,498		629,512			—			27,398

Total hedging derivatives		688,019		1,426		13,992		686,787		344		28,184		780,239			18,298			7,556		686,787			344			28,184

Total derivatives	$	7,477,029	$	175,236	$	1,088,744	$	6,598,107	$	190,634	$	1,209,616	$	7,726,973		$	146,572		$	1,027,941	$	6,598,107		$	190,634		$	1,209,616

The Company has elected to include all derivatives, except embedded derivatives, in the tables below, irrespective of whether they are subject to an enforceable master netting arrangement or a similar agreement. See Note 4 – “Investments” for information regarding the Company’s securities borrowing and repurchase/reverse repurchase programs. See “Embedded Derivatives” below for information regarding the Company’s bifurcated embedded derivatives.

The following table provides information relating to the Company’s derivative instruments as of June 30, 2013 and December 31, 2012 (dollars in thousands):

The Company does not enter into derivative instruments for speculative purposes. As discussed below under “Non-qualifying Derivatives and Derivatives for Purposes Other Than Hedging,” the Company uses various derivative instruments for risk management purposes that either do not qualify or have not been qualified for hedge accounting treatment, including derivatives used to economically hedge changes in the fair value of liabilities associated with the reinsurance of variable annuities with guaranteed living benefits. As of ~~March 31,~~June 30, 2013 and December 31, 2012, the Company held interest rate swaps that were designated and qualified as cash flow hedges of interest rate risk. As of ~~March 31,~~June 30, 2013 and December 31, 2012, the Company held foreign currency swaps that were designated and qualified as hedges of a portion of its net investment in its foreign operations. As of ~~March 31,~~June 30, 2013 and December 31, 2012, the Company also had derivative instruments that were not designated as hedging instruments. See Note 2 – “Summary of Significant Accounting Policies” of the Company’s 2012 Annual Report for a detailed discussion of the accounting treatment for derivative instruments,

including embedded derivatives. Derivative instruments are carried at fair value and generally require an insignificant amount of cash at inception of the contracts.

The Company designates and accounts for certain interest rate swaps, in which the cash flows are denominated in different currencies, commonly referred to as cross-currency swaps, as cash flow hedges when they meet the requirements of the general accounting principles forDerivatives and Hedging.

The following table presents the components of AOCI, before income tax, and the condensed consolidated income statement classification where the gain or loss is recognized related to cash flow hedges for the three and six months ended ~~March 31,~~June 30, 2013 and 2012 (dollars in thousands):


	Three months ended March 31,				Three months ended June 30,
	2013		2012		2013			2012
Accumulated other comprehensive income (loss), balance beginning of period	$	403	$	(828)	$	1,961		$	(862	)
Gains (losses) deferred in other comprehensive income (loss) on the effective portion of cash flow hedges		1,863		323		(6,797	)		464
Amounts reclassified to investment income		(305)		(357)		(201	)		(321	)

Accumulated other comprehensive income (loss), balance end of period					$	(5,037	)	$	(719	)


					Six months ended June 30,
					2013			2012
Accumulated other comprehensive income (loss), balance beginning of period					$	403		$	(828	)
Gains (losses) deferred in other comprehensive income (loss) on the effective portion of cash flow hedges						(4,934	)		787
Amounts reclassified to investment income						(506	)		(678	)

Accumulated other comprehensive income (loss), balance end of period	$	1,961	$	(862)	$	(5,037	)	$	(719	)

As of ~~March 31,~~June 30, 2013, the before-tax deferred net gains on derivative instruments recorded in AOCI that are expected to be reclassified to earnings during the next twelve months are ~~$0.8~~$0.7 million. This expectation is based on the anticipated interest payments on hedged investments in fixed maturity securities that will occur over the next twelve months, at which time the Company will recognize the deferred net gains (losses) as an adjustment to investment income over the term of the investment cash flows. There were no hedged forecasted transactions, other than the receipt or payment of variable interest payments on existing financial instruments, for the three and six months ended ~~March 31,~~June 30, 2013 and 2012.

The following table presents the effects of derivatives in cash flow hedging relationships on the condensed consolidated statements of income and AOCI for the three and six months ended ~~March 31,~~June 30, 2013 and 2012 (dollars in thousands):


Derivatives in Cash Flow Hedging Relationships	Amount of Gains (Losses) Deferred in AOCI on Derivatives		Amount and Location of Gains (Losses) Reclassified from AOCI into Income (Loss)				Amount and Location of Gains (Losses) Recognized in Income (Loss) on Derivatives				Amount of Gains (Losses) Deferred in AOCI on Derivatives			Amount and Location of Gains (Losses) Reclassified from AOCI into Income (Loss)				Amount and Location of Gains (Losses) Recognized in Income (Loss) on Derivatives
	(Effective Portion)		(Effective Portion)				(Ineffective Portion and Amounts Excluded from Effectiveness Testing)
			Investment Related Gains (Losses)		Investment Income		Investment Related Gains (Losses)		Investment Income		(Effective Portion)			(Effective Portion)				(Ineffective Portion and Amounts Excluded from Effectiveness Testing)
For the three months ended March 31, 2013:

														Investment Related Gains (Losses)		Investment Income		Investment Related Gains (Losses)		Investment Income

For the three months ended June 30, 2013:
Interest rate swaps	$	1,863	$	--	$	305	$	(17)	$	--	$	(6,797	)	$	—	$	201	$	31	$	—

For the three months ended March 31, 2012:
For the three months ended June 30, 2012:
Interest rate swaps	$	323	$	--	$	357	$	(24)	$	--	$	464		$	—	$	321	$	27	$	—
For the six months ended June 30, 2013:
Interest rate swaps											$	(4,934	)	$	—	$	506	$	14	$	—
For the six months ended June 30, 2012:
Interest rate swaps											$	787		$	—	$	678	$	3	$	—

The Company uses foreign currency swaps to hedge a portion of its net investment in certain foreign operations against adverse movements in exchange rates. The following table illustrates the Company’s net investments in foreign operations (“NIFO”) hedges for the three and six months ended ~~March 31,~~June 30, 2013 and 2012 (dollars in thousands):


	Derivative Gains (Losses) Deferred in AOCI					Derivative Gains (Losses) Deferred in AOCI
	For the three months ended March 31,					For the three months ended June 30,				For the six months ended June 30,
Type of NIFO Hedge^{(1) (2)}	2013		2012			2013		2012		2013		2012

Foreign currency swaps	$	10,922	$	(10,645	)	$	23,913	$	6,642	$	34,835	$	(4,003	)

The cumulative foreign currency translation ~~loss~~gain (loss) recorded in AOCI related to these hedges was ~~$5.5~~$18.4 million and ~~$16.4~~$(16.4) million at ~~March 31,~~June 30, 2013 and December 31, 2012, respectively. If a foreign operation was sold or substantially liquidated, the amounts in AOCI would be reclassified to the condensed consolidated statements of income. A pro rata portion would be reclassified upon partial sale of a foreign operation.

The Company uses various derivative instruments for risk management purposes that either do not qualify or have not been qualified for hedge accounting treatment, including derivatives used to economically hedge changes in the fair value of liabilities associated with the reinsurance of variable annuities with guaranteed living benefits. The gain or loss related to the change in fair value for these derivative instruments is recognized in investment related gains (losses), in the condensed consolidated statements of income, except where otherwise noted. ~~For the three months ended March 31, 2013 and 2012, the~~The Company recognized investment related ~~losses~~gains (losses) of ~~$60.4~~$52.4 million and ~~$93.3~~$82.1 million, for the three months, and $(112.8) million and $(11.3) million for the six months ended June 30, 2013 and 2012, respectively, related to derivatives (not including embedded derivatives) that do not qualify or have not been qualified for hedge accounting.

A summary of the effect of non-hedging derivatives, including embedded derivatives, on the Company’s income statement for the three and six months ended ~~March 31,~~June 30, 2013 and 2012 is as follows (dollars in thousands):


		Gain (Loss) for the Three Months Ended March 31,					Gain (Loss) for the Three Months Ended June 30,
Type of Non-hedging Derivative	Income Statement Location of Gain (Loss)	2013		2012		Income Statement Location of Gain (Loss)	2013			2012
Interest rate swaps	Investment related gains (losses), net	$	(22,265)	$	(47,352)	Investment related gains (losses), net	$	(38,415	)	$	73,342
Interest rate options	Investment related gains (losses), net		1,982		--	Investment related gains (losses), net		(7,981	)		—
Financial futures	Investment related gains (losses), net		(6,881)		(17,409)	Investment related gains (losses), net		714			11,074
Foreign currency forwards	Investment related gains (losses), net		(5,659)		(1,608)	Investment related gains (losses), net		(2,958	)		516
CPI swaps	Investment related gains (losses), net		(871)		(802)	Investment related gains (losses), net		(1,117	)		(1,431	)
Credit default swaps	Investment related gains (losses), net		3,904		11,813	Investment related gains (losses), net		2,427			(4,795	)
Equity options	Investment related gains (losses), net		(30,623)		(37,983)	Investment related gains (losses), net		(5,049	)		3,367
Embedded derivatives in:
Modco or funds withheld arrangements	Investment related gains (losses), net		90,257		(9,428)	Investment related gains (losses), net		47,717			(4,453	)
Indexed annuity products	Policy acquisition costs and other insurance expenses		--		(998)	Policy acquisition costs and other insurance expenses		—			859
Indexed annuity products	Interest credited		(32,996)		(18,741)	Interest credited		(28,019	)		26,279
Variable annuity products	Investment related gains (losses), net		51,314		146,375	Investment related gains (losses), net		35,809			(74,929	)

Total non-hedging derivatives		$	48,162	$	23,867		$	3,128		$	29,829


							Gain (Loss) for the Six Months Ended June 30,
Type of Non-hedging Derivative						Income Statement Location of Gain (Loss)	2013			2012
Interest rate swaps						Investment related gains (losses), net	$	(60,679	)	$	25,990
Interest rate options						Investment related gains (losses), net		(5,998	)		—
Financial futures						Investment related gains (losses), net		(6,167	)		(6,335	)
Foreign currency forwards						Investment related gains (losses), net		(8,617	)		(1,093	)
CPI swaps						Investment related gains (losses), net		(1,988	)		(2,233	)
Credit default swaps						Investment related gains (losses), net		6,332			7,019
Equity options						Investment related gains (losses), net		(35,672	)		(34,616	)
Embedded derivatives in:
Modco or funds withheld arrangements						Investment related gains (losses), net		137,974			(13,881	)
Indexed annuity products						Policy acquisition costs and other insurance expenses		—			(139	)
Indexed annuity products						Interest credited		(61,015	)		7,538
Variable annuity products						Investment related gains (losses), net		87,123			71,446

Total non-hedging derivatives							$	51,293		$	53,696

Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). With an interest rate swap, the Company agrees with another party to exchange, at specified intervals, the difference between two rates, which can be either fixed-rate or floating-rate interest amounts, tied to an agreed-upon notional principal amount. These transactions are executed pursuant to master agreements that provide for a single net payment or individual gross payments at each due date.

Interest rate options, commonly referred to as swaptions, are used by the Company primarily to hedge living benefit guarantees embedded in certain variable annuity products. A swaption, used to hedge against adverse changes in interest rates, is an option to enter into a swap with a forward starting effective date. The Company pays an upfront premium for the right to exercise this option in the future.

Exchange-traded equity futures are used primarily to economically hedge liabilities embedded in certain variable annuity products. With exchange-traded equity futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the relevant stock indices, and to post variation margin on a daily basis in an amount equal to the difference between the daily estimated fair values of those contracts. The Company enters into exchange-traded equity futures with regulated futures commission merchants that are members of the exchange.

Equity index options are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products. To hedge against adverse changes in equity indices volatility, the Company buys put options. The contracts are net settled in cash based on differentials in the indices at the time of exercise and the strike price.

Consumer price index (“CPI”) swaps are used by the Company primarily to economically hedge liabilities embedded in certain insurance products where value is directly affected by changes in a designated benchmark consumer price index. With a CPI swap transaction, the Company agrees with another party to exchange the actual amount of inflation realized over a specified period of time for a fixed amount of inflation determined at inception. These transactions are executed pursuant to master agreements that provide for a single net payment or individual gross payments to be made by the counterparty at each due date. Most of these swaps will require a single payment to be made by one counterparty at the maturity date of the swap.

Foreign currency swaps are used by the Company to reduce the risk from fluctuations in foreign currency exchange rates associated with its assets and liabilities denominated in foreign currencies. With a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another at a forward exchange rate calculated by reference to an agreed upon principal amount. The principal amount of each currency is exchanged at the termination of the currency swap by each party.

Foreign currency forwards are used by the Company to reduce the risk from fluctuations in foreign currency exchange rates associated with its assets and liabilities denominated in foreign currencies. With a foreign currency forward transaction, the Company agrees with another party to deliver a specified amount of an identified currency at a specified future date. The price is agreed upon at the time of the contract and payment for such a contract is made in a different currency at the specified future date.

The Company sells protection under single name credit default swaps and credit default swap index tranches to diversify its credit risk exposure in certain portfolios and, in combination with purchasing securities, to replicate characteristics of similar investments based on the credit quality and term of the credit default swap. Credit default triggers for indexed reference entities and single name reference entities are defined in the contracts. The Company’s maximum exposure to credit loss equals the notional value for credit default swaps. In the event of default for credit default swaps, the Company is typically required to pay the protection holder the full notional value less a recovery rate determined at auction.

The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of credit default swaps sold by the Company at ~~March 31,~~June 30, 2013 and December 31, 2012 (dollars in thousands):


													June 30, 2013							December 31, 2012
	March 31, 2013						December 31, 2012
Rating Agency Designation of Referenced Credit Obligations⁽¹⁾	Estimated Fair Value of Credit Default Swaps		Maximum Amount of Future Payments under Credit Default Swaps⁽²⁾		Weighted Average Years to Maturity⁽³⁾		Estimated Fair Value of Credit Default Swaps		Maximum Amount of Future Payments under Credit Default Swaps⁽²⁾		Weighted Average Years to Maturity⁽³⁾		Estimated Fair Value of Credit Default Swaps			Maximum Amount of Future Payments under Credit Default Swaps⁽²⁾		Weighted Average Years to Maturity⁽³⁾		Estimated Fair Value of Credit Default Swaps			Maximum Amount of Future Payments under Credit Default Swaps⁽²⁾		Weighted Average Years to Maturity⁽³⁾
AAA/AA-/A+/A/A-
Single name credit default swaps	$	(1,630)	$	124,500		5.7	$	(2,077)	$	124,500		5.9	$	(1,149	)	$	122,500		5.4	$	(2,077	)	$	124,500		5.9
Credit default swaps referencing indices		--		--		--		--		--		--		—			—		—		—			—		—

Subtotal		(1,630)		124,500		5.7		(2,077)		124,500		5.9		(1,149	)		122,500		5.4		(2,077	)		124,500		5.9


BBB+/BBB/BBB-
Single name credit default swaps		(2,030)		138,200		5.7		(2,345)		135,500		5.5		(3,821	)		133,200		5.6		(2,345	)		135,500		5.5
Credit default swaps referencing indices		565		430,000		4.7		937		430,000		5.0		2,551			430,000		4.5		937			430,000		5.0

Subtotal		(1,465)		568,200		5.0		(1,408)		565,500		5.1		(1,270	)		563,200		4.7		(1,408	)		565,500		5.1


BB+
Single name credit default swaps		(110)		6,000		4.2		(222)		6,000		4.5		(101	)		6,000		4.0		(222	)		6,000		4.5
Credit default swaps referencing indices		--		--		--		--		--		--		—			—		—		—			—		—

Subtotal		(110)		6,000		4.2		(222)		6,000		4.5		(101	)		6,000		4.0		(222	)		6,000		4.5


Total	$	(3,205)	$	698,700		5.1	$	(3,707)	$	696,000		5.2	$	(2,520	)	$	691,700		4.8	$	(3,707	)	$	696,000		5.2

The Company also purchases credit default swaps to reduce its risk against a drop in bond prices due to credit concerns of certain bond issuers. If a credit event, as defined by the contract, occurs, the Company is able to put the bond back to the counterparty at par.

The Company sells fee-based synthetic guaranteed investment contracts which include investment-only, stable value contracts, to retirement plans. The assets are owned by the trustees of such plans, who invest the assets under the terms of investment guidelines agreed to with the Company. The contracts contain a guarantee of a minimum rate of return on participant balances supported by the underlying assets, and a guarantee of liquidity to meet certain participant-initiated plan cash flow requirements. These contracts are accounted for as derivatives, recorded at fair value and classified as interest rate derivatives.

The Company has certain embedded derivatives which are required to be separated from their host contracts and reported as derivatives. Host contracts include reinsurance treaties structured on a modified coinsurance (“modco”) or funds withheld basis. Changes in fair values of embedded derivatives on modco or funds withheld treaties are net of ~~a decrease~~an increase (decrease) in investment related gains (losses), net of ~~$1.7~~$(0.4) million and ~~$63.5~~$6.3 million for the three months, and $(2.1) million and $(57.2) million for the six months ended ~~March 31,~~June 30, 2013 and 2012, respectively, associated with the Company’s own credit risk. Changes in fair values of embedded derivatives on variable annuity contracts are net of ~~a decrease~~an increase (decrease) in investment related gains (losses), net of ~~$11.9~~$(0.2) million and ~~$37.0~~$14.6 million for the three months, and $(4.9) million and $51.6 millionfor the six months ended ~~March 31,~~June 30, 2013 and 2012, respectively, associated with the Company’s own credit risk. Additionally, the Company reinsures equity-indexed annuity and variable annuity contracts with benefits that are considered embedded derivatives, including guaranteed minimum withdrawal benefits, guaranteed minimum accumulation benefits, and guaranteed minimum income benefits. The related gains (losses) and the effect on net income after amortization of deferred acquisition costs (“DAC”) and income taxes for the three and six months ended ~~March 31,~~June 30, 2013 and 2012 are reflected in the following table (dollars in thousands):


	Three months ended March 31,				Three months ended June 30,						Six months ended June 30,
	2013		2012		2013			2012			2013			2012
Embedded derivatives in modco or funds withheld arrangements included in investment related gains	$	90,257	$	(9,428)	$	47,717		$	(4,453	)	$	137,974		$	(13,881	)
After the associated amortization of DAC and taxes, the related amounts included in net income		21,624		1,933		13,911			(2,598	)		35,535			(665	)

Embedded derivatives in variable annuity contracts included in investment related gains		51,314		146,375		35,809			(74,929	)		87,123			71,446
After the associated amortization of DAC and taxes, the related amounts included in net income		12,192		15,082		29,082			(16,175	)		41,274			(1,093	)
Amounts related to embedded derivatives in equity-indexed annuities included in benefits and expenses		(32,996)		(19,739)		(28,019	)		27,138			(61,015	)		7,399
After the associated amortization of DAC and taxes, the related amounts included in net income		(29,550)		13,870		(30,845	)		15,378			(60,395	)		29,248

The Company manages its credit risk related to over-the-counter derivatives by entering into transactions with creditworthy counterparties, maintaining collateral arrangements and through the use of master agreements that provide for a single net payment to be made by one counterparty to another at each due date and upon termination. As exchange-traded futures are affected through regulated exchanges, and positions are marked to market on a daily basis, the Company has minimal exposure to credit-related losses in the event of nonperformance by counterparties.

The Company enters into various collateral arrangements, which require both the posting and accepting of collateral in connection with its derivative instruments. Collateral agreements contain attachment thresholds that may vary depending on the posting party’s ratings. Additionally, a decline in the Company’s or the counterparty’s credit ratings to specified levels could result in potential settlement of the derivative positions under the Company’s agreements with its counterparties. The Company also has exchange-traded futures, which require the maintenance of a margin account.

The Company’s credit exposure related to derivative contracts is generally limited to the fair value at the reporting date plus or minus any collateral posted or held by the Company. Information regarding the Company’s credit exposure related to its over-the-counter derivative contracts and margin account for exchange-traded futures at ~~March 31,~~June 30, 2013 and December 31, 2012 are reflected in the following table (dollars in thousands):


	March 31, 2013		December 31, 2012		June 30, 2013			December 31, 2012
Estimated fair value of derivatives in net asset position	$	133,157	$	136,558	$	105,672		$	136,558
Cash provided as collateral⁽¹⁾		6,250		27,867		6,950			27,867
Securities pledged to counterparties as collateral⁽²⁾		14,118		1,565		2,722			1,565
Cash pledged from counterparties as collateral⁽³⁾		(126,329)		(136,414)		(89,829	)		(136,414	)
Securities pledged from counterparties as collateral⁽⁴⁾		(17,664)		(22,458)		(17,010	)		(22,458	)

Net credit exposure	$	9,532	$	7,118	$	8,505		$	7,118


Margin account related to exchange-traded futures⁽⁵⁾	$	3,529	$	5,605	$	5,251		$	5,605

General accounting principles forFair Value Measurements and Disclosuresdefine fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. These principles also establish a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value and describes three levels of inputs that may be used to measure fair value:

When inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). Therefore, gains and losses for such assets and liabilities categorized within Level 3 may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).

Assets and liabilities measured at fair value on a recurring basis as of ~~March 31,~~June 30, 2013 and December 31, 2012 are summarized below (dollars in thousands):

March 31, 2013:       Fair Value Measurements Using:
       Total
        Level 1
       Level 2            Level 3
Assets:

Fixed maturity securities – available-for-sale:

Corporate securities
   $         12,441,501    $ 65,890    $         10,728,708    $         1,646,903
Canadian and Canadian provincial governments
   3,942,198    --       3,942,198    --
Residential mortgage-backed securities
   1,076,770    --       936,053    140,717
Asset-backed securities
   756,544    --       468,313    288,231
Commercial mortgage-backed securities
   1,698,144    --       1,522,850    175,294
U.S. government and agencies securities
   331,201    259,892    71,309    --
State and political subdivision securities
   313,097    --       270,458    42,639
Other foreign government supranational and foreign government-sponsored enterprises
   1,842,204    272,823    1,541,516    27,865








Total fixed maturity securities – available-for-sale
   22,401,659    598,605    19,481,405    2,321,649
Funds withheld at interest – embedded derivatives
   (156,189)       --       --       (156,189)
Cash equivalents
   367,876    367,876    --       --
Short-term investments
   157,281    118,621    16,659    22,001
Other invested assets:

Non-redeemable preferred stock
   84,111    73,446    10,665    --
Other equity securities
   136,554    136,554    --       --
Derivatives:

Interest rate swaps
   83,662    --       83,662    --
Interest rate options
   16,054    --       16,054    --
CPI swaps
   945    --       945    --
Credit default swaps
   (3,391)       --       (3,391)       --
Equity options
   54,351    --       54,351    --
Foreign currency swaps
   140    --       140    --
Collateral
   25,790    14,118    11,672    --
Other
   7,205    7,205    --       --








Total other invested assets
   405,421    231,323    174,098    --








Total
   $ 23,176,048    $ 1,316,425    $ 19,672,162    $ 2,187,461








Liabilities:

Interest sensitive contract liabilities – embedded derivatives
   $ 890,476    $ --       $ --       $ 890,476
Other liabilities:

Derivatives:

Interest rate swaps
   1,463    --       1,463    --
Foreign currency forwards
   7,014    --       7,014    --
Credit default swaps
   (120)       --       (120)       --
Equity options
   (440)       --       (440)       --
Foreign currency swaps
   10,687    --       10,687    --








Total
   $ 909,080    $ --       $ 18,604    $ 890,476


December 31, 2012:				Fair Value Measurements Using:									Fair Value Measurements Using:
	Total		Level 1			Level 2		Level 3		Total			Level 1		Level 2			Level 3
Assets:
Fixed maturity securities – available-for-sale:
Corporate securities	$	12,380,071	$		43,544	$	10,667,964	$	1,668,563	$	12,380,071		$	43,544	$	10,667,964		$	1,668,563
Canadian and Canadian provincial governments		4,049,334			--		4,049,334		--		4,049,334			—		4,049,334			—
Residential mortgage-backed securities		1,042,064			--		948,133		93,931		1,042,064			—		948,133			93,931
Asset-backed securities		691,555			--		459,164		232,391		691,555			—		459,164			232,391
Commercial mortgage-backed securities		1,698,903			--		1,531,897		167,006		1,698,903			—		1,531,897			167,006
U.S. government and agencies securities		265,190			192,780		67,872		4,538		265,190			192,780		67,872			4,538
State and political subdivision securities		302,498			--		259,286		43,212		302,498			—		259,286			43,212
Other foreign government, supranational and foreign government-sponsored enterprises		1,861,999			297,025		1,536,694		28,280		1,861,999			297,025		1,536,694			28,280

Total fixed maturity securities – available-for-sale		22,291,614			533,349		19,520,344		2,237,921		22,291,614			533,349		19,520,344			2,237,921
Funds withheld at interest – embedded derivatives		(243,177)			--		--		(243,177)		(243,177	)		—		—			(243,177	)
Cash equivalents		575,864			575,864		--		--		575,864			575,864		—			—
Short-term investments		239,131			178,923		38,177		22,031		239,131			178,923		38,177			22,031
Other invested assets:
Non-redeemable preferred stock		74,841			64,268		10,573		--		74,841			64,268		10,573			—
Other equity securities		147,859			147,859		--		--		147,859			147,859		—			—
Derivatives:
Interest rate swaps		104,972			--		104,972		--		104,972			—		104,972			—
Foreign currency forwards		1,017			--		1,017		--		1,017			—		1,017			—
CPI swaps		1,446			--		1,446		--		1,446			—		1,446			—
Credit default swaps		(1,741)			--		(1,741)		--		(1,741	)		—		(1,741	)		—
Equity options		62,514			--		62,514		--		62,514			—		62,514			—
Collateral		17,002			1,323		15,679		--		17,002			1,323		15,679			—
Other		11,951			11,951		--		--		11,951			11,951		—			—

Total other invested assets		419,861			225,401		194,460		--		419,861			225,401		194,460			—

Total	$	23,283,293	$		1,513,537	$	19,752,981	$	2,016,775	$	23,283,293		$	1,513,537	$	19,752,981		$	2,016,775


Liabilities:
Interest sensitive contract liabilities – embedded derivatives	$	912,361	$		--	$	--	$	912,361	$	912,361		$	—	$	—		$	912,361
Other liabilities:
Derivatives:
Interest rate swaps		196			--		196		--		196			—		196			—
Foreign currency forwards		2,105			--		2,105		--		2,105			—		2,105			—
Credit default swaps		1,953			--		1,953		--		1,953			—		1,953			—
Foreign currency swaps		27,398			--		27,398		--		27,398			—		27,398			—

Total	$	944,013	$		--	$	31,652	$	912,361	$	944,013		$	—	$	31,652		$	912,361

The Company may utilize information from third parties, such as pricing services and brokers, to assist in determining the fair value for certain assets and liabilities; however, management is ultimately responsible for all fair values presented in the Company’s condensed consolidated financial statements. This includes responsibility for monitoring the fair value process, ensuring objective and reliable valuation practices and pricing of financial instruments, and approving changes to valuation methodologies and pricing sources. The selection of the valuation technique(s) to apply considers the definition of an exit price and the nature of the asset or liability being valued and significant expertise and judgment is required.

The Company performs initial and ongoing analysis and review of the various techniques utilized in determining fair value to ensure that the valuation approaches utilized are appropriate and consistently applied, and that the various assumptions are reasonable. The Company also performs ongoing analysis and review of the information and prices received from third parties to ensure that the prices represent a reasonable estimate of the fair value and to monitor controls around pricing, which includes quantitative and qualitative analysis and is overseen by the Company’s investment and accounting personnel. Examples of procedures performed include, but are not limited to, review of pricing trends, comparison of a sample of executed prices of securities sold to the fair value estimates, comparison of fair value estimates to management’s knowledge of the current market, and ongoing confirmation that third party pricing services use, wherever possible, market-based parameters for valuation. In addition, the Company utilizes both internal and external cash flow models to analyze the reasonableness of fair values utilizing credit spread and other market assumptions, where appropriate. As a result of the analysis, if the Company determines there is a more appropriate fair value based upon the available market data, the price received from the third party is adjusted accordingly. The Company also determines if the inputs used in estimated fair values received from pricing services are observable by assessing whether these inputs can be corroborated by observable market data.

The fair value of embedded derivative liabilities, including those calculated by third parties, are monitored through the use of attribution reports to quantify the effect of underlying sources of fair value change, including capital market inputs based on policyholder account values, interest rates and short-term and long-term implied volatilities, from period to period. Actuarial assumptions are based on experience studies performed internally in combination with available industry information and are reviewed on a periodic basis, at least annually.

For assets and liabilities reported at fair value, the Company utilizes when available, fair values based on quoted prices in active markets that are regularly and readily obtainable. Generally, these are very liquid investments and the valuation does not require management judgment. When quoted prices in active markets are not available, fair value is based on market valuation techniques, market comparable pricing and the income approach. The use of different techniques, assumptions and inputs may have a material effect on the estimated fair values of the Company’s securities holdings. For the quarters ended ~~March 31,~~June 30, 2013 and 2012, the application of market standard valuation techniques applied to similar assets and liabilities has been consistent.

The methods and assumptions the Company uses to estimate the fair value of assets and liabilities measured at fair value on a recurring basis are summarized below.

Fixed Maturity Securities – The fair values of the Company’s publicly-traded fixed maturity securities are generally based on prices obtained from independent pricing services. Prices from pricing services are sourced from multiple vendors, and a vendor hierarchy is maintained by asset type based on historical pricing experience and vendor expertise. The Company generally receives prices from multiple pricing services for each security, but ultimately uses the price from the pricing service highest in the vendor hierarchy based on the respective asset type. To validate reasonableness, prices are periodically reviewed as explained above. Consistent with the fair value hierarchy described above, securities with validated quotes from pricing services are generally reflected within Level 2, as they are primarily based on observable pricing for similar assets and/or other market observable inputs. If the pricing information received from third party pricing services is not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process with the pricing service.

If the Company ultimately concludes that pricing information received from the independent pricing service is not reflective of market activity, non-binding broker quotes are used, if available. If the Company concludes the values from both pricing services and brokers are not reflective of market activity, it may override the information from the pricing service or broker with an internally developed valuation; however, this occurs infrequently. Internally developed valuations or non-binding broker quotes are also used to determine fair value in circumstances where vendor pricing is not available. These estimates may use significant unobservable inputs, which reflect the Company’s assumptions about the inputs that market participants would use in pricing the asset. Circumstances where observable market data are not available may include events such as market illiquidity and credit events related to the security. Pricing service overrides, internally developed valuations and non-binding broker quotes are generally based on significant unobservable inputs and are reflected as Level 3 in the valuation hierarchy.

The inputs used in the valuation of corporate and government securities include, but are not limited to standard market observable inputs which are derived from, or corroborated by, market observable data including market yield curve, duration, call provisions, observable prices and spreads for similar publicly traded or privately traded issues that incorporate the credit quality and industry sector of the issuer. For structured securities, valuation is based primarily on matrix pricing or other similar techniques using standard market inputs including spreads for actively traded securities, spreads off benchmark yields, expected prepayment speeds and volumes, current and forecasted loss severity, rating, weighted average coupon, weighted average maturity, average delinquency rates, geographic region, debt-service coverage ratios and issuance-specific information including, but not limited to: collateral type, payment terms of the underlying assets, payment priority within the tranche, structure of the security, deal performance and vintage of loans.

When observable inputs are not available, the market standard valuation techniques for determining the estimated fair value of certain types of securities that trade infrequently, and therefore have little or no price transparency, rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from or corroborated by observable market data. These unobservable inputs can be based in large part on management judgment or estimation, and cannot be supported by reference to market activity. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and are believed to be consistent with what other market participants would use when pricing such securities.

The fair values of private placement securities are primarily determined using a discounted cash flow model. In certain cases these models primarily use observable inputs with a discount rate based upon the average of spread surveys collected from private market intermediaries who are active in both primary and secondary transactions, taking into account, among other factors, the credit quality and industry sector of the issuer and the reduced liquidity associated with private placements. Generally, these securities have been reflected within Level 3. For certain private fixed maturities, the discounted cash flow

model may also incorporate significant unobservable inputs, which reflect the Company’s own assumptions about the inputs market participants would use in pricing the security. To the extent management determines that such unobservable inputs are not significant to the price of a security, a Level 2 classification is made. Otherwise, a Level 3 classification is used.

Embedded Derivatives– For embedded derivative liabilities associated with the underlying products in reinsurance treaties, primarily equity-indexed and variable annuity treaties, the Company utilizes a discounted cash flow model, which includes an estimate of future equity option purchases and an adjustment for the Company’s own credit risk. The variable annuity embedded derivative calculations are performed by third parties based on methodology and input assumptions provided by the Company. To validate the reasonableness of the resulting fair value, the Company’s internal actuaries perform reviews and analytical procedures on the results. The capital market inputs to the model, such as equity indexes, short-term equity volatility and interest rates, are generally observable. The valuation also requires certain significant inputs, which are generally not observable and accordingly, the valuation is considered Level 3 in the fair value hierarchy, see “Level 3 Measurements and Transfers” below for a description.

The fair value of embedded derivatives associated with funds withheld reinsurance treaties is determined based upon a total return swap technique with reference to the fair value of the investments held by the ceding company that support the Company’s funds withheld at interest asset with an adjustment for the Company’s own credit risk. The fair value of the underlying assets is generally based on market observable inputs using industry standard valuation techniques. The valuation also requires certain significant inputs, which are generally not observable and accordingly, the valuation is considered Level 3 in the fair value hierarchy, see “Level 3 Measurements and Transfers” below for a description.

Company’s Own Credit Risk – The Company uses a structural default risk model to estimate its own credit risk. The input assumptions are a combination of externally derived and published values (default threshold and uncertainty), market inputs (interest rate, Company equity price per share, Company debt per share, Company equity price volatility) and insurance industry data (Loss Given Default), adjusted for market recoverability.

Cash Equivalents and Short-Term Investments – Cash equivalents and short-term investments include money market instruments, commercial paper and other highly liquid debt instruments. Money market instruments are generally valued using unadjusted quoted prices in active markets that are accessible for identical assets and are primarily classified as Level 1. The fair value of certain other short-term investments, such as floating rate notes and bonds with original maturities less then twelve months, are based upon other market observable data and are typically classified as Level 2. However, certain short-term investments may incorporate significant unobservable inputs resulting in a Level 3 classification. Various time deposits carried as cash equivalents or short-term investments are not measured at estimated fair value and therefore are excluded from the tables presented.

Equity Securities – Equity securities consist principally of exchange-traded funds and preferred stock of publicly and privately traded companies. The fair values of publicly traded equity securities are primarily based on quoted market prices in active markets and are classified within Level 1 in the fair value hierarchy. The fair values of preferred equity securities, for which quoted market prices are not readily available, are based on prices obtained from independent pricing services and these securities are generally classified within Level 2 in the fair value hierarchy.

Derivative Assets and Derivative Liabilities –All of the derivative instruments utilized by the Company are classified within Level 2 on the fair value hierarchy. These derivatives are principally valued using an income approach. Valuations of interest rate contracts ~~non-option-based,~~ are based on present value techniques, which utilize significant inputs that may include the swap yield curve, LIBOR basis curves, and repurchase rates. Valuations of foreign currency contracts, non-option-based, are based on present value techniques, which utilize significant inputs that may include the swap yield curve, LIBOR basis curves, currency spot rates, and cross currency basis curves. Valuations of credit contracts, non-option-based, are based on present value techniques, which utilize significant inputs that may include the swap yield curve, credit curves, and recovery rates. Valuations of equity market contracts, non-option-based, are based on present value techniques, which utilize significant inputs that may include the swap yield curve, spot equity index levels, and dividend yield curves. Valuations of equity market contracts, option-based, are based on option pricing models, which utilize significant inputs that may include the swap yield curve, spot equity index levels, dividend yield curves, and equity volatility. The Company does not currently have derivatives included in Level 3 measurement.

As of ~~March 31,~~June 30, 2013 and December 31, 2012, respectively, the Company classified approximately ~~10.4%~~11.0% and 10.0% of its fixed maturity securities in the Level 3 category. These securities primarily consist of private placement corporate securities and bank loans with inactive trading markets. Additionally, the Company has included asset-backed securities with subprime exposure and mortgage-backed securities with below investment grade ratings in the Level 3 category due to market uncertainty associated with these securities and the Company’s utilization of unobservable information from third parties for the valuation of these securities.

The significant unobservable inputs used in the fair value measurement of the Company’s corporate, sovereign, government-backed, other political subdivision and short-term investments are probability of default, liquidity premium and subordination premium. Significant increases (decreases) in any of those inputs in isolation would result in a significantly lower (higher) fair value measurement. Generally, a change in the assumption used for the probability of default is accompanied by a directionally similar change in the assumptions used for the liquidity premium and subordination premium. For securities with a fair value derived using the market comparable pricing valuation technique, liquidity premium is the only significant unobservable input.

The significant unobservable inputs used in the fair value measurement of the Company’s asset and mortgage-backed securities are prepayment rates, probability of default, liquidity premium and loss severity in the event of default. Significant increases (decreases) in any of those inputs in isolation would result in a significantly lower (higher) fair value measurement. Generally, a change in the assumption used for the probability of default is accompanied by a directionally similar change in the assumption used for the liquidity premium and loss severity and a directionally opposite change in the assumption used for prepayment rates.

The actuarial assumptions used in the fair value of embedded derivatives which include assumptions related to lapses, withdrawals, and mortality, are based on experience studies performed by the Company in combination with available industry information and are reviewed on a periodic basis, at least annually. The significant unobservable inputs used in the fair value measurement of embedded derivatives are assumptions associated with policyholder experience and selected capital market assumptions for equity-indexed and variable annuities. The selected capital market assumptions, which include long-term implied volatilities, are projections based on short-term historical information. Changes in interest rates, equity indices, equity volatility, the Company’s own credit risk, and actuarial assumptions regarding policyholder experience may result in significant fluctuations in the value of embedded derivatives.

Fair value measurements associated with funds withheld reinsurance treaties are generally not materially sensitive to changes in unobservable inputs associated with policyholder experience. The primary drivers of change in these fair values are related to movements of credit spreads, which are generally observable. Increases (decreases) in market credit spreads tend to decrease (increase) the fair value of embedded derivatives. Increases (decreases) in the own credit assumption tend to decrease (increase) the magnitude of the fair value of embedded derivatives.

Fair value measurements associated with variable annuity treaties are sensitive to both capital markets inputs and policyholder experience inputs. Increases (decreases) in lapse rates tend to decrease (increase) the value of the embedded derivatives associated with variable annuity treaties. Increases (decreases) in the long-term volatility assumption tend to increase (decrease) the fair value of embedded derivatives. Increases (decreases) in the own credit assumption tend to decrease (increase) the magnitude of the fair value of embedded derivatives.

The following table presents quantitative information about significant unobservable inputs used in Level 3 fair value measurements developed by the Company, which does not include unobservable Level 3 asset and liability measurements provided by third parties, as of ~~March 31,~~June 30, 2013 and December 31, 2012 (dollars in thousands):


March 31, 2013:			Valuation	Unobservable	Range
	Fair Value		Technique(s)	Input	(Weighted Average)

June 30, 2013:							Fair Value			Valuation Technique(s)	Unobservable Input	Range (Weighted Average)
Assets:
State and political subdivision securities	$	5,364	Market comparable securities	Liquidity premium		1%	$	5,139		Market comparable securities	Liquidity premium		1%

Corporate securities		429,817	Market comparable securities	Liquidity premium		0-2% (1%)		403,894		Market comparable securities	Liquidity premium		0-2%(1%)

Short-term investments		22,001	Market comparable securities	Liquidity premium		1%

Funds withheld at interest- embedded derivatives		(156,189)	Total return swap	Mortality		0-100% (1%)		(108,473	)	Total return swap	Mortality		0-100% (1%)

				Lapse		0-35% (6%)

				Withdrawal		0-5% (3%)

				Own Credit		0-1% (1%)					Lapse		0-35% (6%)
											Withdrawal		0-5% (3%)
				Crediting rate		2-4% (3%)					Own Credit		0-1% (1%)
											Crediting rate		2-4% (3%)
Liabilities:
Interest sensitive contract liabilities- embedded derivatives- indexed annuities		769,685	Discounted cash flow	Mortality		0-100% (1%)		793,586		Discounted cash flow	Mortality		0-100% (1%)
											Lapse		0-35% (6%)
				Lapse		0-35% (6%)					Withdrawal		0-5% (3%)
											Option budget projection		2-4% (3%)
Interest sensitive contract liabilities- embedded derivatives- variable annuities								84,982		Discounted cash flow	Mortality		0-100%(2%)
				Withdrawal		0-5% (3%)
											Lapse		0-25%(5%)
				Option budget projection		2-4% (3%)
											Withdrawal		0-7%(3%)

											Own Credit		0-1%(1%)
											Long-term volatility		0-27%(13%)


March 31, 2013 (continued):	Fair Value		Valuation Technique(s)	Unobservable Input	Range (Weighted Average)
Interest sensitive contract liabilities- embedded derivatives- variable annuities		120,791	Discounted cash flow	Mortality		0-100% (2%)

				Lapse		0-25% (5%)

				Withdrawal		0-7% (3%)

				Own Credit		0-1% (1%)

				Long-term volatility		0-27% (13%)

December 31, 2012:	Fair Value		Valuation Technique(s)	Unobservable Input	Range (Weighted Average)		Fair Value			Valuation Technique(s)	Unobservable Input	Range (Weighted Average)
December 31, 2012:	Fair Value			Unobservable Input
Assets:			Valuation Technique(s)		Range (Weighted Average)

State and political subdivision securities	$	5,451	Market comparable securities	Liquidity premium		1%	$	5,451		Market comparable securities	Liquidity premium		1%

Corporate securities		450,177	Market comparable securities	Liquidity premium		0-2% (1%)		450,177		Market comparable securities	Liquidity premium		0-2%(1%)

Short-term investments		22,031	Market comparable securities	Liquidity premium		1%		22,031		Market comparable securities	Liquidity premium		1%

Funds withheld at interest- embedded derivatives		(243,177)	Total return swap	Mortality		0-100% (1%)		(243,177	)	Total return swap	Mortality		0-100%(1%)
											Lapse		0-35%(6%)
				Lapse		0-35% (6%)					Withdrawal		0-5%(3%)
											Own Credit		0-1%(1%)
				Withdrawal		0-5% (3%)					Crediting Rate		2-4%(3%)

				Own Credit		0-1% (1%)

				Crediting Rate		2-4% (3%)

Liabilities:
Interest sensitive contract liabilities- embedded derivatives- indexed annuities		740,256	Discounted cash flow	Mortality		0-100% (1%)		740,256		Discounted cash flow	Mortality		0-100%(1%)

				Lapse		0-35% (6%)

				Withdrawal		0-5% (3%)					Lapse		0-35%(6%)
											Withdrawal		0-5%(3%)
				Option budget projection		2-4% (3%)					Option budget projection		2-4%(3%)

Interest sensitive contract liabilities- embedded derivatives- variable annuities		172,105	Discounted cash flow	Mortality		0-100% (2%)		172,105		Discounted cash flow	Mortality		0-100%(2%)
											Lapse		0-25%(5%)
				Lapse		0-25% (5%)					Withdrawal		0-7%(3%)
											Own Credit		0-1%(1%)
				Withdrawal		0-7% (3%)					Long-term volatility		0-27%(14%)

				Own Credit		0-1% (1%)

				Long-term volatility		0-27% (14%)

The Company recognizes transfers of financial instruments into and out of levels within the fair value hierarchy at the beginning of the quarter in which the actual event or change in circumstances that caused the transfer occurs. Financial instruments transferred into Level 3 are due to a lack of observable market transactions and price information. Financial instruments are transferred out of Level 3 when circumstances change such that significant inputs can be corroborated with market observable data. This may be due to a significant increase in market activity for the financial instrument, a specific event, one or more significant input(s) becoming observable. Transfers out of Level 3 were primarily the result of the Company using observable pricing information or a third party pricing quotation that appropriately reflects the fair value of those financial instruments, without the need for adjustment based on the Company’s own assumptions regarding the characteristics of a specific financial instrument or the current liquidity in the market. In addition, certain transfers out of Level 3 were also due to increased observations of market transactions and price information for those financial instruments.

Transfers from Level 1 to Level 2 are due to the lack of observable market data when pricing these securities, while transfers from Level 2 to Level 1 are due to an increase in the availability of market observable data in an active market. The following tables present the transfers between Level 1 and Level 2 during the three and six months ended ~~March 31,~~June 30, 2013 and 2012 (dollars in thousands):


	Three months ended March 31,								Three months ended June 30,
	2013				2012				2013				2012
	Transfers from Level 1 to Level 2		Transfers from Level 2 to Level 1		Transfers from Level 1 to Level 2		Transfers from Level 2 to Level 1		Transfers from Level 1 to Level 2		Transfers from Level 2 to Level 1		Transfers from Level 1 to Level 2		Transfers from Level 2 to Level 1
Fixed maturity securities - available-for-sale:
Corporate securities	$	--	$	14,012	$	--	$	4	$	—	$	—	$	2,996	$	—
U.S. government and agencies securities										—		—		—		11,152
State and political subdivision securities										—		—		12,794		—
Other foreign government, supranational and foreign government-sponsored enterprises										—		—		1,059		—

Total fixed maturity securities	$	--	$	14,012	$	--	$	4	$	—	$	—	$	16,849	$	11,152


									Six months ended June 30,
									2013				2012
									Transfers from Level 1 to Level 2		Transfers from Level 2 to Level 1		Transfers from Level 1 to Level 2		Transfers from Level 2 to Level 1
Fixed maturity securities - available-for-sale:
Corporate securities									$	—	$	14,012	$	2,996	$	4
U.S. government and agencies securities										—		—		—		11,152
State and political subdivision securities										—		—		12,794		—
Other foreign government, supranational and foreign government-sponsored enterprises										—		—		1,059		—

Total fixed maturity securities									$	—	$	14,012	$	16,849	$	11,156

The tables below provide a summary of the changes in fair value of Level 3 assets and liabilities for the three and six months ended ~~March 31,~~June 30, 2013, as well as the portion of gains or losses included in income for the three and six months ended ~~March 31,~~June 30, 2013 attributable to unrealized gains or losses related to those assets and liabilities still held at ~~March 31,~~June 30, 2013 (dollars in thousands):


For the three months ended March 31, 2013:	Fixed maturity securities - available-for-sale
For the three months ended June 30, 2013:											Fixed maturity securities - available-for-sale

	Corporate securities		Residential mortgage- backed securities		Asset-backed securities		Commercial mortgage- backed securities		U.S. Government and agencies securities		Corporate securities			Residential mortgage- backed securities			Asset-backed securities			Commercial mortgage- backed securities
Fair value, beginning of period	$	1,668,563	$	93,931	$	232,391	$	167,006	$	4,538	$	1,646,903		$	140,717		$	288,231		$	175,294
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses		(2,027)		105		878		502		--		(2,313	)		(111	)		1,526			581
Investment related gains (losses), net		(1,262)		(173)		(1,747)		(870)		--		350			198			226			(8,992	)
Claims & other policy benefits		--		--		--		--		--		—			—			—			—
Interest credited		--		--		--		--		--		—			—			—			—
Policy acquisition costs and other insurance expenses		--		--		--		--		--		—			—			—			—
Included in other comprehensive income		963		2,514		12,036		12,500		--		(37,672	)		(2,714	)		2,601			15,445
Purchases⁽¹⁾		74,671		40,538		55,881		--		--		100,690			11,383			72,542			—
Sales⁽¹⁾		(16,278)		(1,599)		(8,297)		(1,604)		--		(39,793	)		(1,018	)		(7,995	)		(1,118	)
Settlements⁽¹⁾		(65,366)		(4,923)		(5,877)		(2,240)		--		(80,533	)		(7,367	)		(5,559	)		(228	)
Transfers into Level 3		3,773		10,324		2,966		--		--		4,373			4,306			5,340			—
Transfers out of Level 3		(16,134)		--		--		--		(4,538)		—			(5,340	)		(4,306	)		—

Fair value, end of period	$	1,646,903	$	140,717	$	288,231	$	175,294	$	--	$	1,592,005		$	140,054		$	352,606		$	180,982


Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses	$	(2,027)	$	105	$	882	$	501	$	--	$	(2,191	)	$	(112	)	$	1,515		$	580
Investment related gains (losses), net		(202)		--		--		--		--		—			—			—			(10,109	)
Claims & other policy benefits		--		--		--		--		--		—			—			—			—
Interest credited		--		--		--		--		--		—			—			—			—
Policy acquisition costs and other insurance expenses		--		--		--		--		--		—			—			—			—

For the three months ended March 31, 2013 (continued):	Fixed maturity securities available-for-sale
	State and political subdivision securities		Other foreign government, supranational and foreign government- sponsored enterprises		Funds withheld at interest- embedded derivative		Short-term investments		Interest sensitive contract liabilities embedded derivatives
Fair value, beginning of period	$	43,212	$	28,280	$	(243,177)	$	22,031	$	(912,361)
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses		9		(75)		--		(3)		--
Investment related gains (losses), net		(4)		--		86,988		--		51,314
Claims & other policy benefits		--		--		--		--		--
Interest credited		--		--		--		--		(32,996)
Policy acquisition costs and other insurance expenses		--		--		--		--		--
Included in other comprehensive income		(553)		(340)		--		(27)		--
Purchases⁽¹⁾		--		--		--		--		(13,860)
Sales⁽¹⁾		--		--		--		--		--
Settlements⁽¹⁾		(25)		--		--		--		17,427
Transfers into Level 3		--		--		--		--		--
Transfers out of Level 3		--		--		--		--		--

Fair value, end of period	$	42,639	$	27,865	$	(156,189)	$	22,001	$	(890,476)


Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses	$	9	$	(75)	$	--	$	(4)	$	--
Investment related gains (losses), net		--		--		86,988		--		50,123
Claims & other policy benefits		--		--		--		--		--
Interest credited		--		--		--		--		(50,424)
Policy acquisition costs and other insurance expenses		--		--		--		--		--


For the three months ended June 30, 2013 (continued):	Fixed maturity securities available-for-sale

	State and political subdivision securities			Other foreign government, supranational and foreign government- sponsored enterprises			Funds withheld at interest- embedded derivative			Short-term investments			Interest sensitive contract liabilities embedded derivatives
Fair value, beginning of period	$	42,639		$	27,865		$	(156,189	)	$	22,001		$	(890,476	)
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses		9			(76	)		—			—			—
Investment related gains (losses), net		(4	)		—			47,716			—			35,809
Claims & other policy benefits		—			—			—			—			—
Interest credited		—			—			—			—			(28,020	)
Policy acquisition costs and other insurance expenses		—			—			—			—			—
Included in other comprehensive income		(1,087	)		(959	)		—			(1	)		—
Purchases⁽¹⁾		—			—			—			—			(14,764	)
Sales⁽¹⁾		—			—			—			—			—
Settlements⁽¹⁾		(282	)		—			—			(22,000	)		18,883
Transfers into Level 3		—			—			—			—			—
Transfers out of Level 3		—			—			—			—			—

Fair value, end of period	$	41,275		$	26,830		$	(108,473	)	$	—		$	(878,568	)

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses	$	9		$	(76	)	$	—		$	—		$	—
Investment related gains (losses), net		—			—			47,717			—			34,788
Claims & other policy benefits		—			—			—			—			—
Interest credited		—			—			—			—			(46,902	)
Policy acquisition costs and other insurance expenses		—			—			—			—			—

For the six months ended June 30, 2013:	Fixed maturity securities - available-for-sale

	Corporate securities			Residential mortgage-backed securities			Asset-backed securities			Commercial mortgage- backed securities			U.S. Government and agencies securities
Fair value, beginning of period	$	1,668,563		$	93,931		$	232,391		$	167,006		$	4,538
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses		(4,339	)		(6	)		2,405			1,083			—
Investment related gains (losses), net		(913	)		25			(1,521	)		(9,862	)		—
Claims & other policy benefits		—			—			—			—			—
Interest credited		—			—			—			—			—
Policy acquisition costs and other insurance expenses		—			—			—			—			—
Included in other comprehensive income		(36,710	)		(200	)		14,638			27,945			—
Purchases⁽¹⁾		175,362			51,920			128,423			—			—
Sales⁽¹⁾		(56,071	)		(2,617	)		(16,293	)		(2,722	)		—
Settlements⁽¹⁾		(145,899	)		(12,289	)		(11,436	)		(2,468	)		—
Transfers into Level 3		8,146			14,630			8,305			—			—
Transfers out of Level 3		(16,134	)		(5,340	)		(4,306	)		—			(4,538	)

Fair value, end of period	$	1,592,005		$	140,054		$	352,606		$	180,982		$	—


For the six months ended June 30, 2013 (continued):	Fixed maturity securities - available-for-sale

	Corporate securities			Residential mortgage-backed securities			Asset-backed securities			Commercial mortgage- backed securities			U.S. Government and agencies securities
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses	$	(4,218	)	$	(7	)	$	2,397		$	1,081		$	—
Investment related gains (losses), net		(202	)		—			—			(10,109	)		—
Claims & other policy benefits		—			—			—			—			—
Interest credited		—			—			—			—			—
Policy acquisition costs and other insurance expenses		—			—			—			—			—

For the six months ended June 30, 2013 (continued):	Fixed maturity securities available-for-sale

	State and political subdivision securities			Other foreign government, supranational and foreign government- sponsored enterprises			Funds withheld at interest- embedded derivative			Short-term investments			Interest sensitive contract liabilities embedded derivatives
Fair value, beginning of period	$	43,212		$	28,280		$	(243,177	)	$	22,031		$	(912,361	)
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses		18			(150	)		—			(3	)		—
Investment related gains (losses), net		(8	)		—			134,704			—			87,123
Claims & other policy benefits		—			—			—			—			—
Interest credited		—			—			—			—			(61,016	)
Policy acquisition costs and other insurance expenses		—			—			—			—			—
Included in other comprehensive income		(1,639	)		(1,300	)		—			(28	)		—
Purchases⁽¹⁾		—			—			—			—			(28,624	)
Sales⁽¹⁾		—			—			—			—			—
Settlements⁽¹⁾		(308	)		—			—			(22,000	)		36,310
Transfers into Level 3		—			—			—			—			—
Transfers out of Level 3		—			—			—			—			—

Fair value, end of period	$	41,275		$	26,830		$	(108,473	)	$	—		$	(878,568	)

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses	$	18		$	(150	)	$	—		$	(4	)	$	—
Investment related gains (losses), net		—			—			134,705			—			84,911
Claims & other policy benefits		—			—			—			—			—
Interest credited		—			—			—			—			(97,326	)
Policy acquisition costs and other insurance expenses		—			—			—			—			—

The tables below provide a summary of the changes in fair value of Level 3 assets and liabilities for the three and six months ended ~~March 31,~~June 30, 2012, as well as the portion of gains or losses included in income for the three and ~~nine~~six months ended ~~March 31,~~June 30, 2012 attributable to unrealized gains or losses related to those assets and liabilities still held at ~~March 31,~~June 30, 2012 (dollars in thousands):


For the three months ended March 31, 2012:	Fixed maturity securities - available-for-sale
For the three months ended June 30, 2012:												Fixed maturity securities - available-for-sale
	Corporate securities		Residential mortgage- backed securities		Asset-backed securities		Commercial mortgage- backed securities		State. and political subdivision securities			Corporate securities			Residential mortgage- backed securities			Asset-backed securities			Commercial mortgage- backed securities			State. and political subdivision securities
Fair value, beginning of period	$	974,169	$	81,655	$	193,492	$	115,976	$	10,373		$	977,671		$	54,435		$	146,362		$	118,678		$	5,239
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses		30		110		249		588		(5)			77			188			195			545			9
Investment related gains (losses), net		(585)		279		(670)		(12,075)		(4)			(696	)		(315	)		164			393			(4	)
Claims & other policy benefits		--		--		--		--		--			—			—			—			—			—
Interest credited		--		--		--		--		--			—			—			—			—			—
Policy acquisition costs and other insurance expenses		--		--		--		--		--			—			—			—			—			—
Included in other comprehensive income		(682)		1,580		6,696		13,521		406			10,341			(172	)		1,782			(2,273	)		827
Purchases⁽¹⁾		21,161		244		--		--		--			68,275			337			2,012			—			—
Sales⁽¹⁾		(9,408)		(8,004)		--		--		--			(17,876	)		(8,219	)		(7,902	)		(1,552	)		—
Settlements⁽¹⁾		(20,875)		(1,800)		(3,865)		--		(23)			(32,497	)		(1,902	)		(3,238	)		(58	)		(23	)
Transfers into Level 3		17,444		--		1,080		10,846		--			—			7,176			—			—			8,438
Transfers out of Level 3		(3,583)		(19,629)		(50,620)		(10,178)		(5,508)			(11,281	)		(1,937	)		(11,017	)		—			—

Fair value, end of period	$	977,671	$	54,435	$	146,362	$	118,678	$	5,239		$	994,014		$	49,591		$	128,358		$	115,733		$	14,486


Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses	$	30	$	106	$	249	$	588	$	(5)		$	84		$	148		$	151		$	545		$	9
Investment related gains (losses), net		(727)		(108)		(607)		(12,075)		--			(380	)		(161	)		—			—			—
Claims & other policy benefits		--		--		--		--		--			—			—			—			—			—
Interest credited		--		--		--		--		--			—			—			—			—			—
Policy acquisition costs and other insurance expenses		--		--		--		--		--			—			—			—			—			—

For the three months ended June 30, 2012 (continued):											For the three months ended June 30, 2012 (continued):
												Funds withheld at interest- embedded derivatives			Other invested assets- other equity securities			Reinsurance ceded receivable- embedded derivatives			Interest sensitive contract liabilities embedded derivatives
Fair value, beginning of period												$	(370,884	)	$	11,827		$	3,514		$	(903,282	)
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses													—			—			—			—
Investment related gains (losses), net													(4,453	)		1,098			—			(74,929	)
Claims & other policy benefits													—			—			—			(1,721	)
Interest credited													—			—			—			27,825
Policy acquisition costs and other insurance expenses													—			—			1,003			—
Included in other comprehensive income													—			505			—			—
Purchases⁽¹⁾													—			108			—			(16,107	)
Sales⁽¹⁾													—			(3,788	)		—			—
Settlements⁽¹⁾													—			—			(101	)		29,287
Transfers into Level 3													—			—			—			—
Transfers out of Level 3													—			(6,523	)		—			—

Fair value, end of period												$	(375,337	)	$	3,227		$	4,416		$	(938,927	)


For the three months ended March 31, 2012 (continued):	Funds withheld at interest- embedded derivatives		Other invested assets- other equity securities		Reinsurance ceded receivable- embedded derivatives		Interest sensitive contract liabilities embedded derivatives
For the three months ended June 30, 2012 (continued):									For the three months ended June 30, 2012 (continued):
										Funds withheld at interest- embedded derivatives			Other invested assets- other equity securities			Reinsurance ceded receivable- embedded derivatives			Interest sensitive contract liabilities embedded derivatives
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses										$	—		$	—		$	—		$	—
Investment related gains (losses), net											(4,452	)		(183	)		—			(76,737	)
Claims & other policy benefits											—			—			—			(1,959	)
Interest credited											—			—			—			(1,288	)
Policy acquisition costs and other insurance expenses											—			—			1,143			—

For the six months ended June 30, 2012:										Fixed maturity securities - available-for-sale
										Corporate securities			Residential mortgage- backed securities			Asset-backed securities			Commercial mortgage- backed securities			State. and political subdivision securities
Fair value, beginning of period	$	(361,456)	$	11,489	$	4,945	$	(1,028,241)		$	974,169		$	81,655		$	193,492		$	115,976		$	10,373
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses		--		--		--		--			107			298			444			1,133			4
Investment related gains (losses), net		(9,428)		--		--		146,375			(1,280	)		(36	)		(506	)		(11,682	)		(8	)
Claims & other policy benefits		--		--		--		2,278			—			—			—			—			—
Interest credited		--		--		--		(21,193)			—			—			—			—			—
Policy acquisition costs and other insurance expenses		--		--		(1,329)		--			—			—			—			—			—
Included in other comprehensive income		--		338		--		--			9,659			1,408			8,477			11,248			1,233
Purchases⁽¹⁾		--		--		--		(23,590)			89,435			582			2,012			—			—
Sales⁽¹⁾		--		--		--		--			(27,285	)		(16,224	)		(7,902	)		(1,552	)		—
Settlements⁽¹⁾		--		--		(102)		21,089			(53,371	)		(3,702	)		(7,103	)		(58	)		(46	)
Transfers into Level 3		--		--		--		--			17,445			7,176			1,080			10,846			8,438
Transfers out of Level 3		--		--		--		--			(14,865	)		(21,566	)		(61,636	)		(10,178	)		(5,508	)

Fair value, end of period	$	(370,884)	$	11,827	$	3,514	$	(903,282)		$	994,014		$	49,591		$	128,358		$	115,733		$	14,486

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses	$	--	$	--	$	--	$	--		$	114		$	255		$	400		$	1,133		$	4
Investment related gains (losses), net		(9,428)		--		--		144,624			(1,106	)		(269	)		(607	)		(12,075	)		—
Claims & other policy benefits		--		--		--		2,037			—			—			—			—			—
Interest credited		--		--		--		(42,107)			—			—			—			—			—
Policy acquisition costs and other insurance expenses		--		--		(1,188)		--			—			—			—			—			—


For the six months ended June 30, 2012 (continued):	Funds withheld at interest- embedded derivatives			Other invested assets- other equity securities			Reinsurance ceded receivable- embedded derivatives			Interest sensitive contract liabilities embedded derivatives
Fair value, beginning of period	$	(361,456	)	$	11,489		$	4,945		$	(1,028,241	)
Total gains/losses (realized/unrealized)
Included in earnings, net:
Investment income, net of related expenses		—			—			—			—
Investment related gains (losses), net		(13,881	)		1,098			—			71,446
Claims & other policy benefits		—			—			—			557
Interest credited		—			—			—			6,632
Policy acquisition costs and other insurance expenses		—			—			(325	)		—
Included in other comprehensive income		—			843			—			—
Purchases⁽¹⁾		—			108			—			(39,697	)
Sales⁽¹⁾		—			(3,788	)		—			—
Settlements⁽¹⁾		—			—			(204	)		50,376
Transfers into Level 3		—			—			—			—
Transfers out of Level 3		—			(6,523	)		—			—

Fair value, end of period	$	(375,337	)	$	3,227		$	4,416		$	(938,927	)

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Investment income, net of related expenses	$	—		$	—		$	—		$	—
Investment related gains (losses), net		(13,881	)		(183	)		—			67,887
Claims & other policy benefits		—			—			—			79
Interest credited		—			—			—			(43,395	)
Policy acquisition costs and other insurance expenses		—			—			(46	)		—

Certain assets are measured at estimated fair value on a non-recurring basis and are not included in the tables presented above. The amounts below relate to certain investments measured at estimated fair value during the period and still held at the reporting dates (dollars in thousands).


													Three months ended June 30,
													2013							2012

													Carrying Value Prior to Measurement		Estimated Fair Value After Measurement		Net Investment Gains (Losses)			Carrying Value Prior to Measurement		Estimated Fair Value After Measurement		Net Investment Gains (Losses)
Mortgage loans⁽¹⁾													$	13,602	$	13,575	$	(27	)	$	22,323	$	23,375	$	1,052
Real estate⁽³⁾														4,736		4,136		(600	)		—		—		—

	Three months ended March 31,												Six months ended June 30,
	2013						2012						2013							2012
	Carrying Value Prior to Measurement		Estimated Fair Value After Measurement		Net Investment Gains (Losses)		Carrying Value Prior to Measurement		Estimated Fair Value After Measurement		Net Investment Gains (Losses)		Carrying Value Prior to Measurement		Estimated Fair Value After Measurement		Net Investment Gains (Losses)			Carrying Value Prior to Measurement		Estimated Fair Value After Measurement		Net Investment Gains (Losses)
Mortgage loans⁽¹⁾	$	13,581	$	13,700	$	119	$	32,671	$	28,875	$	(3,796)	$	13,482	$	13,575	$	93		$	26,119	$	23,375	$	(2,744	)
Limited partnership interests⁽²⁾		11,590		9,161		(2,429)		--		--		--		11,590		9,161		(2,429	)		—		—		—
Real estate⁽³⁾														4,736		4,136		(600	)		—		—		—

The Company is required by general accounting principles forFair Value Measurements and Disclosures to disclose the fair value of certain financial instruments including those that are not carried at fair value. The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments, which were not measured at fair value on a recurring basis, at ~~March 31,~~June 30, 2013 and December 31, 2012 (dollars in thousands):


March 31, 2013	Carrying Value		Estimated Fair Value			Fair Value Measurement Using:
March 31, 2013	Carrying Value				Level 1			Level 2			Level 3
June 30, 2013														Carrying Value			Estimated Fair Value			Fair Value Measurement Using:
June 30, 2013														Carrying Value					Level 1				Level 2				Level 3
Assets:			Estimated Fair Value														Estimated Fair Value
Mortgage loans on real estate	$	2,325,191	$	2,429,358		$	--		$	--		$	2,429,358	$	2,377,246		$	2,416,787		$	—			$	—			$	2,416,787
Policy loans		1,245,812		1,245,812			--			1,245,812			--		1,245,252			1,245,252			—				1,245,252				—
Funds withheld at interest⁽¹⁾		5,851,967		6,363,220			--			--			6,363,220		5,884,501			6,331,471			—				—				6,331,471
Cash and cash equivalents⁽²⁾		633,965		633,965			633,965			--			--		625,796			625,796			625,796				—				—
Short-term investments⁽²⁾		23,426		23,426			23,426			--			--		17,509			17,509			17,509				—				—
Other invested assets⁽²⁾		552,420		589,979			--			32,250			557,729		524,810			561,899			4,635				37,590				519,674
Accrued investment income		230,269		230,269			--			230,269			--		233,153			233,153			—				233,153				—
Liabilities:
Interest-sensitive contract liabilities⁽¹⁾	$	11,385,069	$	11,805,623		$	--		$	--		$	11,805,623	$	11,250,921		$	11,392,786		$	—			$	—			$	11,392,786
Long-term debt		1,815,392		2,025,511			--			--			2,025,511		1,935,533			2,080,701			—				—				2,080,701
Collateral finance facility		491,987		368,625			--			--			368,625		487,556			373,774			—				—				373,774

December 31, 2012:	Carrying Value		Estimated Fair Value			Fair Value Measurement Using:								Carrying Value			Estimated Fair Value			Fair Value Measurement Using:
December 31, 2012:	Carrying Value				Level 1			Level 2			Level 3
														Carrying Value		Carrying Value					Estimated Fair Value				Level 1				Level 2		Level 3
Assets:			Estimated Fair Value													Carrying Value					Estimated Fair Value
Mortgage loans on real estate	$	2,300,587	$	2,426,688		$	--		$	--		$	2,426,688	$	2,300,587		$	2,426,688			$	—			$	—			$	2,426,688
Policy loans		1,278,175		1,278,175			--			1,278,175			--		1,278,175			1,278,175			—				1,278,175				—
Funds withheld at interest⁽¹⁾		5,837,359		6,362,324			--			--			6,362,324		5,837,359			6,362,324			—				—				6,362,324
Cash and cash equivalents⁽²⁾		684,028		684,028			684,028			--			--		684,028			684,028			684,028				—				—
Short-term investments⁽²⁾		48,951		48,951			48,951			--			--		48,951			48,951			48,951				—				—
Other invested assets⁽²⁾		596,336		626,358			--			32,250			594,108		596,336			626,358			—				32,250				594,108
Accrued investment income		201,344		201,344			--			201,344			--		201,344			201,344			—				201,344				—
Liabilities:
Interest-sensitive contract liabilities⁽¹⁾	$	11,566,962	$	11,926,339		$	--		$	--		$	11,926,339	$	11,566,962		$	11,926,339		$	—			$	—			$	11,926,339
Long-term debt		1,815,253		2,014,062			--			--			2,014,062		1,815,253			2,014,062			—				—				2,014,062
Collateral finance facility		652,010		456,050			--			--			456,050		652,010			456,050			—				—				456,050

Mortgage Loans on Real Estate – The fair value of mortgage loans on real estate is estimated by discounting cash flows, both principal and interest, using current interest rates for mortgage loans with similar credit ratings and similar remaining maturities. As such, inputs include current treasury yields and spreads, which are based on the credit rating and average life

of the loan, corresponding to the market spreads. The valuation of mortgage loans on real estate is considered Level 3 in the fair value hierarchy.

Policy Loans – Policy loans typically carry an interest rate that is adjusted annually based on an observable market index and therefore carrying value approximates fair value. The valuation of policy loans is considered Level 2 in the fair value hierarchy.

Funds Withheld at Interest – The carrying value of funds withheld at interest approximates fair value except where the funds withheld are specifically identified in the agreement. When funds withheld are specifically identified in the agreement, the fair value is based on the fair value of the underlying assets which are held by the ceding company. Ceding companies use a variety of sources and pricing methodologies, which are not transparent to the Company and may include significant unobservable inputs, to value the securities that are held in distinct portfolios, therefore the valuation of these funds withheld assets are considered Level 3 in the fair value hierarchy.

Cash and Cash Equivalents and Short-term Investments – The carrying values of cash and cash equivalents and short-term investments approximates fair values due to the short-term maturities of these instruments and are considered Level 1 in the fair value hierarchy.

Other Invested Assets – This primarily includes limited partnership interests accounted for using the cost method, structured loans and ~~Federal Home Loan Bank of Des Moines~~FHLB common stock. The fair value of limited partnerships and other investments accounted for using the cost method is determined using the net asset values of the Company’s ownership interest as provided in the financial statements of the investees. The valuation of these investments is considered Level 3 in the fair value hierarchy due to the limited activity and price transparency inherent in the market for such investments. The fair value of structured loans is estimated based on a discounted cash flow analysis using discount rates applicable to each structured loan, this is considered Level 3 in the fair value hierarchy. The fair value of the Company’s common stock investment in the Federal Home Loan Bank of Des Moines is considered to be the carrying value and it is considered Level 2 in the fair value hierarchy. The fair value of the Company’s cash collateral is considered to be the carrying value and considered to be Level 1 in the fair value hierarchy.

Accrued Investment Income – The carrying value for accrued investment income approximates fair value as there are no adjustments made to the carrying value. This is considered Level 2 in the fair value hierarchy.

Interest-Sensitive Contract Liabilities– The carrying and fair values of interest-sensitive contract liabilities reflected in the table above exclude contracts with significant mortality risk. The fair value of the Company’s interest-sensitive contract liabilities utilizes a market standard technique with both capital market inputs and policyholder behavior assumptions, as well as cash values adjusted for recapture fees. The capital market inputs to the model, such as interest rates, are generally observable. Policyholder behavior assumptions are generally not observable and may require use of significant management judgment. The valuation of interest-sensitive contract liabilities is considered Level 3 in the fair value hierarchy.

Long-term Debt and Collateral Finance Facility – The fair value of the Company’s long-term debt and collateral finance facility is generally estimated by discounting future cash flows using market rates currently available for debt with similar remaining maturities and reflecting the credit risk of the Company, including inputs when available, from actively traded debt of the Company or other companies with similar credit quality. The valuation of long-term debt and collateral finance facility are generally obtained from brokers and are considered Level 3 in the fair value hierarchy.

The accounting policies of the segments are the same as those described in the Summary of Significant Accounting Policies in Note 2 of the consolidated financial statements accompanying the 2012 Annual Report. The Company measures segment performance primarily based on profit or loss from operations before income taxes. There are no intersegment reinsurance transactions and the Company does not have any material long-lived assets. Investment income is allocated to the segments based upon average assets and related capital levels deemed appropriate to support the segment business volumes.

The Company allocates capital to its segments based on an internally developed economic capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. The economic capital model considers the unique and specific nature of the risks inherent in the Company’s businesses. As a result of the economic capital allocation process, a portion of investment income and investment related gains and losses are attributed to the segments based on the level of allocated capital. In addition, the segments are charged for excess capital utilized above the allocated economic capital basis. This charge is included in policy acquisition costs and other insurance expenses.

The Company’s reportable segments are strategic business units that are primarily segregated by geographic region. Information related to revenues, income (loss) before income taxes and total assets of the Company for each reportable segment are summarized below (dollars in thousands).


					Three months ended June 30,				Six months ended June 30,
	Three months ended March 31,
Total revenues:	2013		2012		2013		2012		2013		2012
U.S.	$	1,500,264	$	1,324,147	$	1,564,386	$	1,370,221	$	3,064,650	$	2,694,368
Canada		297,089		275,623		295,325		276,239		592,414		551,862
Europe & South Africa		339,229		308,337		338,910		323,943		678,139		632,280
Asia Pacific		388,969		359,685		368,173		377,733		757,142		737,418
Corporate and Other		75,551		25,183		23,848		27,617		99,399		52,800

Total	$	2,601,102	$	2,292,975	$	2,590,642	$	2,375,753	$	5,191,744	$	4,668,728


	Three months ended March 31,
Income (loss) before income taxes:	2013		2012
U.S.	$	174,409	$	92,745
Canada		36,308		55,063
Europe & South Africa		17,385		6,606
Asia Pacific		14,518		32,067
Corporate and Other		36,207		(5,718)

Total	$	278,827	$	180,763


	Three months ended June 30,						Six months ended June 30,

Income (loss) before income taxes:	2013			2012			2013			2012
U.S.	$	170,443		$	140,586		$	344,852		$	233,331
Canada		35,659			35,030			71,967			90,093
Europe & South Africa		15,818			19,591			33,203			26,197
Asia Pacific		(290,448	)		23,859			(275,930	)		55,926
Corporate and Other		(6,230	)		(3,174	)		29,977			(8,892	)

Total	$	(74,758	)	$	215,892		$	204,069		$	396,655

The loss before income taxes for the three and six months ended June 30, 2013 in the Asia Pacific segment reflects an increase in Australian group claims liabilities related to total and permanent disability coverage and disability income benefits as well as poor claims experience in the Australian operation’s individual lump sum and individual disability businesses.


Total Assets:	March 31, 2013		December 31, 2012		June 30, 2013		December 31, 2012
U.S.	$	24,802,143	$	24,924,363	$	24,653,033	$	24,924,363
Canada		3,946,500		3,764,002		4,069,624		3,764,002
Europe & South Africa		2,137,397		2,235,199		2,143,826		2,235,199
Asia Pacific		3,051,842		3,208,732		3,216,175		3,208,732
Corporate and Other		6,259,219		6,228,142		4,707,963		6,228,142

Total	$	40,197,101	$	40,360,438	$	38,790,621	$	40,360,438

At ~~March 31,~~June 30, 2013, the Company’s commitments to fund investments were ~~$166.8~~$241.8 million in limited partnerships, ~~$22.2~~$42.5 million in commercial mortgage loans and ~~$80.5~~$74.5 million in bank loans, including revolving credit agreements. At December 31, 2012, the Company’s commitments to fund investments were $176.7 million in limited partnerships, $22.2 million in commercial mortgage loans and $68.5 million in bank loans, including revolving credit agreements. The Company anticipates that the majority of its current commitments will be invested over the next five years; however, these commitments could become due any time at the request of the counterparties. Investments in limited partnerships and private placements are carried at cost or reported using the equity method and included in other invested assets in the condensed consolidated balance sheets. Bank loans are carried at fair value and included in fixed maturities available-for-sale.

The Company is subject to litigation in the normal course of its business. The Company currently has no material litigation. A legal reserve is established when the Company is notified of an arbitration demand or litigation or is notified that an arbitration demand or litigation is imminent, it is probable that the Company will incur a loss as a result and the amount of the probable loss is reasonably capable of being estimated.

The Company has obtained bank letters of credit in favor of various affiliated and unaffiliated insurance companies from which the Company assumes business. These letters of credit represent guarantees of performance under the reinsurance agreements and allow ceding companies to take statutory reserve credits. Certain of these letters of credit contain financial covenant restrictions. At ~~March 31,~~June 30, 2013 and December 31, 2012, there were approximately ~~$60.3~~$76.2 million and $45.4 million, respectively, of undrawn outstanding bank letters of credit in favor of third parties. Additionally, the Company utilizes letters of credit to secure reserve credits when it retrocedes business to its subsidiaries, including Parkway Reinsurance Company (“Parkway Re”), Rockwood Reinsurance Company (“Rockwood Re”), Timberlake Financial L.L.C. (“Timberlake Financial”), RGA Americas Reinsurance, Ltd. (“RGA Americas”), RGA Reinsurance Company (Barbados) Ltd. (“RGA Barbados”) and RGA Atlantic Reinsurance Company, Ltd. (“RGA Atlantic”). The Company cedes business to its affiliates to help reduce the amount of regulatory capital required in certain jurisdictions such as the U.S. and the United Kingdom. The capital required to support the business in the affiliates reflects more realistic expectations than the original jurisdiction of the business, where capital requirements are often considered to be quite conservative. As of ~~March 31,~~June 30, 2013 and December 31, 2012, ~~$864.5~~$861.3 million and $763.5 million, respectively, in undrawn letters of credit from various banks were outstanding, backing reinsurance between the various subsidiaries of the Company. The banks providing letters of

credit to the Company are included on the National Association of Insurance Commissioners (“NAIC”) list of approved banks.

The Company maintains ~~four~~five credit facilities, a syndicated revolving credit facility with a capacity of $850.0 million and ~~three~~four letter of credit facilities with a combined capacity of ~~$590.0~~$690.0 million. The Company may borrow cash and obtain letters of credit in multiple currencies under its syndicated revolving credit facility. The following table provides additional information on the Company’s credit facilities as of ~~March 31,~~June 30, 2013 and December 31, 2012 (dollars in millions):

RGA has issued guarantees to third parties on behalf of its subsidiaries for the payment of amounts due under certain reinsurance treaties, securities borrowing arrangements, financing arrangements and office lease obligations, whereby, if a subsidiary fails to meet an obligation, RGA or one of its other subsidiaries will make a payment to fulfill the obligation. In limited circumstances, treaty guarantees are granted to ceding companies in order to provide them additional security, particularly in cases where RGA’s subsidiary is relatively new, unrated, or not of a significant size, relative to the ceding company. Liabilities supported by the treaty guarantees, before consideration for any legally offsetting amounts due from the guaranteed party, totaled ~~$701.0~~$815.2 million and $686.0 million as of ~~March 31,~~June 30, 2013 and December 31, 2012, respectively, and are reflected on the Company’s condensed consolidated balance sheets in future policy benefits. As of ~~March 31,~~June 30, 2013 and December 31, 2012, the Company’s exposure related to treaty guarantees, net of assets held in trust, was ~~$481.7~~$628.1 million and $463.5 million, respectively. Potential guaranteed amounts of future payments will vary depending on production levels and underwriting results. Guarantees related to borrowed securities provide additional security to third parties should a subsidiary fail to ~~make principal and/or interest payments~~return the borrowed securities when due. As of ~~March 31,~~June 30, 2013 and December 31, 2012, RGA’s obligation related to borrowed securities guarantees was $87.5 million. There were no amounts guaranteed under financing arrangements as of ~~March 31,~~June 30, 2013 and December 31, 2012.

Manor Reinsurance, Ltd. (“Manor Re”), a subsidiary of RGA, has obtained $300.0 million of collateral financing through 2020 from an international bank which enabled Manor Re to deposit assets in trust to support statutory reserve credits for an affiliated reinsurance transaction. The bank has recourse to RGA should Manor Re fail to make payments or otherwise not perform its obligations under this financing.

~~The Company,~~RGA, through a wholly-owned ~~subsidiary,~~subsidiaries, has committed to provide statutory reserve support to ~~a third-party through 2035,~~third-parties, in exchange for a fee, by funding ~~a loan~~loans if certain defined events occur. Such statutory reserves are required under the U.S. Valuation of Life Policies Model Regulation (commonly referred to as Regulation XXX for term life insurance policies and Regulation A-XXX for universal life secondary guarantees). The ~~maximum potential obligation under this commitment is $560.0 million. The third-party has~~third-parties have recourse to RGA should the subsidiary fail to provide the required funding, however, as of ~~March 31,~~June 30, 2013, the Company does not believe that it will be required to provide any funding under ~~this commitment~~these commitments as the occurrence of the defined events is considered remote. The following table presents information about these commitments (dollars in millions):

In addition, the Company indemnifies its directors and officers as provided in its charters and by-laws. Since this indemnity generally is not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount due under this indemnity in the future.

The components of net periodic benefit costs for the three and six months ended ~~March 31,~~June 30, 2013 and 2012 were as follows (dollars in thousands):


	Pension Benefits				Other Benefits				Pension Benefits						Other Benefits
	Three months ended March 31,				Three months ended March 31,				Three months ended June 30,						Three months ended June 30,
	2013		2012		2013		2012		2013			2012			2013		2012
Net periodic benefit cost:
Service cost	$	1,883	$	1,532	$	410	$	279	$	2,129		$	2,196		$	410	$	279
Interest Cost		1,018		980		312		259		1,020			1,090			311		258
Expected return on plan assets		(767)		(734)		--		--		(1,100	)		(799	)		—		—
Amortization of prior service cost		94		99		--		--		213			87			—		—
Amortization of prior actuarial loss		837		275		186		88		782			1,388			186		89

Total	$	3,065	$	2,152	$	908	$	626
Net periodic benefit cost									$	3,044		$	3,962		$	907	$	626


									Pension Benefits						Other Benefits
									Six months ended June 30,						Six months ended June 30,
									2013			2012			2013		2012
Service cost									$	4,012		$	3,728		$	820	$	558
Interest Cost										2,038			2,070			623		517
Expected return on plan assets										(1,867	)		(1,533	)		—		—
Amortization of prior service cost										307			186			—		—
Amortization of prior actuarial loss										1,619			1,663			372		177

Net periodic benefit cost									$	6,109		$	6,114		$	1,815	$	1,252

The Company has ~~not~~ made ~~any~~ pension contributions of $3.4 million during the first ~~three~~six months of 2013 ~~but~~and expects to make total pension contributions of ~~$6.4~~$6.8 million in 2013.

Equity compensation expense was ~~$9.7~~$6.0 million and ~~$8.4~~$5.5 million in the ~~first~~second quarter of 2013 and 2012, respectively. In the first quarter of 2013, the Company granted 0.7 million stock appreciation rights at $58.77 weighted average exercise price per share and 0.3 million performance contingent units to employees. Additionally, non-employee directors were granted a total of 14,200 shares of common stock. As of ~~March 31,~~June 30, 2013, ~~2.1~~1.8 million share options at ~~$49.29~~$50.43 weighted average per share were vested and exercisable with a remaining weighted average exercise period of 5.1 years. As of ~~March 31,~~June 30, 2013, the total compensation cost of non-vested awards not yet recognized in the condensed consolidated financial statements was ~~$44.6~~$38.2 million. It is estimated that these costs will vest over a weighted average period of ~~3.1~~2.2 years.

The Company generally reports retrocession activity on a gross basis. Amounts paid or deemed to have been paid for reinsurance are reflected in reinsurance ceded receivables. The cost of reinsurance related to long-duration contracts is recognized over the terms of the reinsured policies on a basis consistent with the reporting of those policies. In the normal course of business, the Company seeks to limit its exposure to loss on any single insured and to recover a portion of benefits paid by ceding reinsurance to other insurance enterprises or reinsurers under excess coverage, quota share and coinsurance contracts.

Certain retrocessions are arranged through the Company’s retrocession pools for amounts in excess of the Company’s retention limit. As of ~~March 31,~~June 30, 2013 and December 31, 2012, all rated retrocession pool participants rated by the A.M. Best Company were rated “A- (excellent)” or ~~better, except for one pool member that was rated “B++.”~~better. The Company verifies retrocession pool participants’ ratings on a quarterly basis. For a majority of the retrocessionaires that were not rated, security in the form of letters of credit or trust assets has been given as additional security in favor of RGA Reinsurance Company (“RGA Reinsurance”). In addition, the Company performs annual financial reviews of its retrocessionaires to evaluate financial stability and performance.

As of ~~March 31,~~June 30, 2013 and December 31, 2012, the Company had claims recoverable from retrocessionaires of ~~$156.4~~$147.2 million and $156.0 million, respectively, which is included in reinsurance ceded receivables, in the condensed consolidated balance sheets. The Company considers outstanding claims recoverable in excess of 90 days to be past due. There were ~~$16.6~~$9.8 million and $10.4 million of past due claims recoverable as of ~~March 31,~~June 30, 2013 and December 31, 2012, respectively. Based on financial reviews of the counterparties, the Company has not established a valuation allowance for claims recoverable. The Company has never experienced a material default in connection with retrocession arrangements, nor has it experienced any difficulty in collecting claims recoverable from retrocessionaires; however, no assurance can be given as to the future performance of such retrocessionaires or as to recoverability of any such claims.

~~On January 17,~~During the first quarter of 2013, the Company repurchased $160.0 million face amount of its Series A Floating Rate Insured Notes issued by RGA’s subsidiary, Timberlake Financial, L.L.C., for $112.0 million, which was the market value at the date of the purchase. The notes were purchased by RGA Reinsurance Company, also a subsidiary of RGA. As a result, the Company recorded a pre-tax gain of $46.5 million, after fees, in other ~~revenues.~~revenues at that time.

OnIn January ~~24,~~ 2013, RGA’s board of directors authorized a share repurchase program, with no expiration date, for up to $200.0 million of RGA’s outstanding common stock. ~~This authorization was effective~~In April 2013, RGA’s board of directors authorized an increase of $100.0 million to the share repurchase program previously authorized in January ~~24,~~2013. In July 2013, ~~and does not have~~RGA’s board of directors authorized an ~~expiration date.~~ additional increase of $100.0 million to the share repurchase program previously authorized in January 2013. With these authorizations, the total amount of the Company’s outstanding common stock authorized for repurchase is $400.0 million.

During the first quarter of 2013, RGA repurchased 815,011 shares of common stock under this program for $47.6 million. During ~~April~~the second quarter of 2013, the Company repurchased an additional ~~892,047~~2,865,132 shares of common stock under the program for ~~$52.4~~$182.9 million. The common shares repurchased have been placed into treasury to be used for general corporate purposes.

~~On April 18,~~ As of June 30, 2013 ~~RGA’s~~there was $69.5 million remaining under the board of directors authorized ~~an increase of $100.0 million to the~~ share repurchase program, ~~previously authorized on January 24,~~which does not reflect the additional $100.0 million authorization approved by RGA’s board of director’s in July 2013. ~~With this authorization, the total amount of the Company’s outstanding common stock authorized for repurchase is $300.0 million.~~

Changes to the general accounting principles are established by the FASB in the form of accounting standards updates to the FASB Accounting Standards Codification™. Accounting standards updates not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company’s consolidated financial statements.

In December 2011, the FASB amended the general accounting principles forBalance Sheet as it relates to the disclosures about offsetting assets and liabilities. The amendment requires disclosures about the Company’s rights of offset and related arrangements associated with its financial instruments and derivative instruments. This amendment also requires the disclosure of both gross and net information about both instruments and transactions eligible for offset in the balance sheet and instruments and transactions subject to an agreement similar to a master netting arrangement. In January 2013, the FASB amended the general accounting principles forBalance Sheetas it relates to the disclosures about offsetting assets and liabilities. This amendment clarifies that the scope of the Balance Sheet amendment made in December 2011 applies only to derivatives, including bifurcated embedded derivatives, repurchase and reverse repurchase agreements, and securities borrowing and lending transactions that are either offset or subject to an enforceable master netting agreement or a similar agreement. These amendments are effective for interim and annual reporting periods beginning on or after January 1, 2013. The Company adopted these amendments and the required disclosures are provided in Note 45 — ~~“Investments.”~~“Derivative Instruments”.

In April 2011, the FASB amended the general accounting principles forTransfers and Servicing as it relates to the reconsideration of effective control for repurchase agreements. This amendment removes from the assessment of effective control the criterion requiring the transferor to have the ability to repurchase or redeem the financial assets and also removes the collateral maintenance implementation guidance related to that criterion. The amendment is effective for interim and annual periods beginning after December 15, 2011. The adoption of this amendment did not have an impact on the Company’s condensed consolidated financial statements.

In May 2011, the FASB amended the general accounting principles forFair Value Measurements and Disclosures as it relates to the measurement and disclosure requirements about fair value measurements. This amendment clarifies the FASB’s intent about the application of existing fair value measurement requirements. It also changes particular principles and requirements for measuring fair value and for disclosing information about fair value measurements. The amendment is effective for interim and annual periods beginning after December 15, 2011. The Company adopted this amendment and the required disclosures are provided in Note 6 — “Fair Value of Assets and Liabilities.”

In October 2010, the FASB amended the general accounting principles forFinancial Services – Insurance as it relates to accounting for costs associated with acquiring or renewing insurance contracts. This amendment clarifies that only those costs that result directly from and are essential to the contract transaction and that would not have been incurred had the contract transaction not occurred can be capitalized. It also defines acquisitions costs as costs that are related directly to the successful acquisitions of new or renewal insurance contracts. The amendment is effective for fiscal years and interim periods beginning after December 15, 2011. The retrospective adoption of this amendment on January 1, 2012, resulted in a reduction in the Company’s deferred acquisition cost asset and a corresponding reduction to equity, reflected in the financial statements in all periods. There will be a decrease in amortization subsequent to adoption due to the reduced deferred acquisition cost asset. There has also been a reduction in the level of future costs the Company defers; thereby increasing expenses incurred in future periods. The cumulative effect of the adoption of this amendment was a decrease to total stockholders’ equity of $318.4 million and a decrease in the deferred policy acquisition costs balance of $470.1 million on January 1, 2012.

In February 2013, the FASB amended the general accounting principles forComprehensive Income as it relates to the reporting of amounts reclassified out of accumulated other comprehensive income. The amendment requires entities to provide information about the amounts reclassified out of accumulated other comprehensive income by component. This amendment also requires entities to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income. However, this is only necessary if the amount reclassified is required to be reclassified to net income in its entirety in the same reporting period. The amendment is effective for interim and annual reporting periods beginning after December 31, 2012. The Company adopted this amendment and the required disclosures are provided in Note 3 — “Accumulated Other Comprehensive Income.”

In June 2011, the FASB amended the general accounting principles forComprehensive Income as it relates to the presentation of comprehensive income. This amendment requires entities to present the total of comprehensive income, the components of net income, and the components of other comprehensive income in either a continuous statement of comprehensive income or in two separate but consecutive statements. The amendment does not change the items that must be reported in other comprehensive income. In December 2011, the FASB amended the general accounting principles forComprehensive Income as it relates to the presentation of comprehensive income. This amendment defers the requirement to present the effects of reclassifications out of accumulated other comprehensive income on the Company’s consolidated statements of income, which was required in theComprehensive Income amendment made in June 2011. These amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. The Company adopted these amendments and the required presentation is provided in the Condensed Consolidated Statements of Comprehensive Income.

In July 2013, the FASB amended the general accounting principles forIncome Taxes as it relates to the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. This amendment clarifies that an unrecognized tax benefit should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. However, to the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and not combined with deferred tax assets. These amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The adoption of this amendment is not expected to have an impact on the Company’s condensed consolidated financial statements.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including, among others, statements relating to projections of the strategies, earnings, revenues, income or loss, ratios, future financial performance, and growth potential of the Company. The words “intend,” “expect,” “project,” “estimate,” “predict,” “anticipate,” “should,” “believe,” and other similar expressions also are intended to identify forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results, performance, and achievements could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

Numerous important factors could cause actual results and events to differ materially from those expressed or implied by forward-looking statements including, without limitation, (1) adverse capital and credit market conditions and their impact on the Company’s liquidity, access to capital and cost of capital, (2) the impairment of other financial institutions and its effect on the Company’s business, (3) requirements to post collateral or make payments due to declines in market value of assets subject to the Company’s collateral arrangements, (4) the fact that the determination of allowances and impairments taken on the Company’s investments is highly subjective, (5) adverse changes in mortality, morbidity, lapsation or claims experience, (6) changes in the Company’s financial strength and credit ratings and the effect of such changes on the Company’s future results of operations and financial condition, (7) inadequate risk analysis and underwriting, (8) general economic conditions or a prolonged economic downturn affecting the demand for insurance and reinsurance in the Company’s current and planned markets, (9) the availability and cost of collateral necessary for regulatory reserves and capital, (10) market or economic conditions that adversely affect the value of the Company’s investment securities or result in the impairment of all or a portion of the value of certain of the Company’s investment securities, that in turn could affect regulatory capital, (11) market or economic conditions that adversely affect the Company’s ability to make timely sales of investment securities, (12) risks inherent in the Company’s risk management and investment strategy, including changes in investment portfolio yields due to interest rate or credit quality changes, (13) fluctuations in U.S. or foreign currency exchange rates, interest rates, or securities and real estate markets, (14) adverse litigation or arbitration results, (15) the adequacy of reserves, resources and accurate information relating to settlements, awards and terminated and discontinued lines of business, (16) the stability of and actions by governments and economies in the markets in which the Company operates, including ongoing uncertainties regarding the amount of United States sovereign debt and the credit ratings thereof, (17) competitive factors and competitors’ responses to the Company’s initiatives, (18) the success of the Company’s clients, (19) successful execution of the Company’s entry into new markets, (20) successful development and introduction of new products and distribution opportunities, (21) the Company’s ability to successfully integrate and operate reinsurance business that the Company acquires, (22) action by regulators who have authority over the Company’s reinsurance operations in the jurisdictions in which it operates, (23) the Company’s dependence on third parties, including those insurance companies and reinsurers to which the Company cedes some reinsurance, third-party investment managers and others, (24) the threat of natural disasters, catastrophes, terrorist attacks, epidemics or pandemics anywhere in the world where the Company or its clients do business, (25) changes in laws, regulations, and accounting standards applicable to the Company, its subsidiaries, or its business, (26) the effect of the Company’s status as an insurance holding company and regulatory restrictions on its ability to pay principal of and interest on its debt obligations, and (27) other risks and uncertainties described in this document and in the Company’s other filings with the SEC.

Forward-looking statements should be evaluated together with the many risks and uncertainties that affect the Company’s business, including those mentioned in this document and the cautionary statements described in the periodic reports the Company files with the SEC. These forward-looking statements speak only as of the date on which they are made. The Company does not undertake any obligations to update these forward-looking statements, even though the Company’s situation may change in the future. The Company qualifies all of its forward-looking statements by these cautionary statements. For a discussion of these risks and uncertainties that could cause actual results to differ materially from those contained in the forward-looking statements, you are advised to see Item 1A – “Risk Factors” in the 2012 Annual Report.

RGA is an insurance holding company that was formed on December 31, 1992. The condensed consolidated financial statements include the assets, liabilities and results of operations of RGA, RGA Reinsurance, RCM, RGA Barbados, RGA Americas, RGA Atlantic, RGA Canada, RGA Australia and RGA International as well as other subsidiaries, which are primarily wholly owned (collectively, the Company).

The Company is primarily engaged in the reinsurance of individual and group coverages for traditional life and health, longevity, disability, ~~income,~~ annuity and critical illness products, and financial reinsurance. RGA and its predecessor, the Reinsurance Division of General American Life Insurance Company, a Missouri life insurance company, have been engaged

in the business of life reinsurance since 1973. Approximately 66.3% of the Company’s 2012 net premiums were from its operations in North America, represented by its U.S. and Canada segments.

The Company derives revenues primarily from renewal premiums from existing reinsurance treaties, new business premiums from existing or new reinsurance treaties and income earned on invested assets.

The Company’s primary business is life and health reinsurance, which involves reinsuring life insurance policies that are often in force for the remaining lifetime of the underlying individuals insured, with premiums earned typically over a period of 10 to 30 years. Each year, however, a portion of the business under existing treaties terminates due to, among other things, lapses or voluntary surrenders of underlying policies, deaths of insureds, and the exercise of recapture options by ceding companies.

As is customary in the reinsurance business, clients continually update, refine, and revise reinsurance information provided to the Company. Such revised information is used by the Company in preparation of its financial statements and the financial effects resulting from the incorporation of revised data are reflected in the current period.

The Company’s long-term profitability primarily depends on the volume and amount of death and health-related claims incurred and the ability to adequately price the risks assumed. While death claims are reasonably predictable over a period of many years, claims become less predictable over shorter periods and are subject to significant fluctuation from quarter to quarter and year to year. The maximum amount of individual life coverage the Company retains per life varies by market and can be as high as $8.0 million. In certain limited situations the Company has retained more than $8.0 million per individual life. Exposures in excess of these retention amounts are typically retroceded to retrocessionaires; however, the Company remains fully liable to the ceding company for the entire amount of risk it assumes. The Company believes its sources of liquidity are sufficient to cover potential claims payments on both a short-term and long-term basis.

The Company has five geographic-based or function-based operational segments, each of which is a distinct reportable segment: U.S., Canada, Europe & South Africa, Asia Pacific and Corporate and Other. The U.S. operations provide traditional life, long-term care, group life and health reinsurance, annuity and financial reinsurance products. The Canada operations reinsure traditional life products as well as creditor reinsurance, group life and health reinsurance, non-guaranteed critical illness products and longevity reinsurance. Europe & South Africa operations include a variety of life and health products, critical illness and longevity business throughout Europe and in South Africa, in addition to other markets the Company is developing. The principle types of reinsurance in Asia Pacific include life, critical illness, health, disability, ~~income,~~ superannuation and financial reinsurance. Corporate and Other includes results from, among others, RGA Technology Partners, Inc. (“RTP”), a wholly-owned subsidiary that develops and markets technology solutions for the insurance industry, interest expense related to debt and the investment income and expense associated with the Company’s collateral finance facility. The Company measures segment performance based on profit or loss from operations before income taxes.

The Company allocates capital to its segments based on an internally developed economic capital model, the purpose of which is to measure the risk in the business and to provide a consistent basis upon which capital is deployed. The economic capital model considers the unique and specific nature of the risks inherent in RGA’s businesses. As a result of the economic capital allocation process, a portion of investment income and investment related gains and losses is credited to the segments based on the level of allocated capital. In addition, the segments are charged for excess capital utilized above the allocated economic capital basis. This charge is included in policy acquisition costs and other insurance expenses.

Consolidated income before income taxes ~~increased $98.1~~decreased $290.7 million, or ~~54.3%~~134.6%, and $192.6 million, or 48.6%, for the ~~first quarter of~~three and six months ended June 30, 2013, as compared to the same ~~period~~periods in 2012. The ~~increase~~decrease in income before income taxes for the second quarter of 2013 was primarily due to a significant loss in the Asia Pacific segment partially offset by increased investment related gains and higher investment income. The loss in the Asia Pacific segment reflects an increase in Australian group claims liabilities related to total and permanent disability coverage and disability income benefits as well as poor claims experience in the Australian operation’s individual lump sum and individual disability businesses. The decrease in income before income taxes for the first six months of 2013 was primarily due to the aforementioned loss in the Asia Pacific segment related to the Australian operations partially offset by an increase in investment related gains, higher investment income and the recognition in other revenues of gains on the repurchase of collateral finance facility securities of $46.5 million. The increase in investment related gains in the second quarter and first six months reflects a favorable change in the value of embedded derivatives within the U.S. ~~segment due to the~~segment. The effect of tightening credit ~~spreads.~~spreads in the U.S. markets generated an increase in revenue related to embedded derivatives to a greater extent in the first six months of 2013 than 2012. Foreign currency fluctuations relative to the prior year ~~unfavorably~~ favorably

affected income before income taxes by approximately ~~$2.2~~$14.4 million inand $12.2 million for the second quarter and first ~~quarter~~six months of 2013, respectively, as compared to the same ~~period~~periods in 2012.

The Company recognizes in consolidated income, any changes in the value of embedded derivatives on modco or funds withheld treaties, equity-indexed annuity treaties (“EIAs”) and variable annuity products. The change in the value of embedded derivatives related to reinsurance treaties written on a modco or funds withheld basis isare subject to the general accounting principles for derivatives and hedging related to embedded derivatives. The unrealized gains and losses associated with these embedded derivatives, after adjustment for deferred acquisition costs, increased income before income taxes by ~~$30.3~~$25.4 million and $55.7 million in the second quarter and first ~~quarter~~six months of 2013, respectively, as compared to the same ~~period~~periods in 2012. Changes in ~~risk free~~risk-free rates used in the fair value estimates of embedded derivatives associated with EIAs affect the amount of unrealized gains and losses the Company

recognizes. The unrealized gains and losses associated with EIAs, after adjustment for deferred acquisition costs and retrocession, increased income before income taxes by ~~$5.0~~$14.5 million and $19.5 million in the second quarter and first ~~quarter~~six months of 2013, respectively, as compared to the same ~~period~~periods in 2012. The change in the Company’s liability for variable annuities associated with guaranteed minimum living benefits affects the amount of unrealized gains and losses the Company recognizes. The unrealized gains and losses associated with guaranteed minimum living benefits, after adjustment for deferred acquisition costs, ~~decreased~~increased income before income taxes by ~~$4.4~~$69.6 million and $65.2 million in the second quarter and first ~~quarter~~six months of 2013, respectively, as compared to the same ~~period~~periods in 2012.

The combined changes in these three types of embedded derivatives, after adjustment for deferred acquisition costs and retrocession, resulted in an increase of approximately ~~$30.9~~$109.5 million and approximately $140.4 million in consolidated income before income taxes in the second quarter and first ~~quarter~~six months of 2013, respectively, as compared to the same ~~period~~periods in 2012. These fluctuations do not affect current cash flows, crediting rates or spread performance on the underlying treaties. Therefore, management believes it is helpful to distinguish between the effects of changes ~~the fair value of~~ in these embedded derivatives, net of related hedging activity, and the primary factors that drive profitability of the underlying treaties, namely investment income, fee income, and interest credited.

Consolidated net premiums increased ~~$116.2~~$84.5 million, or ~~6.2%~~4.3%, inand $200.7 million, or 5.3%, for the ~~first quarter of~~three and six months ended June 30, 2013, as compared to the same ~~period~~periods in 2012, primarily due to growth in life reinsurance ~~in force.~~partially offset by foreign currency fluctuations. Foreign currency fluctuations unfavorably affected net premiums by approximately ~~$19.6~~$21.2 million inand $40.8 million for the ~~first quarter of~~three and six months ended June 30, 2013, as compared to the same ~~period~~periods in 2012. Consolidated assumed insurance in force increased to $2,823.8 billion as of June 30, 2013 from $2,782.3 billion as of June 30, 2012 due to new business production. Foreign currency fluctuations negatively affected the increase in assumed life insurance in force ~~increased to $2,872.8 billion as of March 31, 2013~~ from ~~$2,771.0 billion as of March 31,~~June 30, 2012 ~~due to new business production.~~by $77.4 billion. The Company added new business production, measured by face amount of insurance in force, of ~~$95.9~~$104.0 billion and ~~$118.5~~$86.8 billion during the ~~first~~second quarter of 2013 and 2012, ~~respectively. Foreign currency fluctuations negatively affected~~respectively, and $199.9 billion and $205.3 billion during the ~~increase in assumed life insurance in force from March 31,~~first six months of 2013 and 2012, ~~by $38.9 billion.~~respectively. Management believes industry consolidation and the established practice of reinsuring mortality risks should continue to provide opportunities for growth, albeit at rates less than historically experienced in some markets.

Consolidated investment income, net of related expenses, increased ~~$84.2~~$115.9 million, or ~~24.7%~~35.3%, and $200.1 million, or 29.9%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. The ~~increase is~~increases are primarily due to ~~$53.5 million of investment income associated with a large fixed annuity transaction executed in the second quarter of 2012. Contributing to~~ the increase isin market value changes related to the Company’s funds withheld at interest investment associated with the reinsurance of certain EIAs which ~~favorably affected~~contributed to the increases in investment income by ~~$20.8 million.~~$92.9 million and 113.7 million in the second quarter and first six months of 2013, respectively. The effect on investment income of the EIAs market value changes is substantially offset by a corresponding change in interest credited to policyholder account balances resulting in an insignificant effect on net income. In addition, investment income associated with a large fixed annuity transaction executed in the second quarter of 2012 contributed $15.4 million and $68.9 million to the increase in the second quarter and first six months of 2013, respectively. The increase also reflects a larger average invested asset base, excluding funds withheld and other spread business, somewhat offset by lower effective investment portfolio yields. Average invested assets at amortized cost, excluding funds withheld and other spread business, for the ~~three~~six months ended ~~March 31,~~June 30, 2013 totaled ~~$18.0~~$17.9 billion, a ~~10.1%~~9.8% increase over ~~March 31,~~June 30, 2012. The average yield earned on investments, excluding funds withheld and other spread business, ~~decreased to 4.83%,~~was 4.77% and 5.06% for the ~~first~~second quarter of 2013 ~~from 5.05%~~and 2012, respectively, and 4.80% and 5.06% for the ~~first quarter of 2012.~~six months ended June 30, 2013 and 2012, respectively. The average yield will vary from quarter to quarter and year to year depending on a number of variables, including the prevailing interest rate and credit spread environment, changes in the mix of the underlying investments and cash balances, and the timing of dividends and distributions on certain investments. AWhile there was some improvement late in the second quarter of 2013, a continued low interest rate environment in the U.S. and Canada is expected to put downward pressure on this yield in future reporting periods.

Total investment related gains (losses), net ~~increased by $50.9~~reflect a favorable change of $24.4 million ~~or 116.8%,~~and $75.3 million, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. The ~~increase is~~increases are primarily due to a favorable change in the embedded derivatives related to reinsurance treaties written on a modco or funds withheld basis of ~~$99.7~~$52.2 million ~~an increase~~and $151.9 million, a favorable change in the embedded derivatives related to guaranteed minimum living benefits of $110.7 million and $15.7 million in the second quarter and first six months of 2013, respectively. Offsetting these increases was a decrease in the fair value of derivatives used to hedge the embedded derivative liabilities associated with guaranteed minimum living benefits of ~~$43.4~~

$134.3 million and ~~a decrease~~$90.9 million in ~~investment~~the second quarter and first six months of 2013, respectively. Investment impairments on fixed maturity and equity securities ~~of $14.6 million. Offsetting these increases was an unfavorable change~~increased by $8.3 million and decreased by $6.3 million in the ~~embedded derivatives related to guaranteed minimum living benefits~~second quarter and first six months of ~~$95.1 million.~~2013, respectively. See Note 4 –- “Investments” and Note 5 –- “Derivative Instruments” in the Notes to Condensed Consolidated Financial Statements for additional information on the impairment losses and derivatives. Investment income and investment related gains and losses are allocated to the operating segments based upon average assets and related capital levels deemed appropriate to support the segment operations.

The effective tax rate on a consolidated basis was ~~33.5%~~33.6% and ~~31.8%~~34.6% for the second quarter of 2013 and 2012, respectively, and 33.4% and 33.3% for the first ~~quarter~~six months of 2013 and 2012, respectively. The second quarter and first six months of 2013 effective tax ~~rate was~~rates were lower than the U.S. ~~Statutory~~statutory rate of ~~35%~~35.0% primarily as a result of income in non-U.S. jurisdictions with lower tax rates than the U.S. ~~and~~, differences in tax basis in foreign ~~jurisdictions.~~jurisdictions, and the establishment of a valuation allowance on a portion of Australia’s deferred tax asset. The second quarter and first six months of 2012 effective tax rate was lower than the U.S. statutory rate of ~~35%~~35.0% primarily as a result of income in non-U.S. jurisdictions with lower tax rates than the U.S. and differences in tax basis in foreign jurisdictions offset by a tax accrual of ~~$1.3~~$2.1 million related to business extender provisions that the U.S. Congress did not pass prior to the end of ~~the quarter.~~2012.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires the application of accounting policies that often involve a significant degree of judgment. Management, on an ongoing basis, reviews estimates and assumptions used in the preparation of financial statements. If management determines that modifications in assumptions and estimates are appropriate given current facts and circumstances, results of operations and financial position as reported in the condensed consolidated financial statements could change significantly.

Management believes the critical accounting policies relating to the following areas are most dependent on the application of estimates and assumptions:

A discussion of each of the critical accounting policies may be found in the Company’s 2012 Annual Report under “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies.”

Further discussion and analysis of the results for 2013 compared to 2012 are presented by segment.

U.S. operations consist of two major sub-segments: Traditional and Non-Traditional. The Traditional sub-segment primarily specializes in individual mortality-risk reinsurance and to a lesser extent, group, health and long-term care reinsurance. The Non-Traditional sub-segment consists of Asset-Intensive and Financial Reinsurance. During 2012, the Asset-Intensive sub-segment issued its first fee-based synthetic guaranteed investment contracts which include investment-only, stable value contracts, to retirement plans.


For the three months ended March 31, 2013			Non-Traditional
For the three months ended June 30, 2013														Non-Traditional

(dollars in thousands)			Asset-Intensive		Financial Reinsurance			Total U.S.			Traditional			Asset-Intensive			Financial Reinsurance			Total U.S.
	Traditional

Revenues:			Asset-Intensive					Total U.S.
Net premiums	$	1,046,049	$	3,838	Financial Reinsurance	$	--		$	1,049,887		$	1,124,292		$	11,129		$	—		$	1,135,421
Investment income, net of related expenses		132,289		179,369		597			312,255			133,259			200,837			819			334,915
Investment related gains (losses), net:
Other-than-temporary impairments on fixed maturity securities		(162)		--		--			(162)			(8,085	)		—			—			(8,085	)
Other-than-temporary impairments on fixed maturity securities transferred to (from) accumulated other comprehensive income		--		--		--			--			(253	)		—			—			(253	)
Other investment related gains (losses), net		7,459		88,584		34			96,077			12,038			43,063			(100	)		55,001

Total investment related gains (losses), net		7,297		88,584		34			95,915			3,700			43,063			(100	)		46,663
Other revenues		529		28,881		12,797			42,207			1,144			29,937			16,306			47,387

Total revenues		1,186,164		300,672		13,428			1,500,264			1,262,395			284,966			17,025			1,564,386

Benefits and expenses:
Claims and other policy benefits		929,680		3,588		--			933,268			972,739			11,083			—			983,822
Interest credited		16,150		108,785		--			124,935			13,590			104,263			—			117,853
Policy acquisition costs and other insurance expenses		139,968		94,663		3,440			238,071			164,393			97,533			3,602			265,528
Other operating expenses		23,521		4,113		1,947			29,581			22,226			2,878			1,636			26,740

Total benefits and expenses		1,109,319		211,149		5,387			1,325,855			1,172,948			215,757			5,238			1,393,943


Income before income taxes	$	76,845	$	89,523	$	8,041		$	174,409		$	89,447		$	69,209		$	11,787		$	170,443


For the three months ended March 31, 2012			Non-Traditional
For the three months ended June 30, 2012														Non-Traditional

(dollars in thousands)			Asset-Intensive		Financial Reinsurance			Total U.S.			Traditional			Asset-Intensive			Financial Reinsurance			Total U.S.
	Traditional

Revenues:			Asset-Intensive					Total U.S.
Net premiums	$	1,021,507	$	3,596	Financial Reinsurance	$	--		$	1,025,103		$	1,082,400		$	3,355		$	—		$	1,085,755
Investment income (loss), net of related expenses		132,417		109,277		164			241,858			133,652			95,957			179			229,788
Investment related gains (losses), net:
Other-than-temporary impairments on fixed maturity securities		(6,030)		--		--			(6,030)			(1,822	)		—			—			(1,822	)
Other-than-temporary impairments on fixed maturity securities transferred to (from) accumulated other comprehensive income		(5,907)		--		--			(5,907)			162			—			—			162
Other investment related gains (losses), net		(1,147)		40,603		(139)			39,317			2,449			12,468			32			14,949

Total investment related gains (losses), net		(13,084)		40,603		(139)			27,380			789			12,468			32			13,289
Other revenues		1,003		19,893		8,910			29,806			401			29,254			11,734			41,389

Total revenues		1,141,843		173,369		8,935			1,324,147			1,217,242			141,034			11,945			1,370,221

Benefits and expenses:
Claims and other policy benefits		907,461		1,902		--			909,363			934,807			5,102			—			939,909
Interest credited		15,054		72,750		--			87,804			14,555			51,926			—			66,481
Policy acquisition costs and other insurance expenses (income)		145,485		59,065		770			205,320			150,958			46,597			704			198,259
Other operating expenses		24,001		3,062		1,852			28,915			20,586			2,807			1,593			24,986

Total benefits and expenses		1,092,001		136,779		2,622			1,231,402			1,120,906			106,432			2,297			1,229,635

Income before income taxes	$	49,842	$	36,590	$	6,313		$	92,745		$	96,336		$	34,602		$	9,648		$	140,586


For the six months ended June 30, 2013				Non-Traditional

(dollars in thousands)	Traditional			Asset-Intensive		Financial Reinsurance			Total U.S.
Revenues:
Net premiums	$	2,170,341		$	14,967	$	—		$	2,185,308
Investment income, net of related expenses		265,548			380,206		1,416			647,170
Investment related gains (losses), net:
Other-than-temporary impairments on fixed maturity securities		(8,247	)		—		—			(8,247	)
Other-than-temporary impairments on fixed maturity securities transferred to (from) accumulated other comprehensive income		(253	)		—		—			(253	)
Other investment related gains (losses), net		19,497			131,647		(66	)		151,078

Total investment related gains (losses), net		10,997			131,647		(66	)		142,578
Other revenues		1,673			58,818		29,103			89,594

Total revenues		2,448,559			585,638		30,453			3,064,650

Benefits and expenses:
Claims and other policy benefits		1,902,419			14,671		—			1,917,090
Interest credited		29,740			213,048		—			242,788
Policy acquisition costs and other insurance expenses		304,361			192,196		7,042			503,599
Other operating expenses		45,747			6,991		3,583			56,321

Total benefits and expenses		2,282,267			426,906		10,625			2,719,798

Income before income taxes	$	166,292		$	158,732	$	19,828		$	344,852


For the six months ended June 30, 2012				Non-Traditional

(dollars in thousands)	Traditional			Asset-Intensive		Financial Reinsurance			Total U.S.
Revenues:
Net premiums	$	2,103,907		$	6,951	$	—		$	2,110,858
Investment income (loss), net of related expenses		266,069			205,234		343			471,646
Investment related gains (losses), net:
Other-than-temporary impairments on fixed maturity securities		(7,852	)		—		—			(7,852	)
Other-than-temporary impairments on fixed maturity securities transferred to (from) accumulated other comprehensive income		(5,745	)		—		—			(5,745	)
Other investment related gains (losses), net		1,302			53,071		(107	)		54,266

Total investment related gains (losses), net		(12,295	)		53,071		(107	)		40,669
Other revenues		1,404			49,147		20,644			71,195

Total revenues		2,359,085			314,403		20,880			2,694,368

Benefits and expenses:
Claims and other policy benefits		1,842,268			7,004		—			1,849,272
Interest credited		29,609			124,676		—			154,285
Policy acquisition costs and other insurance expenses (income)		296,443			105,662		1,474			403,579
Other operating expenses		44,587			5,869		3,445			53,901

Total benefits and expenses		2,212,907			243,211		4,919			2,461,037

Income before income taxes	$	146,178		$	71,192	$	15,961		$	233,331

Income before income taxes for the U.S. operations segment increased by ~~$81.7~~$29.9 million, or 21.2%, and $111.5 million, or 47.8%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. The increase in income before income taxes in the ~~first quarter~~three and six months of 2013 can be largely attributed to the Asset-Intensive segment. The significant increase in income over the prior year for this sub-segment was generated primarily by a large Asset-Intensive transaction completed in the second quarter of 2012, favorable changes in credit spreads on the fair value of embedded derivatives associated with treaties written on a modified coinsurance or funds withheld basis, and favorable returns in the broader equity markets in ~~the first quarter of~~ 2013. ~~In addition, income~~Income before income taxes in the Traditional sub-segment also increased in the first six months of 2013, mainly as a result of an increase in investment related gains.

The U.S. Traditional sub-segment provides life and health reinsurance to domestic clients for a variety of products through yearly renewable term, coinsurance and modified coinsurance agreements. These reinsurance arrangements may involve either facultative or automatic agreements.

Income before income taxes for the U.S. Traditional sub-segment ~~increased~~decreased by ~~$27.0~~$6.9 million, or ~~54.2%~~7.2%, and increased $20.1 million, or 13.8%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. The decrease in the second quarter was primarily due to an increase in the acquisition margin combined with lower yield rates. Overall, while the acquisition ratios are expected to remain in a predictable range, they may fluctuate from period to period. The increase in the first ~~quarter~~six months was primarily due to an increase in investment related gains (losses), net and growth, primarily in the individual health line of business, compared to the same period in 2012.

Net premiums increased ~~$24.5~~$41.9 million, or ~~2.4%~~3.9%, and $66.4 million, or 3.2%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. The increase in net premiums was driven ~~almost entirely~~largely by growth in the health and group related coverages which contributed ~~$24.4~~$27.5 million and $52.0 million to the increase for the second quarter and first ~~quarter~~six months of ~~2013.~~2013, respectively. This sub-segment added new individual life business production, measured by face amount of insurance in force, of ~~$25.7~~$21.8 billion and ~~$85.0~~$24.2 billion during the second quarters, and $47.4 billion and $109.1 billion during the first ~~three~~six months of 2013 and 2012, respectively. Approximately ~~$42.8~~$42.4 billion of the decrease in ~~new business production~~the first six months as compared to the same period in 2012 relates to one large in force transaction recorded in the first quarter of 2012.

Net investment income decreased ~~$0.1~~$0.4 million, or ~~0.1%~~0.3%, and $0.5 million, or 0.2%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. The ~~decrease is~~decreases are due to lower yield rates ~~almost entirely~~ offset by an increase in the average invested asset base. Investment related gains (losses), net increased ~~$20.4~~$2.9 million and $23.3 million, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in ~~2012,~~2012. The increase in the first six months is primarily due to ~~a decrease~~an increase in net investment ~~impairments.~~gains. Investment income and investment related gains and losses are allocated to the various operating segments based on average assets and related capital levels deemed appropriate to support the segment business volumes. Investment performance varies with the composition of investments and the relative allocation of capital to the operating segments.

Claims and other policy benefits as a percentage of net premiums (“loss ratios”) were ~~88.9%~~86.5% and ~~88.8%~~86.4% for the ~~first~~second quarter of 2013 and 2012, ~~respectively. The Company’s experience indicates that claims flow is typically higher in~~respectively, and 87.7% and 87.6% for the ~~first quarter due to seasonality of death claims as more people die in winter~~six months ~~than other months of the year in several of the Company’s major markets. Although reasonably predictable over a period of years, death claims can be volatile over shorter periods.~~ended June 30, 2013, respectively.

Interest credited expense ~~increased $1.1~~decreased $1.0 million, or ~~7.3%~~6.6%, and increased $0.1 million, or 0.4%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. This expense relates primarily to one treaty in which the related investment income ~~increased~~decreased proportionately, resulting in minimal net income impact. Interest credited in this sub-segment relates to amounts credited on cash value products which also have a significant mortality component. Income before income taxes is affected by the spread between the investment income and the interest credited on the underlying products. Interest earned rates and related interest crediting rates are index driven. The spread remained relatively constant in both periods.

Policy acquisition costs and other insurance expenses as a percentage of net premiums were ~~13.4%~~14.6% and ~~14.2%~~13.9% for the ~~first~~second quarter of 2013 and 2012, and 14.0% and 14.1% for the six months ended June 30, 2013 and 2012, respectively. Overall, while these ratios are expected to remain in a predictable range, they may fluctuate from period to period due to varying allowance levels within coinsurance-type arrangements. In addition, the amortization pattern of previously capitalized amounts, which are subject to the form of the reinsurance agreement and the underlying insurance policies, may vary. Also, the mix of first year coinsurance business versus yearly renewable term business can cause the percentage to fluctuate from period to period.

Other operating expenses ~~decreased $0.5~~increased $1.6 million, or ~~2.0%~~8.0%, and $1.2 million, or 2.6%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. Other operating expenses, as a percentage of net premiums were ~~2.2%~~2.0% and ~~2.3%~~1.9% for the ~~first~~second quarter of 2013 and 2012, and 2.1% for both six month periods ended June 30, 2013 and 2012, respectively.

The U.S. Asset-Intensive sub-segment primarily assumes investment risk within underlying annuities and corporate-owned life insurance policies. Most of these reinsurance agreements are coinsurance, coinsurance with funds withheld or modified coinsurance whereby the Company recognizes profits or losses primarily from the spread between the investment income earned and the interest credited on the underlying deposit liabilities, as well as fees associated with variable annuity account values.

Income for the asset-intensive business tends to be volatile due to changes in the fair value of certain derivatives, including embedded derivatives associated with reinsurance treaties structured on a modco basis or funds withheld basis, as well as embedded derivatives associated with the Company’s reinsurance of equity-indexed annuities and variable annuities with guaranteed minimum benefit riders. Fluctuations occur period to period primarily due to changing investment conditions including, but not limited to, interest rate movements (including risk-free rates and credit spreads), implied volatility and equity market performance, all of which are factors in the calculations of fair value. Therefore, management believes it is helpful to distinguish between the effects of changes in these derivatives, net of related hedging activity, and the primary factors that drive profitability of the underlying treaties, namely investment income, fee income (included in other revenues), and interest credited. These fluctuations are considered unrealized by management and do not affect current cash flows, crediting rates or spread performance on the underlying treaties.

The following table summarizes the asset-intensive results and quantifies the impact of these embedded derivatives for the periods presented. Revenues before certain derivatives, benefits and expenses before certain derivatives, and income before income taxes and certain derivatives, should not be viewed as substitutes for GAAP revenues, GAAP benefits and expenses, and GAAP income before income taxes.


(dollars in thousands)	For the three months ended March 31,				Three months ended June 30,						Six months ended June 30,
	2013		2012		2013			2012			2013			2012
Revenues:
Total revenues	$	300,672	$	173,369	$	284,966		$	141,034		$	585,638		$	314,403
Less:
Embedded derivatives – modco/funds withheld treaties		90,201		(9,387)		46,326			(4,593	)		136,527			(13,980	)
Guaranteed minimum benefit riders and related free standing derivatives		(1,039)		50,670		(7,473	)		16,127			(8,513	)		66,797

Revenues before certain derivatives		211,510		132,086		246,113			129,500			457,624			261,586


Benefits and expenses:
Total benefits and expenses		211,149		136,779		215,757			106,432			426,906			243,211
Less:
Embedded derivatives – modco/funds withheld treaties		56,990		(12,402)		26,316			(455	)		83,306			(12,857	)
Guaranteed minimum benefit riders and related free standing derivatives		(1,411)		33,470		(3,034	)		10,011			(4,446	)		43,481
Equity-indexed annuities		(6,846)		(1,836)		(12,727	)		1,793			(19,573	)		(43	)

Benefits and expenses before certain derivatives		162,416		117,547		205,202			95,083			367,619			212,630


Income before income taxes:
Income before income taxes		89,523		36,590		69,209			34,602			158,732			71,192
Less:
Embedded derivatives – modco/funds withheld treaties		33,211		3,015		20,010			(4,138	)		53,221			(1,123	)
Guaranteed minimum benefit riders and related free standing derivatives		372		17,200		(4,439	)		6,116			(4,067	)		23,316
Equity-indexed annuities		6,846		1,836		12,727			(1,793	)		19,573			43

Income before income taxes and certain derivatives		49,094		14,539	$	40,911		$	34,417		$	90,005		$	48,956

Embedded Derivatives - Modco/Funds Withheld Treaties- Represents the change in the fair value of embedded derivatives on funds withheld at interest associated with treaties written on a modco or funds withheld basis. The fair value changes of embedded derivatives on funds withheld at interest associated with treaties written on a modco or funds withheld basis are reflected in revenues, while the related impact on deferred acquisition expenses is reflected in benefits and expenses. Changes in the fair value of the embedded derivative are driven by changes in investment credit spreads, including the Company’s own credit risk. Generally, an increase in investment credit spreads, ignoring changes in the Company’s own credit risk, will have a negative impact on the fair value of the embedded derivative (decrease in income). Changes in fair values of these embedded derivatives are net of ~~a decrease~~an increase (decrease) in revenues of ~~$1.7~~$(0.4) million and ~~$63.5~~$6.3 million for the three months, and $(2.1) million and $(57.2) million for the six months ended ~~March 31,~~June 30, 2013 and 2012, respectively, associated with the Company’s own credit risk. A 10% increase in the Company’s own credit risk rate would have increased revenues for the ~~three~~six months ended ~~March 31,~~June 30, 2013 by approximately $0.1 million. Conversely, a 10% decrease in the Company’s own credit risk rate would have decreased revenues for the ~~three~~six months ended ~~March 31,~~June 30, 2013 by approximately $0.1 million.

In the ~~first~~second quarter of 2013, the change in fair value of the embedded derivative increased revenues by ~~$90.2~~$46.3 million and related deferred acquisition expenses ~~decreased~~increased benefits and expenses by ~~$57.0~~$26.3 million, for a positive pre-tax income impact of ~~$33.2~~$20.0 million. During the ~~first~~second quarter of 2012, the change in fair value of the embedded derivative decreased revenues by ~~$9.4~~$4.6 million and related deferred acquisition expenses decreased benefits and expenses by ~~$12.4~~$0.5 million, for a negative pre-tax income impact of $4.1 million. In the first six months of 2013, the change in fair value of the embedded derivative increased revenues by $136.5 million and related deferred acquisition expenses increased benefits and expenses by $83.3 million, for a positive pre-tax income impact of ~~$3.0~~$53.2 million. During the first six months of 2012, the change in fair value of the embedded derivative decreased revenues by $14.0 million and related deferred acquisition expenses decreased benefits and expenses by $12.9 million, for a negative pre-tax income impact of $1.1 million.

Guaranteed Minimum Benefit Riders- Represents the impact related to guaranteed minimum benefits associated with the Company’s reinsurance of variable annuities. The fair value changes of the guaranteed minimum benefits along with the changes in fair value of the free standing derivatives purchased by the Company to partially hedge the liability are reflected in revenues, while the related impact on deferred acquisition expenses is reflected in expenses. Changes in fair values of these embedded derivatives are net of an increase (decrease) in revenues of ~~$11.9~~$(0.2) million and ~~$37.0~~$14.6 million for the three months, and $(4.9) million and $51.6 million for the six months ended ~~March 31,~~June 30, 2013 and 2012, respectively, associated with the Company’s own credit risk. A 10% increase in the Company’s own credit risk rate would have increased revenues for the ~~three~~six months ended ~~March 31,~~June 30, 2013 by approximately ~~$1.1~~$1.2 million. Conversely, a 10% decrease in the Company’s own credit risk rate would have decreased revenues for the ~~three~~six months ended ~~March 31,~~June 30, 2013 by approximately ~~$1.1~~$1.2 million.

In the ~~first~~second quarter of 2013, the change in the fair value of the guaranteed minimum benefits, after allowing for changes in the associated free standing derivatives, decreased revenues by ~~$1.0~~$7.5 million and deferred acquisition expenses decreased benefits and expenses by ~~$1.4~~$3.0 million for a ~~positive~~negative pre-tax income impact of ~~$0.4~~$4.4 million. In the ~~first~~second quarter of 2012, the change in the fair value of the guaranteed minimum benefits after allowing for changes in the associated free standing derivatives increased revenues by ~~$50.7~~$16.1 million and deferred acquisition expenses increased benefits and expenses by ~~$33.5~~$10.0 million for a positive pre-tax income impact of ~~$17.2~~$6.1 million. In the first six months of 2013, the change in the fair value of the guaranteed minimum benefits, after allowing for changes in the associated free standing derivatives, decreased revenues by $8.5 million and deferred acquisition expenses decreased benefits and expenses by $4.4 million for a negative pre-tax income impact of $4.1 million. In the first six months of 2012, the change in the fair value of the guaranteed minimum benefits after allowing for changes in the associated free standing derivatives increased revenues by $66.8 million and deferred acquisition expenses increased benefits and expenses by $43.5 million for a positive pre-tax income impact of $23.3 million.

Equity-Indexed Annuities- Represents the impact of changes in the benchmark rate on the calculation of the fair value of embedded derivative liabilities associated with equity-indexed annuities, after adjustments for related deferred acquisition expenses. In the ~~first~~second quarter of 2013 and 2012, expenses decreased ~~$6.8~~$12.7 million and increased $1.8 million, respectively. In the first six months of 2013 and 2012, expenses decreased $19.6 million and less than $0.1 million, respectively.

The changes in derivatives discussed above are considered unrealized by management and do not affect current cash flows, crediting rates or spread performance on the underlying treaties. Fluctuations occur period to period primarily due to changing investment conditions including, but not limited to, interest rate movements (including benchmark rates and credit spreads), implied volatility and equity market performance, all of which are factors in the calculations of fair value. Therefore, management believes it is helpful to distinguish between the effects of changes in these derivatives and the primary factors that drive profitability of the underlying treaties, namely investment income, fee income (included in other revenues) and interest credited.

The increase in income before income taxes and certain derivatives of $6.5 million and $41.0 million in the second quarter and first ~~quarter~~six months of 2013, ~~of $34.6 million~~as compared to the same periods in 2012, was primarily due to a large coinsurance agreement entered into in the second quarter of 2012. ~~In addition,~~This increase was partially offset, particularly in the second quarter compared to 2012 by the net impact of investment related gains (losses) and corresponding changes in DAC related to capital gains (losses) in the funds withheld portfolios, ~~also contributed~~as significant net gains were taken in 2012 compared to ~~the favorable variance.~~net losses in 2013. Funds withheld capital gains and losses are reported through investment income.

The increase in revenue before certain derivatives of ~~$79.4~~$116.6 million and $196.0 million in the second quarter and first ~~quarter~~six months of 2013, as compared to the same periods in 2012, was ~~largely~~ driven by a combination of changes in investment income related to equity options held in a funds withheld portfolio associated with equity-indexed annuity treaties and an increase in investment income attributed to the new coinsurance agreement ~~referred~~mentioned above. The effect on investment income related to ~~above.~~equity options is substantially offset by a corresponding change in interest credited expense.

The increase in benefits and expenses before certain derivatives of ~~$44.9~~$110.1 million and $155.0 million in the second quarter and first ~~quarter~~six months of 2013, as compared to the same periods in 2012, was ~~primarily due to~~driven by a ~~change~~combination of changes in ~~the~~ interest credited ~~expense~~ related to equity options held in funds withheld portfolio associated with equity-indexed annuity treaties and an increase in interest credited attributed to the new coinsurance ~~transaction~~agreement mentioned above. ~~This change was mostly~~The effect on interest credited related to equity options is substantially offset by a corresponding change in investment income.

The average invested asset base supporting this sub-segment ~~increased~~decreased to ~~$11.3~~$11.2 billion in the ~~first~~second quarter of 2013 from ~~$5.9~~$11.6 billion in the ~~first~~second quarter of 2012. The ~~growth~~decrease in the asset base was ~~driven~~due primarily byto one large closed-block transaction in which the ~~significant coinsurance transaction previously mentioned.~~business is beginning to run-off. As of ~~March 31,~~June 30, 2013, $4.3 billion of the invested assets were funds withheld at interest, of which ~~93.6%~~94.4% is associated with one client.

U.S. Financial Reinsurance sub-segment income before income taxes consists primarily of net fees earned on financial reinsurance transactions. Financial reinsurance risks are assumed by the U.S. segment and a portion ~~are~~is retroceded to other insurance companies or brokered business in which the Company does not participate in the assumption of risk. The fees earned from financial reinsurance contracts and brokered business are reflected in other revenues, and the fees paid to retrocessionaires are reflected in policy acquisition costs and other insurance expenses.

Income before income taxes increased ~~$1.7~~$2.1 million, or ~~27.4%~~22.2%, and $3.9 million, or 24.2%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. The increase in the ~~first~~second quarter of 2013 was the result of additional surplus relief provided as compared to the same period in 2012. At ~~March 31,~~June 30, 2013 and 2012, the amount of reinsurance assumed from client companies, as measured by pre-tax statutory surplus, risk based capital and other financial structures was ~~$2.7~~$3.1 billion and ~~$2.0~~$2.1 billion, respectively. The increase was primarily due to a number of new transactions entered into in the last half of 2012 and the first half of 2013. Fees earned from this business can vary significantly depending on the size of the transactions and the timing of their completion and therefore can fluctuate from period to period.

The Company conducts reinsurance business in Canada primarily through RGA Life Reinsurance Company of Canada (“RGA Canada”), a wholly-owned subsidiary. RGA Canada assists clients with capital management activity and mortality and morbidity risk management, and is primarily engaged in traditional individual life reinsurance, as well as creditor, group life and health, critical illness, and longevity reinsurance. Creditor insurance covers the outstanding balance on personal, mortgage or commercial loans in the event of death, disability or critical illness and is generally shorter in duration than traditional life insurance.

(dollars in thousands)            For the three months ended
March 31,
   2013    2012
Revenues:

Net premiums
   $ 243,271    $ 218,210
Investment income, net of related expenses
   50,555    48,900
Investment related gains (losses), net:

Other-than-temporary impairments on fixed maturity securities
   --       --
Other-than-temporary impairments on fixed maturity securities transferred to (from) accumulated other comprehensive income
   --       --
Other investment related gains (losses), net
   3,055    8,543




Total investment related gains (losses), net
   3,055    8,543
Other revenues
   208    (30)




Total revenues
   297,089    275,623




Benefits and expenses:

Claims and other policy benefits
   189,698    160,625
Interest credited
   12    --
Policy acquisition costs and other insurance expenses
   60,832    50,285
Other operating expenses
   10,239    9,650




Total benefits and expenses
   260,781    220,560




Income before income taxes
   $ 36,308    $ 55,063

Income before income taxes ~~decreased~~increased by ~~$18.8~~$0.6 million, or ~~34.1%~~1.8%, and decreased $18.1 million, or 20.1%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. The decrease in income in the first ~~quarter~~six months of 2013 was primarily due to better traditional individual life mortality experience in the prior ~~quarter compared to this quarter~~year and a decrease of ~~$5.5~~$7.4 million in net investment related gains. In addition, the first ~~quarter~~six months of 2012 included $6.3 million of income from the recapture of a previously assumed block of individual life ~~business. In~~business recognized in the first ~~three months~~quarter of ~~2013, a~~2012. A weaker Canadian dollar resulted in a decrease in income before income taxes of ~~$0.5~~$0.6 million and $1.1 million for the second quarter and first six months of 2013, respectively, as compared to the same ~~period~~periods in 2012.

Net premiums increased ~~$25.1~~$18.5 million, or ~~11.5%~~8.3%, and $43.5 million, or 9.9%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. Premiums increased in the second quarter and first ~~quarter~~six months of 2013 due to new business from both new and existing treaties. Excluding the impact of foreign currency exchange, reinsurance in force at ~~March 31,~~June 30, 2013 increased ~~7.0%~~6.5% over ~~March 31,~~June 30, 2012. ~~The~~Also contributing to the increase in net premiums is ~~also due to~~ an increase in premiums from creditor treaties of ~~$16.7 million.~~$3.4 million and $20.1 million for the second quarter and first six months of 2013, as compared to the same periods in 2012. Foreign currency exchange fluctuation in the Canadian dollar resulted in a decrease in net premiums of approximately ~~$1.6~~$3.1 million inand $4.7 million for the second quarter and first ~~quarter~~six months of 2013, respectively, as compared to the same periods in 2012. Premium levels can be significantly influenced by currency fluctuations, large transactions, mix of business and reporting practices of ceding companies and therefore may fluctuate from period to period.

Net investment income increased ~~$1.7~~$5.4 million, or ~~3.4%~~11.7%, and $7.1 million, or 7.4%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. The increase in investment income, excluding the impact of foreign currency exchange, was mainly the result of ~~a 11.0%~~an increase in the allocated asset base due to growth in the underlying business volume, offset by a lower investment yield. Foreign currency exchange fluctuation in the Canadian dollar resulted in a decrease to net investment income of approximately ~~$0.4~~$0.7 million and $1.1 million in the second quarter and first ~~quarter~~six months of 2013, respectively, as compared to the same ~~period~~periods in 2012. Investment income and investment related gains and losses are allocated to the segments based upon average assets and related capital levels deemed appropriate to support the segment business volumes. Investment performance varies with the composition of investments and the relative allocation of capital to the operating segments.

Other revenues decreased by $2.9 million, or 90.6%, and $2.7 million, or 83.9%, for the three and six months ended June 30, 2013, as compared to the same periods in 2012. These decreases were primarily due to $3.3 million fees earned in the prior year from the recapture of a previously assumed block of individual life business.

Loss ratios for this segment were ~~78.0%~~82.0% and ~~73.6%~~83.6% for the ~~first~~second quarter of 2013 and 2012, and 80.0% and 78.6%, for the six months ended June 30, 2013 and 2012, respectively. Excluding creditor business, ~~claims~~loss ratios for this segment were 94.5% and ~~other policy benefits, as a percentage of net premiums and investment income were 72.9% and 65.4%~~95.5% for the ~~first~~second quarter of 2013 and 2012, respectively, and 93.9% and 89.7% for the six months ended June 30, 2013 and 2012, respectively. The increase in the loss ratio for the first six months of 2013 is due to better than expected traditional individual life mortality experience in the prior ~~quarter~~year compared to the current ~~quarter.~~year.

Policy acquisition costs and other insurance expenses as a percentage of net premiums were ~~25.0%~~21.8% and ~~23.0%~~21.5% for the ~~first~~second quarter of 2013 and 2012, and 23.4% and 22.2% for the six months ended June 30, 2013 and 2012, respectively. Policy acquisition costs and other insurance expenses as a percentage of net premiums for traditional individual life business were ~~12.9%~~12.3% and ~~14.6%~~12.1% for the ~~first~~second quarter of 2013 and 2012, and 12.6% and 13.4% for the six months ended June 30, 2013 and 2012, respectively. Overall, while these ratios are expected to remain in a predictable range, they may fluctuate from period to period due to varying allowance levels and product mix. In addition, the amortization pattern of previously capitalized amounts, which are subject to the form of the reinsurance agreement and the underlying insurance policies, may vary.

Other operating expenses increased by ~~$0.6~~$2.1 million, or ~~6.1%~~23.3%, and $2.7 million, or 14.3%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. Other operating expenses as a percentage of net premiums were ~~4.2%~~4.6% and ~~4.4%~~4.0% for the ~~first~~second quarter of 2013 and 2012, and 4.4% and 4.2% for the six months ended June 30, 2013 and 2012 respectively.

The Europe & South Africa segment includes operations in the United Kingdom (“UK”), South Africa, France, Germany, India, Italy, Mexico, the Netherlands, Poland, Spain and the United Arab Emirates. The segment provides reinsurance for a variety of life and health products through yearly renewable term and coinsurance agreements, critical illness coverage and longevity risk related to payout annuities. Reinsurance agreements may be facultative or automatic agreements covering primarily individual risks and, in some markets, group risks.


(dollars in thousands)	For the three months ended March 31,				Three months ended June 30,				Six months ended June 30,
	2013		2012		2013		2012		2013		2012
Revenues:
Net premiums	$	323,908	$	292,771	$	319,375	$	310,075	$	643,283	$	602,846
Investment income, net of related expenses		12,224		11,331		14,457		11,248		26,681		22,579
Investment related gains (losses), net:
Other-than-temporary impairments on fixed maturity securities		--		--		—		—		—		—
Other-than-temporary impairments on fixed maturity securities transferred to (from) accumulated other comprehensive income		--		--		—		—		—		—
Other investment related gains (losses), net		1,810		1,982		470		1,156		2,280		3,138

Total investment related gains (losses), net		1,810		1,982		470		1,156		2,280		3,138
Other revenues		1,287		2,253		4,608		1,464		5,895		3,717

Total revenues		339,229		308,337		338,910		323,943		678,139		632,280


Benefits and expenses:
Claims and other policy benefits		283,915		261,484		283,230		263,992		567,145		525,476
Policy acquisition costs and other insurance expenses		11,734		15,052		11,753		13,550		23,487		28,602
Other operating expenses		26,195		25,195		28,109		26,810		54,304		52,005

Total benefits and expenses		321,844		301,731		323,092		304,352		644,936		606,083


Income before income taxes	$	17,385	$	6,606	$	15,818	$	19,591	$	33,203	$	26,197

Income before income taxes ~~increased~~decreased by ~~$10.8~~$3.8 million, or ~~163.2%~~19.3%, and increased $7.0 million, or 26.7%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. The decrease in income before income taxes for the second quarter was primarily due to higher mortality claims in the UK. The increase in income before income taxes for the first ~~quarter~~six months was primarily due to ~~favorable claims experience over the prior period,~~increased business volumes partially offset by ~~adverse critical illness~~unfavorable claims ~~in the UK and disability income claims in South Africa.~~experience. Unfavorable foreign currency exchange fluctuations contributed to the decrease in income before income taxes totaling ~~$0.9~~$1.0 million and $1.9 million for the second quarter and first ~~quarter~~six months of ~~2013.~~2013, respectively, as compared to the same periods in 2012.

Net premiums increased ~~$31.1~~$9.3 million, or ~~10.6%~~3.0%, and $40.4 million, or 6.7%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. Net premiums increased as a result of new business from both new and existing treaties including ~~a $11.0 million~~an increase associated with reinsurance of longevity risk in the ~~UK.~~UK of $2.2 million and $24.0 million in the second quarter and first six months of 2013, respectively. During 2013, there ~~was an~~were unfavorable foreign currency exchange ~~fluctuation,~~fluctuations, particularly with the British pound and the South African rand weakening against the U.S. dollar ~~when compared to the same periods in 2012,~~ which decreased net premiums by approximately ~~$9.9~~$10.0 million and $19.9 million in the second quarter and first ~~quarter~~six months of 2013, respectively, as compared to the same ~~period~~periods in 2012.

A portion of the net premiums for the segment, in each period presented, relates to reinsurance of critical illness coverage, primarily in the UK. This coverage provides a benefit in the event of the diagnosis of a pre-defined critical illness. Net premiums earned from this coverage totaled ~~$63.6~~$63.1 million and ~~$61.5~~$62.0 million in the ~~first~~second quarter of 2013 and 2012, respectively, and $126.8 million and $123.5 million for the six months ended June 30, 2013 and 2012, respectively. Premium levels can be significantly influenced by currency fluctuations, large transactions and reporting practices of ceding companies and therefore can fluctuate from period to period.

Net investment income increased ~~$0.9~~$3.2 million, or ~~7.9%~~28.5%, and $4.1 million, or 18.2%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. ~~This increase was~~These increases were primarily due to an increase in the invested asset base. Investment income and investment related gains and losses are allocated to the various operating segments based on average assets and related capital levels deemed appropriate to support the segment business volumes. Investment performance varies with the composition of investments and the relative allocation of capital to the operating segments.

Loss ratios for this segment were ~~87.7%~~88.7% and ~~89.3%~~85.1% for the ~~first~~second quarter of 2013 and 2012, and 88.2% and 87.2% for the six months ended June 30, 2013 and 2012, respectively. The ~~decreased~~increase in the loss ~~ratio for the current quarter~~ratios is attributable to ~~favorable~~unfavorable individual life claims experience over the same prior ~~period, partially offset by adverse critical illness claims~~periods primarily in the UK ~~and disability income claims in South Africa.~~market. Although reasonably predictable over a period of years, claims can be volatile over shorter periods. Management views recent experience as normal short-term volatility that is inherent in the business.

Policy acquisition costs and other insurance expenses as a percentage of net premiums ~~was 3.6%~~were 3.7% and ~~5.1%~~4.4% for the ~~first~~second quarter of 2013 and 2012, and 3.7% and 4.7% for the six months ended June 30, 2013 and 2012, respectively. These percentages fluctuate due to timing of client company reporting, variations in the mixture of business and the relative maturity of the business. In addition, as the segment grows, renewal premiums, which have lower allowances than first-year premiums, represent a greater percentage of the total net premiums.

Other operating expenses increased ~~$1.0~~$1.3 million, or ~~4.0%~~4.8%, and $2.3 million, or 4.4%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. Other operating expenses as a percentage of net premiums totaled ~~8.1%~~8.8% and 8.6% for the ~~first~~second quarter of 2013 and 2012, and 8.4% and 8.6% for the six months ended June 30, 2013 and 2012, respectively.

While concerns continue in 2013 relating to the European sovereign debt and European economies, approximately ~~88.6%~~86.1% of revenues for the segment were earned outside of the eurozone in the ~~first~~second quarter of 2013. Approximately ~~5.4%~~7.9% of the segment’s revenues were earned in Spain, Italy and Portugal inover the ~~first quarter of 2013.~~same period.

The Asia Pacific segment includes operations in Australia, Hong Kong, Japan, Malaysia, Singapore, New Zealand, South Korea, Taiwan and mainland China. The principal types of reinsurance include life, critical illness, disability, ~~income,~~ superannuation, and financial reinsurance. Superannuation is the Australian government mandated compulsory retirement savings program. Superannuation funds accumulate retirement funds for employees, and, in addition, offer life and disability insurance coverage. Reinsurance agreements may be facultative or automatic agreements covering primarily individual risks and in some markets, group risks.


(dollars in thousands)	For the three months ended March 31,				Three months ended June 30,					Six months ended June 30,

	2013		2012		2013			2012		2013			2012
Revenues:
Net premiums	$	363,604	$	325,350	$	340,466		$	331,945	$	704,070		$	657,295
Investment income, net of related expenses		22,081		22,578		21,402			20,711		43,483			43,289
Investment related gains (losses), net:
Other-than-temporary impairments on fixed maturity securities		--		--		—			—		—			—
Other-than-temporary impairments on fixed maturity securities transferred to (from) accumulated other comprehensive income		--		--		—			—		—			—
Other investment related gains (losses), net		(4,465)		4,349		(4,156	)		968		(8,621	)		5,317

Total investment related gains (losses), net		(4,465)		4,349		(4,156	)		968		(8,621	)		5,317
Other revenues		7,749		7,408		10,461			24,109		18,210			31,517

Total revenues		388,969		359,685		368,173			377,733		757,142			737,418


Benefits and expenses:
Claims and other policy benefits		281,945		248,620		567,050			236,733		848,995			485,353
Interest credited		311		238		274			216		585			454
Policy acquisition costs and other insurance expenses		62,063		50,847		60,163			89,996		122,226			140,843
Other operating expenses		30,132		27,913		31,134			26,929		61,266			54,842
Interest expense						—			—		—			—

Total benefits and expenses		374,451		327,618		658,621			353,874		1,033,072			681,492

Income (loss) before income taxes					$	(290,448	)	$	23,859	$	(275,930	)	$	55,926

Income before income taxes	$	14,518	$	32,067

Income before income taxes decreased by ~~$17.5~~$314.3 million ~~or 54.7%,~~and $331.9 million for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. The decrease in income ~~was~~before income taxes in the second quarter and first six months is primarily ~~attributable~~due to ~~more favorable~~a $274.1 million increase in Australian group claims liabilities related to total and permanent disability coverage and disability income benefits, as discussed further below, as well as poor claims experience in ~~several markets~~the Australian operation’s individual lump sum and individual disability businesses. Other operations in this segment reported results in line with management’s expectations. In total, the ~~prior year and an unfavorable change~~Australia operation reported a loss before income taxes of $300.3 million for the second quarter of 2013, while the other operations in ~~investment related gains (losses), net.~~this segment reported income before income taxes of $9.9 million for the same period. Additionally, foreign currency exchange fluctuations resulted in ~~a decrease~~an increase to income before income taxes totaling approximately ~~$0.9~~$16.1 million and $15.2 million for the second quarter and first ~~quarter~~six months of 2013, respectively, as compared to the same ~~period~~periods in 2012.

Net premiums increased ~~$38.3~~$8.5 million, or ~~11.8%~~2.6%, and $46.8 million, or 7.1%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. Premiums in the second quarter and first ~~quarter~~six months of 2013 increased mainly in Hong Kong and South East Asia, and Australia with new treaties and growth in existing treaties, partially offset by a decrease in premiums in ~~Japan.~~Japan and South Korea. Unfavorable changes in Asia Pacific segment currencies resulted in a decrease in net premiums of approximately $8.1 million and $16.2 million for the second quarter and first ~~quarter~~six months of 2013, respectively, as compared to the same ~~period~~periods in 2012.

A portion of the net premiums for the segment, in each period presented, relates to reinsurance of critical illness coverage. This coverage provides a benefit in the event of the diagnosis of a pre-defined critical illness. Reinsurance of critical illness in the Asia Pacific ~~operations~~segment is offered primarily in South Korea, Australia and Hong Kong. Net premiums earned from this coverage totaled ~~$54.5~~$51.2 million and ~~$40.3~~$46.7 million in the ~~first~~second quarter of 2013 and 2012, respectively, and $105.8 million and $87.0 million for the first six months ended June 30, 2013 and 2012, respectively. Premium levels can be significantly influenced by currency fluctuations, large transactions and reporting practices of ceding companies and can fluctuate from period to period.

Net investment income ~~decreased $0.5~~increased $0.7 million, or ~~2.2%~~3.3%, and $0.2 million, or 0.4%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. ~~This decrease~~These increases can be primarily attributed to ~~a lower investment yield largely offset by~~ an increase in the invested asset ~~base. Also contributing to the decrease was an~~base largely offset by lower investment yields. Offsetting these increases were unfavorable ~~change~~changes in foreign currency exchange fluctuations of ~~$0.5 million.~~$0.6 million and $1.2 million for the second quarter and first six months of 2013, respectively, as compared to the same periods in 2012. Investment income and investment related gains and losses are allocated to the various operating segments based on average assets and related capital levels deemed appropriate to support the segment business volumes. Investment performance varies with the composition of investments and the relative allocation of capital to the operating segments.

Other revenues ~~increased~~decreased by ~~$0.3~~$13.6 million, or ~~4.6%~~56.6%, and $13.3 million, or 42.2%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. ~~The increase~~These decreases in other revenues ~~relates~~relate to ~~new financial reinsurance treaties~~a transaction with a client in ~~Japan,~~Australia which isresulted in a one-time fee of $12.2 million recognized in the ~~primary source~~second quarter of ~~other revenues.~~2012. The transaction did not have a significant impact on income before taxes because the amount was offset by additional amortization of deferred acquisition costs, net of the release of reserves. At ~~March 31,~~June 30, 2013 and 2012, the amount of reinsurance assumed from client companies, as measured by pre-tax statutory surplus, risk based capital and other financial reinsurance structures was ~~$2.0~~$1.8 billion and ~~$2.3~~$2.5 billion, respectively. The decrease was primarily due to several financial reinsurance agreements, which are performing as expected, where the amount of reinsurance assumed from the client decreases over time. Fees earned from this business can vary significantly depending on the size of the transactions and the timing of their completion and, therefore, can fluctuate from period to period.

Loss ratios for this segment were ~~77.5%~~166.6% and ~~76.4%~~71.3% for the ~~first~~second quarter of 2013 and 2012, and 120.6% and 73.8% for the six months ended June 30, 2013 and 2012, respectively. The increase in the loss ~~ratio for the first quarter of 2013 compared to 2012~~ratios is primarily due to ~~less favorable~~a $274.1 million increase in Australian group claims liabilities as well as poor claims experience in the Australian operation’s individual lump sum and individual disability businesses. The increase in liabilities is reflected in the table above in claims and other policy benefits. Excluding the Australia operation, loss ratios for this segment were 76.5% and 78.1% for the three and six months ended June 30, 2013, respectively. Excluding Australia, loss ratios for this segment were in line with management’s expectations.

The largest portion of the Australian liability increase relates to group total and permanent disability coverage, and to a lesser extent, group disability income benefits. Even though these group contracts are typically only three years in duration, the increase in loss ratios to this extent, compared to pricing, has created the ~~prior year, most notably~~need for this significant increase in ~~Australia. Although reasonably predictable over~~claims liabilities. The Company completed a ~~period of years,~~comprehensive claims ~~can be volatile over shorter periods. Recent experience has reflected under-performing business in Australia. Loss ratios will fluctuate due to timing of client company reporting, variations~~analysis in the ~~mixture~~second quarter of ~~business~~2013 that indicated an increase in claim incidences as well as an increase in claim lags throughout the claim reporting process and the ~~relative maturity~~additional liabilities reflect potential additional deterioration in the projection of future claims development. The Company believes a number of factors in the current Australian market are leading to a significant rise in claim levels and reporting lags and the Company is working with the ceding companies to better manage this business. The Company has suspended all quoting activity in the Australian group total and permanent disability market indefinitely. Group premiums recognized in Australia for all group coverage types, including total and permanent disability, were $91.3 million and $186.3 million for the three and six months ended June 30, 2013, respectively, and $369.1 million for the year ended December 31, 2012.

Policy acquisition costs and other insurance expenses as a percentage of net premiums were ~~17.1%~~17.7% and ~~15.6%~~27.1% for the second quarter of 2013 and 2012, and 17.4% and 21.4% for the first ~~quarter of~~six months ended June 30, 2013 and 2012, respectively. The ratio of policy acquisition costs and other insurance expenses as a percentage of net premiums should generally decline as the business matures; however, the percentage does fluctuate periodically due to timing of client company reporting and variations in the mixture of business. Additionally, the prior year figure was affected by the aforementioned transaction with an Australian client.

Other operating expenses increased ~~$2.2~~$4.2 million, or ~~7.9%~~15.6%, and $6.4 million, or 11.7%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. Other operating expenses as a percentage of net premiums totaled ~~8.3%~~9.1% and ~~8.6%~~8.1% for the ~~first~~second quarter of 2013 and ~~2012.~~2012 and 8.7% and 8.3% for the first six months ended June 30, 2013 and 2012, respectively. The timing of premium flows and the level of costs associated with the entrance into and development of new markets in the growing Asia Pacific segment may cause other operating expenses as a percentage of net premiums to fluctuate over periods of time.

Corporate and Other revenues include investment income and investment related gains and losses from unallocated invested assets. Corporate and Other expenses consist of the offset to capital charges allocated to the operating segments within the policy acquisition costs and other insurance expenses line item, unallocated overhead and executive costs, interest expense related to debt, and the investment income and expense associated with the Company’s collateral finance facility. Additionally, Corporate and Other includes results from, among others, RTP, a wholly-owned subsidiary that develops and markets technology solutions for the insurance industry.


(dollars in thousands)	For the three months ended March 31,					Three months ended June 30,						Six months ended June 30,
	2013		2012			2013			2012			2013			2012
Revenues:					��
Net premiums	$	(977)	$	2,048		$	261		$	1,719		$	(716	)	$	3,767
Investment income, net of related expenses		28,016		16,273			21,818			20,345			49,834			36,618
Investment related gains (losses), net:
Other-than-temporary impairments on fixed maturity securities		(40)		(1,577)			(1,718	)		(137	)		(1,758	)		(1,714	)
Other-than-temporary impairments on fixed maturity securities transferred to (from) accumulated other comprehensive income		-		(1,314)			(53	)		—			(53	)		(1,314	)
Other investment related gains (losses), net		(1,904)		4,157			3,289			2,900			1,385			7,057

Total investment related gains (losses), net		(1,944)		1,266			1,518			2,763			(426	)		4,029
Other revenues		50,456		5,596			251			2,790			50,707			8,386

Total revenues		75,551		25,183			23,848			27,617			99,399			52,800


Benefits and expenses:
Claims and other policy benefits		84		57			(112	)		(45	)		(28	)		12
Interest credited		225		-			212			—			437			—
Policy acquisition costs and other insurance expenses (income)		(15,343)		(13,870)			(19,073	)		(13,342	)		(34,416	)		(27,212	)
Other operating expenses		23,354		18,425			16,483			17,940			39,837			36,365
Interest expenses		28,486		23,322			29,918			23,360			58,404			46,682
Collateral finance facility expense		2,538		2,967			2,650			2,878			5,188			5,845

Total benefits and expenses		39,344		30,901			30,078			30,791			69,422			61,692


Income (loss) before income taxes	$	36,207	$	(5,718)		$	(6,230	)	$	(3,174	)	$	29,977		$	(8,892	)

Income ~~(loss)~~ before income taxes decreased by $3.1 million, or 96.3%, and increased by ~~$41.9~~$38.9 million, or 437.1%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. The ~~increase~~decrease for the ~~first~~second quarter is primarily due to a ~~$44.9~~$2.5 million decrease to other revenue and an increase in interest expense of $6.6 million partially offset by a decrease in policy acquisition costs and other insurance expenses of $5.7 million. The increase for the first six months is primarily due to a $42.3 million increase to other ~~revenue.~~revenue partially offset by an increase in interest expense of $11.7 million.

Total revenues decreased by $3.8 million and increased by ~~$50.4~~$46.6 million for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. The decrease for the second quarter is primarily due to a $2.5 million decrease to other revenue related to a decrease in foreign currency gain (loss). The increase for the first six months was largely due to a $46.5 million gain on repurchase of collateral finance facility ~~securities.~~

securities in the first quarter of 2013. Additionally, there was ~~an $11.7~~a $13.2 million increase in investment income mainly due to a higher investment yield, primarily on limited partnership investments, in addition to growth in the invested asset base.

Total benefits and expenses ~~increased~~decreased by ~~$8.4~~$0.7 million, or ~~27.3%~~2.3%, and increased $7.7 million, or 12.5%, for the three and six months ended ~~March 31,~~June 30, 2013, as compared to the same ~~period~~periods in 2012. The decrease in the second quarter was primarily due to a decrease of $5.7 million in policy acquisition costs and other insurance expenses primarily related to the offset to capital charges allocated to the operating segments and a reduction in other operating expenses of $1.5 million, largely offset by a $6.6 million increase ~~for~~in interest expense due to a higher level of outstanding debt. The increase in the first ~~quarter~~six months of 2013 was primarily due to an increase in interest expense of $11.7 million, as a result of a higher level of outstanding debt, and an increase in other operating expenses of ~~$4.9~~$3.5 million primarily relating to employee compensation, partially offset by a $7.2 million decrease in policy acquisition and ~~an increase in interest expense of $5.2 million on a higher level of outstanding debt.~~other insurance expenses primarily related to the offset to capital charges allocated to the operating segments.

The current interest rate environment in select markets, primarily the U.S., is negatively affecting the Company’s earnings. The average investment yield, excluding funds withheld and other spread business, has decreased 2226 basis points for the ~~three~~six months ended ~~March 31,~~June 30, 2013 as compared to the same period in 2012. In addition, the Company’s insurance liabilities, in particular its annuity products, are sensitive to changing market factors. Results of operations in the first ~~three~~six months of 2013 compared to the same period in 2012 ~~are~~include favorable ~~largely due to~~ changes in the value of embedded ~~derivatives as~~derivatives. The effect of tightening credit spreads ~~have tightened. There has been a continued~~in the U.S. markets generated an increase in revenue related to embedded derivatives to a greater extent in the first six months of 2013 than 2012. However, rising interest rates late in the second quarter of 2013 have reduced gross unrealized gains on fixed maturity and equity securities available-for-sale, which were ~~$2,691.6~~$1,838.2 million and ~~$2,197.8~~$2,487.0 million at ~~March 31,~~June 30, 2013 and 2012, respectively. Gross unrealized losses totaled ~~$122.5~~$310.7 million and ~~$214.4~~$196.3 million at ~~March 31,~~June 30, 2013 and 2012, respectively. ~~The increase in the gross unrealized gains is primarily due to lower interest rates.~~

The Company continues to be in a position to hold any investment security showing an unrealized loss until recovery, provided it remains comfortable with the credit of the issuer. As indicated above, gross unrealized gains on investment securities of ~~$2,691.6~~$1,838.2 million are well in excess of gross unrealized losses of ~~$122.5~~$310.7 million as of ~~March 31,~~June 30, 2013. Historically low interest rates continued to put pressure on the Company’s investment yield. In January 2012, U.S. Federal Reserve officials indicated that economic conditions in the U.S. would likely warrant exceptionally low federal funds rate through 2014. The Company does not rely on short-term funding or commercial paper and to date it has experienced no liquidity pressure, nor does it anticipate such pressure in the foreseeable future.

The Company projects its reserves to be sufficient and it would not expect to write down deferred acquisition costs or be required to take any actions to augment capital, even if interest rates remain at current levels for the next five years, assuming all other factors remain constant. While the Company has felt the pressures of sustained low interest rates and volatile equity markets and may continue to do so, its business operations are not overly sensitive to these risks. Although management believes the Company’s current capital base is adequate to support its business at current operating levels, it continues to monitor new business opportunities and any associated new capital needs that could arise from the changing financial landscape.

RGA is an insurance holding company whose primary uses of liquidity include, but are not limited to, the immediate capital needs of its operating companies, dividends paid to its shareholders, repurchase of common stock and interest payments on its indebtedness. RGA recognized interest expense of ~~$38.0~~$77.4 million and ~~$32.8~~$65.6 million for the ~~three~~six months ended ~~March 31,~~June 30, 2013 and 2012, respectively. RGA made capital contributions to subsidiaries of $17.0 million and ~~$1.0~~$0.8 million for the ~~three~~six months ended ~~March 31,~~June 30, 2013 and 2012, respectively. Dividends to shareholders were ~~$17.8~~$35.2 million and ~~$13.3~~$26.5 million for the ~~three~~six months ended ~~March 31,~~June 30, 2013 and 2012, respectively. There were no principal payments on RGA’s debt for the ~~three~~six months ended ~~March 31,~~June 30, 2013 and 2012. The primary sources of RGA’s liquidity include proceeds from its capital raising efforts, interest income on undeployed corporate investments, interest income received on surplus notes with ~~RGA Reinsurance, Reinsurance Company of Missouri, Incorporated (“RCM”) and Rockwood Re~~its subsidiaries and dividends from operating subsidiaries. RGA recognized interest and dividend income of ~~$25.7~~$51.2 million and ~~$19.2~~$40.8 million for the ~~three~~six months ended ~~March 31,~~June 30, 2013 and 2012, respectively. There was no issuance of unaffiliated ~~or affiliated long term~~long-term debt for the ~~three~~six months ended ~~March 31,~~June 30, 2013 and 2012. Net proceeds from affiliated long-term debt issuance were $120.0 million for the six months ended June 30, 2013. There was no issuance of unaffiliated long-term debt for the six months ended June 2012. As the Company continues its business operations, RGA will continue to be dependent upon these sources of liquidity. As of ~~March 31,~~June 30, 2013 and December 31, 2012, RGA held ~~$684.6~~$497.1 million and $722.3 million, respectively, of cash and cash equivalents, short-term and other investments and fixed maturity investments.

RGA has established an intercompany revolving credit facility where certain subsidiaries can lend to or borrow from each other and from RGA in order to manage capital and liquidity more efficiently. The intercompany revolving credit facility, which is a series of demand loans among RGA and its affiliates, is permitted under applicable insurance laws. This facility reduces overall borrowing costs by allowing RGA and its operating companies to access internal cash resources instead of incurring third-party transaction costs. The statutory borrowing and lending limit for RGA’s Missouri-domiciled insurance subsidiaries is currently 3% of the insurance company’s admitted assets as of its most recent year-end. There ~~were no amounts~~was $138.0 million outstanding under the intercompany revolving credit facility as of ~~March 31,~~June 30, 2013 and none as of December 31, 2012. In addition to loans associated with the intercompany revolving credit facility, RGA Capital LLC, a subsidiary of RGA, provided a loan to RGA Australian Holdings Pty Limited, another RGA subsidiary, with an outstanding balance of $27.4 million as of June 30, 2013.

The Company believes that it has sufficient liquidity for the next 12 months to fund its cash needs under various scenarios that include the potential risk of early recapture of reinsurance treaties and higher than expected death claims. Historically, the Company has generated positive net cash flows from operations. However, in the event of significant unanticipated cash requirements beyond normal liquidity, the Company has multiple liquidity alternatives available based on market conditions and the amount and timing of the liquidity need. These options include borrowings under committed credit facilities, secured borrowings, the ability to issue long-term debt, preferred securities or common equity and, if necessary, the sale of invested assets subject to market conditions.

On January 24, 2013, RGA’s board of directors authorized a share repurchase program for up to $200.0 million of RGA’s outstanding common stock. This authorization was effective January 24, 2013 and does not have an expiration date. During the first quarter of 2013, RGA repurchased 815,011 shares of common stock under this program for $47.6 million. During April 2013, the Company repurchased an additional 892,047 shares of common stock under the program for $52.4 million. The common shares repurchased have been placed into treasury to be used for general corporate purposes.

On April 18, 2013, RGA’s board of directors authorized an increase of $100.0 million to the share repurchase program previously authorized on January 24, 2013. With this authorization, the total amount of the Company’s outstanding common stock authorized for repurchase is $300.0 million.

In ~~April~~July 2013, the Company’s ~~board of directors declared a~~quarterly dividend ofwas increased to $0.30 per share from $0.24 per share. All future payments of dividends are at the discretion of RGA’s board of directors and will depend on the Company’s earnings, capital requirements, insurance regulatory conditions, operating conditions, and other such factors as the board of directors may deem relevant. The amount of dividends that RGA can pay will depend in part on the operations of its reinsurance subsidiaries. See Note 13 - “Stock Transactions” in the Notes to Condensed Consolidated Financial Statements for information on the Company’s share repurchase program.

The Company’s net cash flows provided by operating activities for the ~~three~~six months ended ~~March 31,~~June 30, 2013 and 2012 were ~~$494.9~~$805.1 million and ~~$554.7~~$818.3 million, respectively. Cash flows from operating activities are affected by the timing of premiums received, claims paid, and working capital changes. The Company believes the short-term cash requirements of its business operations will be sufficiently met by the positive cash flows generated. Additionally, the Company believes it maintains a high quality fixed maturity portfolio that can be sold, if necessary, to meet the Company’s short- and long-term obligations.

Net cash used in investing activities for the ~~three~~six months ended ~~March 31,~~June 30, 2013 and 2012 was ~~$385.4~~$408.0 million and ~~$509.3~~$784.8 million, respectively. Cash flows from investing activities primarily reflect the sales, maturities and purchases of fixed maturity securities related to the management of the Company’s investment portfolios and the investment of excess cash generated by operating and financing activities. Cash flows from investing activities also include the investment activity related to mortgage loans, policy loans, funds withheld at interest, short-term investments and other invested assets.

Net cash used in financing activities for the ~~three~~six months ended ~~March 31,~~June 30, 2013 and 2012 was ~~$351.6~~$637.2 million and ~~$140.4~~$40.8 million, respectively. Cash flows from financing activities primarily reflects the Company’s capital management efforts, treasury stock activity, dividends to stockholders, changes in collateral for derivative positions and the activity related to universal life and other investment type policies and contracts.

Certain of the Company’s debt agreements contain financial covenant restrictions related to, among others, liens, the issuance and disposition of stock of restricted subsidiaries, minimum requirements of consolidated net worth, maximum ratios of debt to capitalization and change of control provisions. The Company is required to maintain a minimum consolidated net worth, as defined in the debt agreements, of $2.8 billion, calculated as of the last day of each fiscal quarter. Also, consolidated indebtedness, calculated as of the last day of each fiscal quarter, cannot exceed 35% of the sum of the Company’s consolidated indebtedness plus adjusted consolidated net worth. A material ongoing covenant default could require immediate payment of the amount due, including principal, under the various agreements. Additionally, the Company’s debt agreements contain cross-default covenants, which would make outstanding borrowings immediately payable in the event of a material uncured covenant default under any of the agreements, including, but not limited to, non-payment of indebtedness when due for an amount in excess of $100.0 million, bankruptcy proceedings, or any other event which results in the acceleration of the maturity of indebtedness. As of ~~March 31,~~June 30, 2013 and December 31, 2012, the Company had ~~$1,815.4~~$1,815.5 million and $1,815.3 million, respectively, in outstanding borrowings under its debt agreements and was in compliance with

all covenants under those agreements. The ability of the Company to make debt principal and interest payments depends on the earnings and surplus of subsidiaries, investment earnings on undeployed capital proceeds, and the Company’s ability to raise additional funds. Scheduled repayments of debt over the next five years total $300.0 million, all due in 2017.

The Company enters into derivative agreements with counterparties that reference either the Company’s debt rating or its financial strength rating. If either rating is downgraded in the future, it could trigger certain terms in the Company’s derivative agreements, which could negatively affect overall liquidity. For the majority of the Company’s derivative agreements, there is a termination event should the long-term senior debt ratings drop below either BBB+ (S&P) or Baa1 (Moody’s) or the financial strength ratings drop below either A- (S&P) or A3 (Moody’s).

The Company may borrow up to $850.0 million in cash and obtain letters of credit in multiple currencies on its revolving credit facility that expires in December 2015. As of ~~March 31,~~June 30, 2013, the Company had no cash borrowings outstanding and ~~$140.0~~$94.2 million in issued, but undrawn, letters of credit under this facility. As of ~~March 31,~~June 30, 2013 and December 31, 2012, the average interest rate on short-term and long-term debt outstanding was 5.64% and 5.99%., respectively.

Based on the historic cash flows and the current financial results of the Company, management believes RGA’s cash flows will be sufficient to enable RGA to meet its obligations for at least the next 12 months.

In 2006, RGA’s subsidiary, Timberlake Financial L.L.C. (“Timberlake Financial”), issued $850.0 million of Series A Floating Rate Insured Notes due June 2036 in a private placement. The notes were issued to fund the collateral requirements for statutory reserves required by the U.S. Valuation of Life Policies Model Regulation (commonly referred to as Regulation XXX) on specified term life insurance policies reinsured by RGA Reinsurance and retroceded to Timberlake Reinsurance Company II (“Timberlake Re”). Proceeds from the notes, along with a $112.8 million direct investment by the Company, were deposited into a series of accounts that collateralize the notes and are not available to satisfy the general obligations of the Company. Interest on the notes accrues at an annual rate of 1-month LIBOR plus a base rate margin, payable monthly. The payment of interest and principal on the notes is insured through a financial guaranty insurance policy by a monoline insurance company whose parent company ~~is operating under~~emerged from Chapter 11 ~~bankruptcy.~~bankruptcy during the second quarter of 2013. The notes represent senior, secured indebtedness of Timberlake Financial without legal recourse to RGA or its other subsidiaries.

Timberlake Financial relies primarily upon the receipt of interest and principal payments on a surplus note and dividend payments from its wholly-owned subsidiary, Timberlake Re, a South Carolina captive insurance company, to make payments of interest and principal on the notes. The ability of Timberlake Re to make interest and principal payments on the surplus note and dividend payments to Timberlake Financial is contingent upon the South Carolina Department of Insurance’s regulatory approval. As of ~~March 31,~~June 30, 2013, Timberlake Re’s ~~surplus totaled $32.6 million. Reserve decreases and statutory profits are expected to increase~~ capital and surplus totaled $42.4 million. The increase in capital and surplus is primarily due to reserve decreases and favorable mortality during the second quarter of 2013. Timberlake Re’s capital and surplus is expected to remain above $35.0 ~~million by year-end 2014.~~million. Since Timberlake Re’s capital and surplus fell below the minimum requirement in its licensing order of $35.0 million, it has been required, since the second quarter of 2011, to request approval on a quarterly rather than annual basis and provide additional scenario testing results. Approval to pay interest on the surplus note was granted through ~~June 28,~~September 30, 2013.

~~On January 17,~~During the first quarter of 2013, the Company repurchased $160.0 million face amount of the Timberlake Financial notes for $112.0 million, which was the market value at the date of the purchase. The notes were purchased by RGA Reinsurance. As a result, the Company recorded a pre-tax gain of $46.5 million, after fees, in other ~~revenues.~~revenues at that time.

In 2010, Manor Re obtained $300.0 million of collateral financing through 2020 from an international bank which enabled Manor Re to deposit assets in trust to support statutory reserve credit for an affiliated reinsurance transaction. The bank has recourse to RGA should Manor Re fail to make payments or otherwise not perform its obligations under this financing. Interest on the collateral financing accrues at an annual rate of 3-month LIBOR plus a base rate margin, payable quarterly.

The Company actively manages its cash and invested assets using an approach that is intended to balance quality, diversification, asset/liability matching, liquidity and investment return. The goals of the investment process are to optimize after-tax, risk-adjusted investment income and after-tax, risk-adjusted total return while managing the assets and liabilities on a cash flow and duration basis.

The Company has established target asset portfolios for each major insurance product, which represent the investment strategies intended to profitably fund its liabilities within acceptable risk parameters. These strategies include objectives and limits for effective duration, yield curve sensitivity and convexity, liquidity, asset sector concentration and credit quality.

The Company’s asset-intensive products are primarily supported by investments in fixed maturity securities reflected on the Company’s balance sheet and under funds withheld arrangements with the ceding company. Investment guidelines are established to structure the investment portfolio based upon the type, duration and behavior of products in the liability portfolio so as to achieve targeted levels of profitability. The Company manages the asset-intensive business to provide a

targeted spread between the interest rate earned on investments and the interest rate credited to the underlying interest-sensitive contract liabilities. The Company periodically reviews models projecting different interest rate scenarios and their effect on profitability. Certain of these asset-intensive agreements, primarily in the U.S. operating segment, are generally funded by fixed maturity securities that are withheld by the ceding company.

The Company’s liquidity position (cash and cash equivalents and short-term investments) was ~~$1,182.5~~$1,012.2 million and $1,548.0 million at ~~March 31,~~June 30, 2013 and December 31, 2012, respectively. Cash and cash equivalents includes cash collateral received from derivative counterparties of ~~$126.3~~$89.8 million and $136.4 million as of ~~March 31,~~June 30, 2013 and December 31, 2012, respectively. This unrestricted cash collateral is included in cash and cash equivalents and the obligation to return it is included in other liabilities in the Company’s condensed consolidated balance sheets. Liquidity needs are determined from valuation analyses conducted by operational units and are driven by product portfolios. Periodic evaluations of demand liabilities and short-term liquid assets are designed to adjust specific portfolios, as well as their durations and maturities, in response to anticipated liquidity needs.

RGA Reinsurance is a member of the Federal Home Loan Bank of Des Moines (“FHLB”) and holds ~~$32.3~~$37.6 million of FHLB common stock, ~~in the FHLB,~~ which is included in other invested assets on the Company’s condensed consolidated balance sheets. Membership provides RGA Reinsurance ~~occasionally enters into traditional funding agreements~~access to borrowing arrangements with the FHLB (“advances”) and ~~had no outstanding traditional~~ funding agreements, ~~with~~discussed below. RGA Reinsurance had $120.0 million outstanding in advances at June 30, 2013, which is included in short-term debt on the ~~FHLB~~Company’s condensed consolidated balance sheets. RGA Reinsurance did not have advances at ~~March 31, 2013 and~~ December 31, 2012. ~~The Company had no traditional funding agreements~~RGA Reinsurance’s average outstanding balance of advances was $17.0 million and $8.5 million during the second quarter and first six months of 2013, respectively. RGA Reinsurance did not have advances during the first ~~three nine~~six months of ~~2013 and~~ 2012. Interest on ~~traditional funding agreements with the FHLB~~advances is reflected in interest expense on the Company’s condensed consolidated statements of income.

In addition, RGA Reinsurance has also entered into funding agreements with the FHLB under guaranteed investment contracts whereby RGA Reinsurance has issued the funding agreements in exchange for cash and for which the FHLB has been granted a blanket lien on RGA Reinsurance’s commercial and residential mortgage-backed securities and commercial mortgage loans used to collateralize RGA Reinsurance’s obligations under the funding agreements. RGA Reinsurance maintains control over these pledged assets, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. The funding agreements and the related security agreements represented by this blanket lien provide that upon any event of default by RGA Reinsurance, the FHLB’s recovery is limited to the amount of RGA Reinsurance’s liability under the outstanding funding agreements. The amount of the ~~Company’s~~RGA Reinsurance’s liability for the funding agreements with the FHLB under guaranteed investment contracts was $500.0 million at both ~~March 31,~~June 30, 2013 and December 31, 2012, which is included in interest sensitive contract ~~liabilities.~~liabilities on the Company’s condensed consolidated balance sheets. The advances on these agreements are collateralized primarily by commercial and residential mortgage-backed securities and commercial mortgage loans. The amount of collateral exceeds the liability and is dependent on the type of assets collateralizing the guaranteed investment contracts.

The Company’s investment and derivative strategies involve matching the characteristics of its reinsurance products and other obligations and to seek to closely approximate the interest rate sensitivity of the assets with estimated interest rate sensitivity of the reinsurance liabilities. The Company achieves its income objectives through strategic and tactical asset allocations, security and derivative strategies within an asset/liability management and disciplined risk management framework. Derivative strategies are employed within the Company’s risk management framework to help manage duration, currency, and other risks in assets and/or liabilities and to replicate the credit characteristics of certain assets. For a discussion of the Company’s risk management process see “Market Risk” in the “Enterprise Risk Management” section below.

The Company’s portfolio management groups work with the Enterprise Risk Management function to develop the investment policies for the assets of the Company’s domestic and international investment portfolios. All investments held by the Company, directly or in a funds withheld at interest reinsurance arrangement, are monitored for conformance with the

Company’s stated investment policy limits as well as any limits prescribed by the applicable jurisdiction’s insurance laws and regulations. See Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for additional information regarding the Company’s investments.

The Company had total cash and invested assets of ~~$34.0~~$32.7 billion and $34.2 billion at ~~March 31,~~June 30, 2013 and December 31, 2012, respectively, as illustrated below (dollars in thousands):


	March 31, 2013		December 31, 2012		June 30, 2013		% of Total		December 31, 2012		% of Total
Fixed maturity securities, available-for-sale	$	22,401,659	$	22,291,614	$	21,284,216		65.0%	$	22,291,614		65.2%
Mortgage loans on real estate		2,325,191		2,300,587		2,377,246		7.3%		2,300,587		6.7%
Policy loans		1,245,812		1,278,175		1,245,252		3.8%		1,278,175		3.7%
Funds withheld at interest		5,698,594		5,594,182		5,777,395		17.6%		5,594,182		16.4%
Short-term investments		180,707		288,082		38,601		0.1%		288,082		0.9%
Other invested assets		1,129,651		1,159,543		1,035,809		3.2%		1,159,543		3.4%
Cash and cash equivalents		1,001,841		1,259,892		973,619		3.0%		1,259,892		3.7%

Total cash and invested assets	$	33,983,455	$	34,172,075	$	32,732,138		100.0%	$	34,172,075		100.0%

The following table presents consolidated average invested assets at amortized cost, net investment income and investment yield, excluding funds withheld at interest and spread related business. Funds withheld at interest assets and other spread related business are primarily associated with the reinsurance of annuity contracts on which the Company earns an interest rate spread between assets and liabilities. Fluctuations in the yield on funds withheld assets and other spread related business are ~~substantially offset~~generally subject to varying degrees, by a corresponding ~~adjustment~~adjustments to the interest credited on the liabilities (dollars in thousands).


	Three months ended March 31,						Three months ended June 30,						Six months ended June 30,
	2013		2012		Increase/ (Decrease)		2013		2012		Increase/ (Decrease)		2013		2012		Increase/ (Decrease)
Average invested assets at amortized cost	$	17,992,152	$	16,342,741		10.1%	$	18,112,841	$	16,539,380		9.5%	$	17,946,154	$	16,339,042		9.8%
Net investment income		213,322		202,603		5.3%		212,047		205,471		3.2%		425,369		408,074		4.2%
Investment yield (ratio of net investment income to average invested assets)		4.83%		5.05%		(22) bps		4.77%		5.06%		(29) bps		4.80%		5.06%		(26) bps

~~The current~~Although interest rates rose during the second quarter of 2013, especially in the month of June, the low U.S. interest rate environment iscompared to historical rates continues to negatively ~~affecting~~affect the Company’s earnings through reinvestment of maturing assets and investment of new liability cash flows. Investment yield decreased for the three and six months ended ~~March 31,~~June 30, 2013 in comparison to the same periods in the prior year due primarily to slightly lower yields on investments within several asset classes, including fixed maturity securities, mortgage loans and policy loans. The lower yields are due primarily to a lower interest rate environment on a historical basis which decreases the yield on new investment purchases.

See “Fixed Maturity and Equity Securities Available-for-Sale” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables that provide the amortized cost, unrealized gains and losses, estimated fair value of fixed maturity and equity securities, and other-than-temporary impairments in AOCI by sector as of ~~March 31,~~June 30, 2013 and December 31, 2012.

The Company’s fixed maturity securities are invested primarily in corporate bonds, mortgage- and asset-backed securities, and U.S. and Canadian government securities. As of ~~March 31,~~June 30, 2013 and December 31, 2012, approximately ~~93.4%~~93.2% and 94.2%, respectively, of the Company’s consolidated investment portfolio of fixed maturity securities were investment grade.

Important factors in the selection of investments include diversification, quality, yield, total rate of return potential and call protection. The relative importance of these factors is determined by market conditions and the underlying product or portfolio characteristics. Cash equivalents are primarily invested in high-grade money market instruments. The largest asset class in which fixed maturity securities were invested was corporate securities, which represented approximately 55.4% and 55.5% of total fixed maturity securities as of ~~March 31,~~June 30, 2013 and December 31, 2012. See “Corporate Fixed Maturity Securities” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables showing the major industry types, which comprise the corporate fixed maturity holdings at ~~March 31,~~June 30, 2013 and December 31, 2012.

As of ~~March 31,~~June 30, 2013, the Company’s investments in Canadian and Canadian provincial government securities represented ~~17.6%~~16.6% of the fair value of total fixed maturity securities compared to 18.2% of the fair value of total fixed maturity securities at December 31, 2012. These assets are primarily high quality, long duration provincial strips whose valuation is closely

linked to the interest rate curve. The Company’s holdings in Canadian securities were one of the largest ~~contributor~~contributors to the decrease in net unrealized gain reported in the accumulated other comprehensive income reflected in the Company’s condensed consolidated balance sheets. These assets are longer in duration and held primarily for asset/liability management to meet Canadian regulatory requirements. See “Fixed Maturity and Equity Securities Available-for-Sale” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables showing the various sectors as of ~~March 31,~~June 30, 2013 and December 31, 2012.

The creditworthiness of Greece, Ireland, Italy, Portugal and Spain, commonly referred to as “Europe’s peripheral region,” and Cyprus is under ongoing stress and uncertainty due to high debt levels and economic weakness. The Company did not have material exposure to sovereign fixed maturity securities, which includes global government agencies, from Europe’s peripheral region and Cyprus, as of ~~March 31,~~June 30, 2013 and December 31, 2012. In addition, the Company did not purchase or sell credit protection, through credit default swaps, referenced to sovereign entities of Europe’s peripheral region and Cyprus.

The tables below show the Company’s exposure to fixed maturity securities and equity securities, based on the security’s country of issuance, from Europe’s peripheral region and Cyprus as of ~~March 31,~~June 30, 2013 and December 31, 2012 (dollars in thousands):


March 31, 2013:			Estimated
June 30, 2013:									Estimated
	Amortized Cost		Fair Value		% of Total		Amortized Cost		Fair Value		% of Total
Sovereign:
Ireland	$	5,000		4,997		3.3%	$	5,000	$	4,627		3.4%
Spain		9,969		9,922		6.6		4,985		4,955		3.6

Total sovereign		14,969		14,919		9.9		9,985		9,582		7.0


Financial institutions:
Ireland		6,877		7,304		4.8		6,925		7,183		5.2
Italy		11,466		11,140		7.4		13,566		13,264		9.7
Spain		40,903		43,173		28.5		30,983		33,937		24.7

Total financial institutions		59,246		61,617		40.7		51,474		54,384		39.6


Other:
Ireland		39,556		41,939		27.6		39,556		40,386		29.4
Italy		6,356		6,551		4.3		6,394		6,821		5.0
Spain		24,505		26,432		17.5		24,523		26,191		19.0

Total other		70,417		74,922		49.4		70,473		73,398		53.4

Total	$	144,632	$	151,458		100.0%	$	131,932	$	137,364		100.0%


December 31, 2012:			Estimated						Estimated
	Amortized Cost		Fair Value		% of Total		Amortized Cost		Fair Value		% of Total
Financial institutions:
Ireland	$	4,093	$	4,520		3.8%	$	4,093	$	4,520		3.8%
Spain		38,422		39,920		33.7		38,422		39,920		33.7

Total financial institutions		42,515		44,440		37.5		42,515		44,440		37.5


Other:
Ireland		38,852		41,019		34.6		38,852		41,019		34.6
Italy		6,434		6,653		5.6		6,434		6,653		5.6
Spain		24,725		26,547		22.3		24,725		26,547		22.3

Total other		70,011		74,219		62.5		70,011		74,219		62.5

Total	$	112,526	$	118,659		100.0%	$	112,526	$	118,659		100.0%

Strong improvement in European financial markets, as the governments of the European Union have demonstrated willingness to negotiate a solution to the region’s debt problems during 2013, has resulted in unrealized gains in both financial institutions and all other fixed maturity and equity securities held by the Company that were issued within the region with the exception of the Company’s sovereign exposure to ~~Greece~~Ireland and Spain and the Company’s exposure to Italy’s financial institutions which had fair values slightly below amortized cost.

The tables below show the Company’s exposure to sovereign fixed maturity securities originated in countries other than Europe’s peripheral region, included in “Other foreign government, supranational and foreign government-sponsored enterprises,” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements, as of ~~March 31,~~June 30, 2013 and December 31, 2012 (dollars in thousands):


March 31, 2013:			Estimated
June 30, 2013:									Estimated
	Amortized Cost		Fair Value		% of Total		Amortized Cost		Fair Value		% of Total
Australia	$	466,464	$	475,498		30.9%	$	440,212	$	445,431		29.7%
Japan		264,152		272,823		17.7		287,929		290,708		19.3
United Kingdom		133,207		141,893		9.2		157,304		160,204		10.6
South Africa		75,057		75,785		4.9		78,289		75,994		5.0
New Zealand		60,889		61,631		4.0
Cayman Islands		48,235		55,246		3.6		53,362		55,993		3.7
France								51,504		53,384		3.5
South Korea		51,196		54,546		3.5		50,623		51,639		3.4
France		50,309		53,683		3.5
Germany		48,255		51,312		3.3		47,726		49,764		3.3
United Arab Emirates								37,294		40,255		2.7
Other		272,196		297,769		19.4		278,916		282,651		18.8

Total	$	1,469,960	$	1,540,186		100.0%	$	1,483,159	$	1,506,023		100.0%


December 31, 2012:			Estimated						Estimated
	Amortized Cost		Fair Value		% of Total		Amortized Cost		Fair Value		% of Total
Australia	$	472,188	$	483,629		30.9%	$	472,188	$	483,629		30.9%
Japan		291,955		297,025		19.0		291,955		297,025		19.0
United Kingdom		130,792		139,826		8.9		130,792		139,826		8.9
Cayman Islands		69,172		77,912		5.0		69,172		77,912		5.0
South Africa		63,721		66,372		4.2		63,721		66,372		4.2
South Korea		52,613		55,563		3.5		52,613		55,563		3.5
Germany		51,413		54,602		3.5		51,413		54,602		3.5
New Zealand		53,593		54,092		3.5		53,593		54,092		3.5
France		45,342		48,761		3.1		45,342		48,761		3.1
Other		258,578		287,421		18.4		258,578		287,421		18.4

Total	$	1,489,367	$	1,565,203		100.0%	$	1,489,367	$	1,565,203		100.0%

As of ~~March 31,~~June 30, 2013, the Company’s investment in sovereign fixed maturity securities represented ~~6.9%~~7.1% of the fair value of total fixed maturity securities compared to 7.0% of the fair value of total fixed maturity securities at December 31, 2012. The Company typically invests in sovereign fixed maturity securities to help mitigate exposure to foreign currency fluctuations from liabilities denominated in the same currencies.

The Company references rating agency designations in some of its investment disclosures. These designations are based on the ratings from nationally recognized rating organizations, primarily those assigned by S&P. In instances where a S&P rating is not available, the Company will reference the rating provided by Moody’s and in the absence of both the Company will assign equivalent ratings based on information from the NAIC. The NAIC assigns securities quality ratings and uniform valuations called “NAIC Designations” which are used by insurers when preparing their statutory filings. The NAIC assigns designations to publicly traded as well as privately placed securities. The designations assigned by the NAIC range from class 1 to class 6, with designations in classes 1 and 2 generally considered investment grade (BBB or higher rating agency designation). NAIC designations in classes 3 through 6 are generally considered below investment grade (BB or lower rating agency designation).

The quality of the Company’s available-for-sale fixed maturity securities portfolio, as measured at fair value and by the percentage of fixed maturity securities invested in various ratings categories, relative to the entire available-for-sale fixed maturity security portfolio, at ~~March 31,~~June 30, 2013 and December 31, 2012 was as follows (dollars in thousands):


		June 30, 2013						December 31, 2012
NAIC Designation	Rating Agency Designation	Amortized Cost		Estimated Fair Value		% of Total		Amortized Cost		Estimated Fair Value		% of Total
1	AAA/AA/A	$	12,307,880	$	13,643,772		64.1%	$	12,059,154	$	14,300,571		64.2%
2	BBB		5,997,232		6,189,030		29.1%		6,186,536		6,692,929		30.0%
3	BB		723,316		728,014		3.4%		694,349		712,712		3.2%
4	B		519,789		530,990		2.5%		444,996		444,035		2.0%
5	CCC and lower		90,970		84,157		0.4%		118,738		95,906		0.4%
6	In or near default		118,134		108,253		0.5%		55,659		45,461		0.2%

	Total	$	19,757,321	$	21,284,216		100.0%	$	19,559,432	$	22,291,614		100.0%

The Company’s fixed maturity portfolio includes structured securities. The following table shows the types of structured securities the Company held at ~~March 31,~~June 30, 2013 and December 31, 2012 (dollars in thousands):


	March 31, 2013				December 31, 2012
			Estimated				Estimated		June 30, 2013				December 31, 2012
	Amortized Cost		Fair Value		Amortized Cost		Fair Value		Amortized Cost		Estimated Fair Value		Amortized Cost		Estimated Fair Value
Residential mortgage-backed securities:
Agency	$	520,081	$	575,274	$	497,918	$	555,535	$	546,603	$	579,317	$	497,918	$	555,535
Non-agency		485,151		501,496		471,349		486,529		468,552		475,651		471,349		486,529

Total residential mortgage-backed securities		1,005,232		1,076,770		969,267		1,042,064		1,015,155		1,054,968		969,267		1,042,064
Commercial mortgage-backed securities		1,596,659		1,698,144		1,608,376		1,698,903		1,564,924		1,638,632		1,608,376		1,698,903
Asset-backed securities		752,280		756,544		700,455		691,555		789,849		790,310		700,455		691,555

Total	$	3,354,171	$	3,531,458	$	3,278,098	$	3,432,522	$	3,369,928	$	3,483,910	$	3,278,098	$	3,432,522

The residential mortgage-backed securities include agency-issued pass-through securities and collateralized mortgage obligations. A majority of the agency-issued pass-through securities are guaranteed or otherwise supported by the Federal Home Loan Mortgage Corporation, Federal National Mortgage Association, or the Government National Mortgage Association. The weighted average credit rating of residential mortgage-backed securities was ~~A and~~ “A+” as of ~~March 31,~~both June 30, 2013 and December 31, ~~2012, respectively.~~2012. The principal risks inherent in holding mortgage-backed securities are prepayment and extension risks, which will affect the timing of when cash will be received and are dependent on the level of mortgage interest rates. Prepayment risk is the unexpected increase in principal payments, primarily as a result of owner refinancing. Extension risk relates to the unexpected slowdown in principal payments. In addition, non-agency mortgage-backed securities face credit risk should the borrower be unable to pay the contractual interest or principal on their obligation. The Company monitors its mortgage-backed securities to mitigate exposure to the cash flow uncertainties associated with these risks.

As of ~~March 31,~~June 30, 2013 and December 31, 2012, the Company had exposure to commercial mortgage-backed securities with amortized costs totaling ~~$1,965.8~~$1,945.9 million and $1,969.4 million, and estimated fair values of ~~$2,095.8~~$2,045.1 million and $2,090.0 million, respectively. Those amounts include exposure to commercial mortgage-backed securities held directly in the Company’s investment portfolios within fixed maturity securities, as well as securities held by ceding companies that support the Company’s funds withheld at interest investment. The securities are generally highly rated with weighted average S&P credit ratings of approximately “A+” at both ~~March 31,~~June 30, 2013 and December 31, 2012. Approximately ~~30.2%~~29.6% and 30.3%, based on estimated fair value, were classified in the “AAA” category at ~~March 31,~~June 30, 2013 and December 31, 2012, respectively. The Company ~~did not record any~~recorded $10.1 million of other-than-temporary impairments in its direct investments in commercial mortgage-backed securities for the first ~~three~~six months ended ~~March 31,~~June 30, 2013. The Company recorded $12.1 million of other-than-temporary impairments in its direct investments in commercial mortgage-backed securities for the first ~~three~~six months ended ~~March 31,~~June 30, 2012. The following tables summarize the commercial mortgage-backed securities by rating and underwriting year at ~~March 31,~~June 30, 2013 and December 31, 2012 (dollars in thousands):


June 30, 2013:													AAA				AA				A
Underwriting Year													Amortized Cost		Estimated Fair Value		Amortized Cost		Estimated Fair Value		Amortized Cost		Estimated Fair Value
2006 & Prior													$	294,583	$	317,295	$	175,038	$	188,762	$	181,070	$	190,519
2007														161,197		173,999		32,862		36,525		67,277		73,370
2008														—		—		53,660		64,675		18,061		20,058
2009														1,653		1,784		7,139		7,832		3,490		5,455
2010														27,995		29,350		47,168		50,095		19,146		20,535
2011														15,745		15,902		18,182		19,996		40,444		40,898
2012														32,265		31,054		34,672		34,662		58,193		56,413
2013														36,744		35,712		10,427		9,906		2,486		2,438

Total													$	570,182	$	605,096	$	379,148	$	412,453	$	390,167	$	409,686


													BBB				Below Investment Grade				Total
Underwriting Year													Amortized Cost		Estimated Fair Value		Amortized Cost		Estimated Fair Value		Amortized Cost		Estimated Fair Value
2006 & Prior													$	202,213	$	207,205	$	99,391	$	100,075	$	952,295	$	1,003,856
2007														93,813		106,225		108,771		104,126		463,920		494,245
2008														—		—		21,729		22,561		93,450		107,294
2009														4,002		5,332		—		—		16,284		20,403
2010														—		—		—		—		94,309		99,980
2011														33,146		31,483		—		—		107,517		108,279
2012														43,379		40,852		—		—		168,509		162,981
2013														—		—		—		—		49,657		48,056

Total													$	376,553	$	391,097	$	229,891	$	226,762	$	1,945,941	$	2,045,094


December 31, 2012:	AAA				AA				A				AAA				AA				A
	Amortized		Estimated		Amortized		Estimated		Amortized		Estimated
Underwriting Year	Cost		Fair Value		Cost		Fair Value		Cost		Fair Value		Amortized Cost		Estimated Fair Value		Amortized Cost		Estimated Fair Value		Amortized Cost		Estimated Fair Value
2005 & Prior	$	69,810	$	75,706	$	129,430	$	141,189	$	99,840	$	103,112	$	69,810	$	75,706	$	129,430	$	141,189	$	99,840	$	103,112
2006		243,222		270,756		59,773		66,862		85,198		93,688		243,222		270,756		59,773		66,862		85,198		93,688
2007		182,456		201,131		32,810		37,542		69,266		77,657		182,456		201,131		32,810		37,542		69,266		77,657
2008		7,674		7,672		53,510		67,624		14,387		17,098		7,674		7,672		53,510		67,624		14,387		17,098
2009		1,655		1,820		17,399		19,483		3,463		5,599		1,655		1,820		17,399		19,483		3,463		5,599
2010		27,984		29,956		47,085		53,027		13,273		14,405		27,984		29,956		47,085		53,027		13,273		14,405
2011		15,748		16,411		16,069		18,184		40,546		42,726		15,748		16,411		16,069		18,184		40,546		42,726
2012		28,324		29,080		36,340		36,925		58,376		59,595		28,324		29,080		36,340		36,925		58,376		59,595

Total	$	576,873	$	632,532	$	392,416	$	440,836	$	384,349	$	413,880	$	576,873	$	632,532	$	392,416	$	440,836	$	384,349	$	413,880


	BBB				Below Investment Grade				Total				BBB				Below Investment Grade				Total
Underwriting Year	Amortized Cost		Estimated Fair Value		Amortized Cost		Estimated Fair Value		Amortized Cost		Estimated Fair Value		Amortized Cost		Estimated Fair Value		Amortized Cost		Estimated Fair Value		Amortized Cost		Estimated Fair Value
2005 & Prior	$	110,887	$	113,801	$	42,838	$	37,720	$	452,805	$	471,528	$	110,887	$	113,801	$	42,838	$	37,720	$	452,805	$	471,528
2006		83,565		84,689		67,131		65,645		538,889		581,640		83,565		84,689		67,131		65,645		538,889		581,640
2007		93,414		108,902		115,028		91,505		492,974		516,737		93,414		108,902		115,028		91,505		492,974		516,737
2008		--		--		22,416		17,386		97,987		109,780		—		—		22,416		17,386		97,987		109,780
2009		3,880		5,547		--		--		26,397		32,449		3,880		5,547		—		—		26,397		32,449
2010		--		--		--		--		88,342		97,388		—		—		—		—		88,342		97,388
2011		33,242		33,757		--		--		105,605		111,078		33,242		33,757		—		—		105,605		111,078
2012		43,346		43,811		--		--		166,386		169,411		43,346		43,811		—		—		166,386		169,411

Total	$	368,334	$	390,507	$	247,413	$	212,256	$	1,969,385	$	2,090,011	$	368,334	$	390,507	$	247,413	$	212,256	$	1,969,385	$	2,090,011

Asset-backed securities include credit card and automobile receivables, sub-prime mortgage-backed securities, home equity loans, manufactured housing bonds and collateralized debt obligations. The Company’s asset-backed securities are diversified by issuer and contain both floating and fixed rate securities and had a weighted average credit rating of “A+” and “AA-” at ~~March 31,~~June 30, 2013 and December 31, 2012, respectively. The Company owns floating rate securities that represent approximately ~~15.3%~~15.8% and 15.0% of the total fixed maturity securities at ~~March 31,~~June 30, 2013 and December 31, 2012, respectively. These investments have a higher degree of income variability than the other fixed income holdings in the portfolio due to the floating rate nature of the interest payments. The Company holds these investments to match specific floating rate liabilities primarily reflected in the consolidated balance sheets as collateral finance facility. In addition to the risks associated with floating rate securities, principal risks in holding asset-backed securities are structural, credit and capital market risks. Structural risks include the securities’ cash flow priority in the capital structure and the inherent prepayment sensitivity of the underlying collateral. Credit risks include the adequacy and ability to realize proceeds from the collateral. Credit risks are mitigated by credit enhancements which include excess spread, over-collateralization and subordination. Capital market risks include general level of interest rates and the liquidity for these securities in the marketplace.

Since the financial crisis of 2008, the Company has continued to monitor its exposure in other structured security investments that includes subprime mortgage securities as well as Alt-A securities, a classification of mortgage loans where the risk profile of the borrower falls between prime and subprime. At ~~March 31,~~June 30, 2013 and December 31, 2012, the Company directly held investments in asset-backed securities with subprime mortgage exposure and also within the portfolios supporting the Company’s funds withheld at interest with amortized costs totaling $117.2 million and $122.6 million, and estimated fair values of ~~$106.9~~$111.4 million and $103.0 million, respectively. While ratings and vintage year are important factors to consider, the tranche seniority and evaluation of forecasted future losses within a tranche is critical to the valuation of these types of securities. At ~~March 31,~~June 30, 2013 and December 31, 2012, the Company’s Alt-A securities had an amortized cost of ~~$180.3~~$190.9 million and $169.0 million, and estimated fair values of ~~$188.3~~$196.2 million and $174.4 million, respectively. The Alt-A securities are held directly as well as within the portfolios supporting the Company’s funds withheld at interest. The Company did not record any other-than-temporary impairments in its direct subprime or Alt-A portfolios during the first ~~quarter~~six months of ~~2013~~2013. During the first six months of 2012, the Company recorded $0.3 million in other-than-temporary impairments in its direct subprime or ~~2012.~~Alt-A portfolios.

The Company does not invest in the common equity securities of Fannie Mae and Freddie Mac, both of which are government sponsored ~~entities; however,~~entities. However, as of ~~March 31,~~June 30, 2013 and December 31, 2012, the Company held in its ~~general~~direct portfolio ~~$66.0~~$46.5 million and $64.7 million, respectively, at amortized cost with direct exposure in the form of senior unsecured agency and preferred securities. Additionally, as of ~~March 31,~~June 30, 2013 and December 31, 2012, the portfolios held by the Company’s ceding companies that support its funds withheld asset contain approximately ~~$309.7~~$317.4 million and $307.2 million, respectively, in amortized cost of unsecured agency bond holdings and no equity exposure. As of ~~March 31,~~June 30, 2013 and December 31, 2012, indirect exposure in the form of secured, structured mortgaged securities issued by Fannie Mae and Freddie Mac totaled approximately ~~$721.8~~$733.6 million and $700.9 million, respectively, in amortized cost across the Company’s ~~general~~direct and funds

The Company monitors its fixed maturity and equity securities to determine impairments in value and evaluates factors such as financial condition of the issuer, payment performance, the length of time and the extent to which the market value has been below amortized cost, compliance with covenants, general market and industry sector conditions, current intent and ability to hold securities, and various other subjective factors. See “Investments – Other-than-Temporary Impairment” in Note 2 – “Summary of Significant Accounting Policies” in the Notes to Consolidated Financial Statements in the 2012 Annual Report for additional information. The Company recorded ~~$0.2~~$10.1 million and $10.3 million in other-than-temporary impairments in its fixed maturity securities, ~~none~~including $10.1 million of ~~which related to Subprime/Alt-A/Other~~other-than-temporary impairment losses on structured securities in the second quarter and first ~~quarter~~six months of 2013. The Company recorded ~~$15.7~~$4.0 million and $19.7 million in other-than-temporary impairments in its fixed maturity and equity securities, including ~~$12.8~~$0.2 million and $13.0 million of other-than-temporary impairment losses on ~~Subprime / Alt-A / Other~~ structured securities, in the second quarter and first ~~quarter~~six months of 2012, primarily due to a decline in value of structured securities with exposure to mortgages and general credit deterioration in select corporate and foreign securities. The ~~increase in other impairments was primarily due to impairments in the limited partnership asset class in the first quarter of 2013. The~~ table below summarizes other-than-temporary impairments for the ~~first quarter of~~three and six months ended June 30, 2013 and 2012 (dollars in thousands).


					Three Months Ended						Six Months Ended
Asset Class	Three Months Ended				June 30, 2013			June 30, 2012			June 30, 2013		June 30, 2012
Asset Class	March 31, 2013		March 31, 2012
Subprime / Alt-A / Other structured securities	$	--	$	12,790
Structured securities					$	10,109		$	220		$	10,109	$	13,010
Corporate / Other fixed maturity securities		202		2,038		—			1,577			202		3,615
Equity securities		--		839		—			2,186			—		3,025
Other impairments (primarily mortgage loans and limited partnerships)		1,626		5,843		(125	)		(1,762	)		1,501		4,081

Total	$	1,828	$	21,510	$	9,984		$	2,221		$	11,812	$	23,731

At ~~March 31,~~June 30, 2013 and December 31, 2012, the Company had ~~$122.5~~$310.7 million and $133.6 million, respectively, of gross unrealized losses related to its fixed maturity and equity securities. The distribution of the gross unrealized losses related to these securities is shown below.

See “Unrealized Losses for Fixed Maturity and Equity Securities Available-for-Sale” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for a table that presents the total gross unrealized losses for fixed maturity and equity securities at ~~March 31,~~June 30, 2013 and December 31, 2012, respectively, where the estimated fair value had declined and remained below amortized cost by less than 20% or more than 20%.

The Company’s determination of whether a decline in value is other-than-temporary includes analysis of the underlying credit and the extent and duration of a decline in value. The Company’s credit analysis of an investment includes determining whether the issuer is current on its contractual payments, evaluating whether it is probable that the Company will be able to collect all amounts due according to the contractual terms of the security and analyzing the overall ability of the Company to recover the amortized cost of the investment. The Company continues to consider valuation declines as a potential indicator of credit deterioration. The Company believes that due to fluctuating market conditions and an extended period of economic uncertainty, the extent and duration of a decline in value have become less indicative of when there has been credit deterioration with respect to a fixed maturity security since it may not have an impact on the ability of the issuer

to service all scheduled payments and the Company’s evaluation of the recoverability of all contractual cash flows or the ability to recover an amount at least equal to amortized cost. In the Company’s impairment review process, the duration and severity of an unrealized loss position for equity securities are given greater weight and consideration given the lack of contractual cash flows and deferability features of these securities.

See “Unrealized Losses for Fixed Maturity and Equity Securities Available-for-Sale” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables that present the estimated fair values and gross unrealized losses, including other-than-temporary impairment losses reported in AOCI, for fixed maturity and equity securities that have estimated fair values below amortized cost as of ~~March 31,~~June 30, 2013 and December 31, 2012.

As of ~~March 31,~~June 30, 2013 and December 31, 2012, respectively, the Company classified approximately ~~10.4%~~11.0% and 10.0% of its fixed maturity securities in the Level 3 category (refer to Note 6 – “Fair Value of Assets and Liabilities” in the Notes to Condensed Consolidated Financial Statements for additional information). These securities primarily consist of private placement corporate securities, below investment grade commercial and residential mortgage-backed securities and sub-prime asset-backed securities with inactive trading markets.

Mortgage loans represented approximately ~~6.8%~~7.3% and 6.7% of the Company’s cash and invested assets as of ~~March 31,~~June 30, 2013 and December 31, 2012, respectively. The Company’s mortgage loan portfolio consists principally of investments in U.S.-based commercial offices, light industrial properties and retail locations. The mortgage loan portfolio is diversified by geographic region and property type as discussed further in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements.

Valuation allowances on mortgage loans are established based upon losses expected by management to be realized in connection with future dispositions or settlement of mortgage loans, including foreclosures. The valuation allowances are established after management considers, among other things, the value of underlying collateral and payment capabilities of debtors. Any subsequent adjustments to the valuation allowances will be treated as investment gains or losses.

See “Mortgage Loans on Real Estate” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for information regarding for information regarding valuation allowances and impairments.

Policy loans comprised approximately 3.8% and 3.7% of the Company’s cash and invested assets as of both ~~March 31,~~June 30, 2013 and December 31, 2012, respectively, substantially all of which are associated with one client. These policy loans present no credit risk because the amount of the loan cannot exceed the obligation due the ceding company upon the death of the insured or surrender of the underlying policy. The provisions of the treaties in force and the underlying policies determine the policy loan interest rates. Because policy loans represent premature distributions of policy liabilities, they have the effect of reducing future disintermediation risk. In addition, the Company earns a spread between the interest rate earned on policy loans and the interest rate credited to corresponding liabilities.

Funds withheld at interest comprised approximately ~~16.8%~~17.6% and 16.4% of the Company’s cash and invested assets as of ~~March 31,~~June 30, 2013 and December 31, 2012, respectively. For reinsurance agreements written on a modified coinsurance basis and certain agreements written on a coinsurance basis, assets equal to the net statutory reserves are withheld and legally owned and managed by the ceding company, and are reflected as funds withheld at interest on the Company’s consolidated balance sheets. In the event of a ceding company’s insolvency, the Company would need to assert a claim on the assets supporting its reserve liabilities. However, the risk of loss to the Company is mitigated by its ability to offset amounts it owes the ceding company for claims or allowances with amounts owed by the ceding company. Interest accrues to these assets at rates defined by the treaty terms. Additionally, under certain treaties the Company is subject to the investment performance on the withheld assets, although it does not directly control them. These assets are primarily fixed maturity investment securities and pose risks similar to the fixed maturity securities the Company owns. To mitigate the risk, the Company helps set the investment guidelines followed by the ceding company and monitors compliance. Ceding companies with funds withheld at interest had an average rating of “A” at ~~March 31,~~June 30, 2013 and December 31, 2012. Certain ceding companies maintain segregated portfolios for the benefit of the Company.

Other invested assets include equity securities, collateral, limited partnership interests, real estate joint ventures, real estate held-for-investment, structured loans and derivative contracts. Other invested assets represented approximately ~~3.3%~~3.2% and 3.4% of the Company’s cash and invested assets as of ~~March 31,~~June 30, 2013 and December 31, 2012, respectively. See “Other Invested Assets” in Note 4 – “Investments” in the Notes to Condensed Consolidated Financial Statements for a table that presents the carrying value of the Company’s other invested assets by type as of ~~March 31,~~June 30, 2013 and December 31, 2012.

The Company did not record any other-than-temporary impairments on equity securities in the second quarter and first ~~three~~six months of 2013. ~~In the first three months of 2012, the~~The Company recorded ~~$0.8~~$2.2 million and $3.0 million of other-than-temporary impairments on equity ~~securities.~~securities in the second quarter and first six months of 2012. The Company recorded ~~$2.4 million and $0.8 million of~~no other-than-temporary impairments on limited partnership interests in the second quarter, and $2.4 million and $0.8 million in the first ~~quarter~~six months of 2013 and 2012, ~~respectively.~~respectively

The Company may be exposed to credit-related losses in the event of non-performance by counterparties to derivative financial instruments. Generally, the credit exposure of the Company’s derivative contracts is limited to the fair value at the reporting date plus or minus any collateral pledged to or from the Company. The Company had credit exposure related to its derivative contracts, excluding futures, of ~~$9.5~~$8.5 million and $7.1 million at ~~March 31,~~June 30, 2013 and December 31, 2012, respectively. See “Credit Risk” in Note 5 – “Derivative Instruments” in the Notes to Condensed Consolidated Financial Statements for additional information.

From December 31, 2012 to ~~March 31,~~June 30, 2013, the Company’s obligation related to its collateral finance facility, including interest, was reduced by ~~$169.9~~$177.2 million due to the repurchase of a portion of the outstanding notes as previously discussed. In addition, since December 31, 2012, the Company’s obligation for short-term debt, including interest, increased by $120.0 million due to advances from the FHLB as previously discussed and the Company’s obligation to fund limited partnerships increased by $65.1 million. There were no other material changes in the Company’s contractual obligations from those reported in the 2012 Annual Report.

RGA maintains an Enterprise Risk Management (“ERM”) program to consistently identify, assess, mitigate, monitor, and communicate all material risks facing the organization in order to effectively manage all risks, increasing protection of RGA’s clients, shareholders, employees, and other stakeholders. RGA’s ERM framework provides a platform to assess the risk / return profiles of risks throughout the organization, thereby enabling enhanced decision making. This includes development and implementation of mitigation strategies to reduce exposures to these risks to acceptable levels. Risk management is an integral part of the Company’s culture and is interwoven in day to day activities. It includes guidelines, risk appetites, risk targets, risk limits, and other controls in areas such as mortality, morbidity, longevity, pricing, underwriting, currency, administration, investments, asset liability management, counterparty exposure, geographic exposure, financing, asset leverage, regulatory change, business continuity planning, human resources, liquidity, collateral, sovereign risks and information technology development.

The Chief Risk Officer (“CRO”), aided by the Risk Management Steering Committee (“RMSC”), Business Unit Chief Risk Officers, Risk Management Officers and a dedicated ERM function, is responsible for ensuring, on an ongoing basis, that objectives of the ERM framework are met; this includes ensuring proper risk controls are in place, risks are effectively identified, assessed and managed, and key risks to which the Company is exposed are disclosed to appropriate stakeholders. For each Business Unit and key risk, a Risk Management Officer is assigned. A Risk Officer is also assigned to take overall responsibility of a specific risk across all markets to monitor and assess this risk consistently. In addition to this network of Risk Management Officers, the Company also has risk focused committees such as the Business Continuity and Information Governance Steering Committee, Consolidated Investment Committee, Derivatives Risk Oversight Committee, Asset and Liability Management Committee, Hedging Oversight Committee, Collateral and Liquidity Committee, and the Currency Risk Management Committee. These committees are comprised of various risk experts and have overlapping membership, enabling consistent and holistic management of risks. These committees report directly or indirectly to the RMSC. The RMSC, which includes senior management executives, including the Chief Executive Officer, the Chief Financial Officer, the Chief Operating Officer (“COO”) and the CRO, is the primary risk management oversight for the Company.

The RMSC approves both targets and limits for each material risk and reviews these limits annually. Exposure to these risks is calculated and presented to the RMSC at least quarterly. Any exception to established risk limits or waiver needs to be approved by the RMSC.

The CRO, reports regularly to the Finance, Investment and Risk Management (“FIRM”) Committee, a sub-committee of the Board of Directors responsible, among other duties, for overseeing the management of RGA’s ERM programs and policies. An extensive ERM report is presented to the FIRM quarterly. The report contains information on all risks as well as qualitative and quantitative assessments. A list of all breaches, exceptions and waivers is also included in the report. The Board of Directors has other committees, such as the Audit Committee, whose responsibilities include aspects of risk management. The CRO reports to the COO and has direct access to the RGA Board of Directors, through the FIRM Committee.

The Company has devoted significant resources to develop its ERM program, and expects continuing to do so in the future. Nonetheless, the Company’s policies and procedures to identify, manage and monitor risks may not be fully effective. Many of the Company’s methods for managing risk are based on historical information, which may not be a good predictor of

future risk exposures, such as the risk of a pandemic causing a large number of deaths. Management of operational, legal and regulatory risk rely on policies and procedures which may not be fully effective under all scenarios.

Specific risk assessments and descriptions can be found below and in Item 1A – “Risk Factors” of the 2012 Annual Report.

The risk of loss due to experience deviating adversely from expectations for mortality, morbidity, and policyholder behavior or lost future profits due to treaty recapture by clients. This category is further divided into mortality, morbidity, longevity, policyholder behavior, and client recapture. The Company uses multiple approaches to managing insurance risk: active insurance risk assessment and pricing appropriately for the risks assumed, transferring undesired risks, and managing the retained exposure prudently. These strategies are explained below.

The Company has developed extensive expertise in assessing insurance risks which ultimately forms an integral part of ensuring that it is compensated commensurately for the risks it assumes and that it does not overpay for the risks it transfers to third parties. This expertise includes a vast array of market and product knowledge supported by a large information database of historical experience which is closely monitored. Analysis and experience studies derived from this database help form the basis for the Company’s pricing assumptions which are used in developing rates for new risks. If actual mortality or morbidity experience is materially adverse, some reinsurance treaties allow for increases to future premium rates.

Misestimation of any key risk can threaten the long term viability of the enterprise. Further, the pricing process is a key operational risk and significant effort is applied to ensuring the appropriateness of pricing assumptions. Some of the safeguards the Company uses to ensure proper pricing are: experience studies, strict underwriting, sensitivity and scenario testing, pricing guidelines and controls, authority limits and internal and external pricing reviews. In addition, the Global ERM function provides additional pricing oversight which includes periodic pricing audits.

To minimize volatility in financial results and reduce the impact of large losses, the Company transfers some of its insurance risk to third parties using vehicles such as retrocession and catastrophe coverage.

In the normal course of business, the Company seeks to limit its exposure to loss on any single insured and to recover a portion of claims paid by ceding reinsurance to other insurance enterprises (or retrocessionaires) under excess coverage and coinsurance contracts. In individual life markets, the Company retains a maximum of $8.0 million of coverage per individual life. In certain limited situations the Company has retained more than $8.0 million per individual life. The Company enters into agreements with other reinsurers to mitigate the residual risk related to the over-retained policies. Additionally, due to some lower face amount reinsurance coverages provided by the Company in addition to individual life, such as group life, disability and health, under certain circumstances, the Company could potentially incur claims totaling more than $8.0 million per individual life.

The Company accesses the markets each year for annual catastrophic coverages and reviews current coverage and pricing of current and alternate designs. Purchases vary from year to year based on the Company’s perceived value of such coverages. The current policy covers events involving 10 or more insured deaths from a single occurrence and covers $100 million of claims in excess of the Company’s $50 million deductible.

The Company retains most of the inbound insurance risk. The Company manages the retained exposure proactively using various mitigating factors such as diversification and limits. Diversification is the primary mitigating factor of short term volatility risk, but it also mitigates adverse impacts of changes in long term trends and catastrophic events. The Company’s insured populations are dispersed globally, diversifying the insurance exposure because factors that cause actual experience to deviate materially from expectations do not affect all areas uniformly and synchronously or in close sequence. A variety of

limits mitigate retained insurance risk. Examples of these limits include geographic exposure limits, which set the maximum amount of business that can be written in a given locale, and jumbo limits, which prevent excessive coverage on a given individual.

In the event that mortality or morbidity experience develops in excess of expectations, some reinsurance treaties allow for increases to future premium rates. Other treaties include experience refund provisions, which may also help reduce RGA’s mortality risk.

~~Liquidity risk is the risk that cash resources are insufficient to meet the Company’s cash demands without incurring unacceptable costs.~~

Liquidity demands come primarily from payment of claims, expenses and investment purchases, all of which are known or can be reasonably forecasted. Contingent liquidity demands exist and require the Company to inventory and estimate likely and potential liquidity demands stemming from stress scenarios.

The Company maintains cash, cash equivalents, credit facilities, and short-term liquid investments to support its current and future anticipated liquidity requirements. The Company may also borrow via the reverse repo market, and holds a large pool of unrestricted, FHLB-eligible collateral that may be pledged to support any FHLB advances needed to provide additional liquidity.

~~The amount of liquidity available both within 24 hours and within 72 hours is reviewed and reported at least weekly.~~

Market risk is the risk that net asset and liability values or revenue will be affected adversely by changes in market conditions such as market prices, exchange rates, and nominal interest ~~rates~~rates. The Company is primarily exposed to interest rate, foreign currency, inflation and equity ~~and currency~~ risks.

Interest rate risk is the potential for loss, on a net asset and liability basis, due to changes in interest rates, including both normal rate changes and credit spread changes. This risk arises from many of the Company’s primary activities, as the Company invests substantial funds in interest-sensitive assets and also has certain interest-sensitive contract liabilities. The Company manages interest rate risk to maximize the return on the Company’s capital effectively and to preserve the value created by its business operations. As such, certain management monitoring processes are designed to minimize the effect of sudden and/or sustained changes in interest rates on fair value, cash flows, and net interest income. The Company manages its exposure to interest rates principally by matching floating rate liabilities with corresponding floating rate assets and by matching fixed rate liabilities with corresponding fixed rate assets. On a limited basis, the Company uses equity options to minimize its exposure to movements in equity markets that have a direct correlation with certain of its reinsurance products.

The Company’s exposure to interest rate price risk and interest rate cash flow risk is reviewed on a quarterly basis. Interest rate price risk exposure is measured using interest rate sensitivity analysis to determine the change in fair value of the Company’s financial instruments in the event of a hypothetical change in interest rates. Interest rate cash flow risk exposure is measured using interest rate sensitivity analysis to determine the Company’s variability in cash flows in the event of a hypothetical change in interest rates.

In order to reduce the exposure of changes in fair values from interest rate fluctuations, the Company has developed strategies to manage the interest rate sensitivity of its asset base. From time to time, the Company has utilized the swap market to manage the volatility of cash flows to interest rate fluctuations.

The Company is subject to foreign currency translation, transaction, and net income exposure. The Company manages its exposure to currency principally by matching invested assets with the underlying liabilities to the extent possible. The Company has in place net investment hedges for a portion of its investments in its Canadian and Australian operations to reduce excess exposure to these currencies. Translation differences resulting from translating foreign subsidiary balances to U.S. dollars are reflected in stockholders’ equity on the condensed consolidated balance sheets.

The Company generally does not hedge the foreign currency exposure of its subsidiaries transacting business in currencies other than their functional currency (transaction exposure). However, the Company has entered into certain interest rate swaps in which the cash flows are denominated in different currencies, commonly referred to as cross currency swaps. Those interest rate swaps have been designated as cash flow hedges. The majority of the Company’s foreign currency transactions are denominated in Australian dollars, British pounds, Canadian dollars, Euros, Japanese yen, Korean won, and the South African rand.

The maximum amount of assets held in a specific currency (with the exception of the U.S. Dollar) is measured relative to risk targets and is monitored regularly.

The primary direct effect on the Company of inflation is the increase in operating expenses. A large portion of the Company’s operating expenses consists of salaries, which are subject to wage increases at least partly affected by the rate of inflation. The rate of inflation also has an indirect effect on the Company. To the extent that a government’s policies to control the level of inflation result in changes in interest rates, the Company’s investment income is affected.

Equity risk is the risk that net asset and liability (e.g. variable annuities or other equity linked exposures) values or revenues will be affected adversely by changes in equity markets. The Company assumes equity risk from embedded derivatives in alternative investments, fixed indexed annuities and variable annuities.

Alternative Investments are investments in non-traditional asset classes that are most commonly backing capital and surplus and not liabilities. The Company generally restricts the alternative investments portfolio to non-liability supporting assets: that is, free surplus. For (re)insurance companies, alternative investments generally encompass: hedge funds, owned commercial real estate, emerging markets debt, distressed debt, commodities, infrastructure, tax credits, and equities, both public and private. The Company mitigates its exposure to alternative investments by limiting the size of the alternative investments holding.

Credits for fixed indexed annuities are affected by changes in equity markets. Thus the fair value of the benefit is a function of primarily index returns and volatility. The Company hedges some of the underlying equity exposure.

The Company reinsures variable annuities including those with guaranteed minimum death benefits (“GMDB”), guaranteed minimum income benefits (“GMIB”), guaranteed minimum accumulation benefits (“GMAB”) and guaranteed minimum withdrawal benefits (“GMWB”). Strong equity markets, increases in interest rates and decreases in volatility will generally decrease the fair value of the liabilities underlying the benefits. Conversely, a decrease in the equity markets along with a decrease in interest rates and an increase in volatility will generally result in an increase in the fair value of the liabilities underlying the benefits, which has the effect of increasing reserves and lowering earnings. The Company maintains a customized dynamic hedging program that is designed to substantially mitigate the risks associated with income volatility around the change in reserves on guaranteed benefits, ignoring the Company’s own credit risk assessment. However, the hedge positions may not fully offset the changes in the carrying value of the guarantees due to, among other things, time lags, high levels of volatility in the equity and derivative markets, extreme swings in interest rates, unexpected contract holder behavior, and divergence between the performance of the underlying funds and hedging indices. These factors, individually or collectively, may have a material adverse effect on the Company’s net income, financial condition or liquidity. The table below provides a summary of variable annuity account values and the fair value of the guaranteed benefits as of ~~March 31,~~June 30, 2013 and December 31, 2012.


(dollars in millions)	March 31, 2013		December 31, 2012		June 30, 2013		December 31, 2012
No guarantee minimum benefits	$	960	$	948	$	946	$	948
GMDB only		80		79		56		79
GMIB only		6		6		6		6
GMAB only		54		54		52		54
GMWB only		1,707		1,662		1,660		1,662
GMDB / WB		465		455		450		455
Other		32		31		30		31

Total variable annuity account values	$	3,304	$	3,235	$	3,200	$	3,235


Fair value of liabilities associated with living benefit riders	$	121	$	172	$	85	$	172

There has been no significant change in the Company’s quantitative or qualitative aspects of market risk during the quarter ended ~~March 31,~~June 30, 2013 from that disclosed in the 2012 Annual Report.

Credit risk is the risk of loss due to counterparty (obligor, client, retrocessionaire, or partner) credit deterioration or unwillingness to meet its obligations. Credit risk has two forms: investment credit risk (asset default and credit migration) and insurance counterparty risk.

Investment credit risk, which includes default risk, is risk of loss due to credit quality deterioration of an individual financial investment, derivative or non-derivative contract or instrument. Credit quality deterioration may or may not be accompanied by a ratings downgrade. Generally, the investment credit exposure is limited to the fair value, net of any collateral received, at the reporting date.

The creditworthiness of Europe’s peripheral region is under ongoing stress and uncertainty due to high debt levels and economic weakness. The Company does not have material exposure to sovereign fixed maturity securities, which includes global government agencies, from Europe’s peripheral region and Cyprus. However, the Company does have exposure to non-sovereign fixed maturity and equity securities issued from Europe’s peripheral region. The Company increased its exposure to fixed maturity and equity securities in Europe’s peripheral region and Cyprus from an estimated fair value of $118.7 million at December 31, 2012 to ~~$151.5~~$137.4 million as of ~~March 31,~~June 30, 2013, primarily due to sovereign security investments in Ireland and Spain. The Company believes it has adequately evaluated and is appropriately managing this additional risk. See “Investments” above for additional information on the Company’s exposure related to investment securities.

The Company manages investment credit risk using per-issuer investments limits. In addition to per-issuer limits, the Company also limits the total amounts of investments per rating category. An automated compliance system checks for compliance for all investment positions and sends warning messages when there is a breach. The Company manages its credit risk related to over-the-counter derivatives by entering into transactions with creditworthy counterparties, maintaining collateral arrangements and through the use of master agreements that provide for a single net payment to be made by one counterparty to another at each due date and upon termination. Because exchange-traded futures are affected through regulated exchanges, and positions are marked to market on a daily basis, the Company has minimal exposure to credit-related losses in the event of nonperformance by counterparties to such derivative instruments.

The Company enters into various collateral arrangements, which require both the posting and accepting of collateral in connection with its derivative instruments. Collateral agreements contain attachment thresholds that vary depending on the posting party’s financial strength ratings. Additionally, a decrease in the Company’s financial strength rating to a specified level results in potential settlement of the derivative positions under the Company’s agreements with its counterparties. The Collateral and Liquidity Committee sets rules, approves and oversees all deals requiring collateral. See “Credit Risk” in Note 5 – “Derivative Instruments” in the Notes to Condensed Consolidated Financial Statements for additional information on credit risk related to derivatives.

Insurance counterparty risk is the potential for the Company to incur losses due to a client, retrocessionaire, or partner becoming distressed or insolvent. This includes run-on-the-bank risk and collection risk.

The risk that a client’s in force block incurs substantial surrenders and/or lapses due to credit impairment, reputation damage or other market changes affecting the counterparty. Severely higher than expected surrenders and/or lapses could result in inadequate in force business to recover cash paid out for acquisition costs.

For clients and retrocessionaires, this includes their inability to satisfy a reinsurance agreement because the right of offset is disallowed by the receivership court; the reinsurance contract is rejected by the receiver, resulting in a premature termination of the contract; and/or the security supporting the transaction becomes unavailable to RGA.

The Company manages insurance counterparty risk by limiting the total exposure to a single counterparty and by only initiating contracts with creditworthy counterparties. In addition, some of the counterparties have set up trusts and letters of credit, reducing the Company’s exposure to these counterparties.

Generally, RGA’s insurance subsidiaries retrocede amounts in excess of their retention to RGA Reinsurance, Parkway Re, RGA Barbados, RGA Americas, Rockwood Re, Manor Re, RGA Worldwide or RGA Atlantic. External retrocessions are arranged through the Company’s retrocession pools for amounts in excess of its retention. As of ~~March 31,~~June 30, 2013, all retrocession pool members in this excess retention pool rated by the A.M. Best Company were rated “A-” or ~~better except for one pool member that was rated “B++.”~~better. A rating of “A-” is the fourth highest rating out of fifteen possible ratings. For a majority of the retrocessionaires that were not rated, letters of credit or trust assets have been given as additional security. In addition, the Company performs annual financial and in force reviews of its retrocessionaires to evaluate financial stability and performance.

The Company has never experienced a material default in connection with retrocession arrangements, nor has it experienced any material difficulty in collecting claims recoverable from retrocessionaires; however, no assurance can be given as to the future performance of such retrocessionaires or as to the recoverability of any such claims.

In addition to investment credit limits and insurance counterparty limits, there are aggregate counterparty risk limits which include counterparty exposures from reinsurance, financing and investment activities at an aggregated level to control total exposure to a single counterparty. Counterparty risk aggregation is important because it enables the Company to capture risk exposures at a comprehensive level and under more extreme circumstances compared to analyzing the components individually.

All counterparty exposures are calculated on a quarterly basis, reviewed by management and monitored by the ERM function.

Operational risk is the risk of loss due to inadequate or failed internal processes, people or systems, or external events. These risks are sometimes residual risks after insurance, market and credit risks have been identified. Operational risk is further divided into: Process, Legal/Regulatory, Financial, and Intangibles. The Company’s financial risk includes liquidity risk, which is risk that cash resources are insufficient to meet the Company’s cash demands without incurring unacceptable costs.

The amount of liquidity available both within 24 hours and within 72 hours is reviewed and reported at least weekly.

In order to effectively manage operational risks, management primarily relies on:

Risk management is embedded in RGA’s business processes in accordance with RGA’s risk philosophy. As the cornerstone of the ERM framework, risk culture plays a preeminent role in the effective management of risks assumed by RGA. At the heart of RGA’s risk culture is prudent risk management. Senior management sets the tone for RGA risk culture, inculcating positive risk attitudes so as to entrench sound risk management practices into day-to-day activities.

Structural controls provide additional safeguards against undesired risk exposures. Examples of structural controls include: pricing and underwriting reviews, standard treaty language, etc.

Proactive risk monitoring and reporting enable early detection and mitigation of emerging risks. For example, there is elevated regulatory activity in the wake of the global financial crisis and RGA is actively monitoring regulatory proposals in order to respond optimally. Risk escalation channels coupled with open communication lines enhance the mitigants explained above.

See Note 14 — “New Accounting Standards” in the Notes to Condensed Consolidated Financial Statements.

See “Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations – Market Risk” which is included herein.

The Chief Executive Officer and the Chief Financial Officer have evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as defined in Exchange Act Rule 13a-15(e) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that these disclosure controls and procedures were effective.

There was no change in the Company’s internal control over financial reporting as defined in Exchange Act Rule 13a-15(f) during the quarter ended ~~March 31,~~June 30, 2013, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

There have been no material changes from the risk factors previously disclosed in the 2012 Annual Report.

The following table summarizes RGA’s repurchase activity of its common stock during the quarter ended ~~March 31,~~June 30, 2013:

~~During April~~In January 2013, ~~the Company repurchased an additional 892,047 shares of common stock under its~~RGA’s board of directors authorized a share repurchase program for ~~$52.4 million. On~~up to $200.0 million of RGA’s outstanding common stock. In April ~~18,~~ 2013, RGA’s board of directors authorized an increase of $100.0 million to the share repurchase program previously authorized onin January ~~24,~~2013. In July 2013, RGA’s board of directors authorized an additional increase of $100.0 million to the share repurchase program previously authorized in January 2013. With ~~this authorization,~~these authorizations, the total amount of the Company’s outstanding common stock authorized for repurchase is ~~$300.0~~$400.0 million.

On August 2, 2013, RGA entered into a standard Indemnification Agreement with each of RGA’s executive officers (including the principal executive officer, principal financial officer and each named executive officer) and each member of the RGA Board of Directors (the “Indemnification Agreements”). The Indemnification Agreements supplement the indemnification coverage afforded to the indemnitees by RGA’s Amended and Restated Articles of Incorporation and require RGA to indemnify each indemnitee to the fullest extent permitted by the General and Business Corporation Law of Missouri. The form of the Indemnification Agreements is filed with this report as Exhibit 10.2 and is incorporated by reference herein.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


(Mark One)
x		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
		OF THE SECURITIES EXCHANGE ACT OF 1934

		For the quarterly period ended ~~March 31,~~June 30, 2013

		OR

¨		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
		OF THE SECURITIES EXCHANGE ACT OF 1934


MISSOURI		43-1627032
(State or other jurisdiction		~~(IRS~~(IRS employer
of incorporation or organization)		identification number)


Item		Page		Page

	PART I – FINANCIAL INFORMATION		PART I – FINANCIAL INFORMATION

1	Financial Statements		Financial Statements

	Condensed Consolidated Balance Sheets (Unaudited) March 31, 2013 and December 31, 2012	3	Condensed Consolidated Balance Sheets (Unaudited) June 30, 2013 and December 31, 2012		3

	Condensed Consolidated Statements of Income (Unaudited) Three months ended March 31, 2013 and 2012	4	Condensed Consolidated Statements of Income (Unaudited) Three and six months ended June 30, 2013 and 2012		4

	Condensed Consolidated Statements of Comprehensive Income (Unaudited) Three months ended March 31, 2013 and 2012	5	Condensed Consolidated Statements of Comprehensive Income (Unaudited) Three and six months ended June 30, 2013 and 2012		5

	Condensed Consolidated Statements of Cash Flows (Unaudited) Three months ended March 31, 2013 and 2012	6	Condensed Consolidated Statements of Cash Flows (Unaudited) Six months ended June 30, 2013 and 2012		6

	Notes to Condensed Consolidated Financial Statements (Unaudited)	7	Notes to Condensed Consolidated Financial Statements (Unaudited)		7

2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	40	Management’s Discussion and Analysis of Financial Condition and Results of Operations		50

3	Quantitative and Qualitative Disclosure About Market Risk	69	Quantitative and Qualitative Disclosure About Market Risk		84

4	Controls and Procedures	69	Controls and Procedures		84

	PART II – OTHER INFORMATION		PART II – OTHER INFORMATION

1	Legal Proceedings	70	Legal Proceedings		85

1A	Risk Factors	70	Risk Factors		85

2	Unregistered Sales of Equity Securities and Use of Proceeds	70	Unregistered Sales of Equity Securities and Use of Proceeds		85

5			Other Information		85

6	Exhibits	70	Exhibits		85

	Signatures	71	Signatures		86

	Index to Exhibits	72	Index to Exhibits		87


	March 31, 2013		December 31, 2012
					June 30, 2013			December 31, 2012
	(Dollars in thousands, except share data)				(Dollars in thousands, except share data)
Assets
Fixed maturity securities:
Available-for-sale at fair value (amortized cost of $19,838,949 and $19,559,432 at March 31, 2013 and December 31, 2012, respectively)	$	22,401,659	$	22,291,614
Mortgage loans on real estate (net of allowances of $9,924 and $11,580 at March 31, 2013 and December 31, 2012, respectively)		2,325,191		2,300,587
Available-for-sale at fair value (amortized cost of $19,757,321 and $19,559,432)					$	21,284,216		$	22,291,614
Mortgage loans on real estate (net of allowances of $7,903 and $11,580)						2,377,246			2,300,587
Policy loans		1,245,812		1,278,175		1,245,252			1,278,175
Funds withheld at interest		5,698,594		5,594,182		5,777,395			5,594,182
Short-term investments		180,707		288,082		38,601			288,082
Other invested assets		1,129,651		1,159,543		1,035,809			1,159,543

Total investments		32,981,614		32,912,183		31,758,519			32,912,183
Cash and cash equivalents		1,001,841		1,259,892		973,619			1,259,892
Accrued investment income		230,269		201,344		233,153			201,344
Premiums receivable and other reinsurance balances		1,259,281		1,356,087		1,314,004			1,356,087
Reinsurance ceded receivables		602,373		620,901		585,555			620,901
Deferred policy acquisition costs		3,545,063		3,619,274		3,453,513			3,619,274
Other assets		576,660		390,757		472,258			390,757

Total assets	$	40,197,101	$	40,360,438	$	38,790,621		$	40,360,438


Liabilities and Stockholders’ Equity
Future policy benefits	$	11,355,882	$	11,372,856	$	11,491,692		$	11,372,856
Interest-sensitive contract liabilities		13,141,402		13,353,502		12,991,981			13,353,502
Other policy claims and benefits		3,243,948		3,160,250		3,316,727			3,160,250
Other reinsurance balances		250,606		233,630		254,815			233,630
Deferred income taxes		2,105,391		2,120,501		1,839,909			2,120,501
Other liabilities		877,405		742,249		584,488			742,249
Short-term debt						120,000			—
Long-term debt		1,815,392		1,815,253		1,815,533			1,815,253
Collateral finance facility		491,987		652,010		487,556			652,010

Total liabilities		33,282,013		33,450,251		32,902,701			33,450,251

Commitments and contingent liabilities (See Note 8)

Stockholders’ Equity:
Preferred stock (par value $.01 per share; 10,000,000 shares authorized; no shares issued or outstanding)		--		--
Common stock (par value $.01 per share; 140,000,000 shares authorized; shares issued: 79,137,758 at March 31, 2013 and December 31, 2012)		791		791
Preferred stock - par value $.01 per share, 10,000,000 shares authorized, no shares issued or outstanding						—			—
Common stock - par value $.01 per share, 140,000,000 shares authorized, 79,137,758 shares issued at June 30, 2013 and December 31, 2012						791			791
Additional paid-in-capital		1,765,255		1,755,421		1,772,811			1,755,421
Retained earnings		3,521,492		3,357,255		3,428,646			3,357,255
Treasury stock, at cost; 5,836,961 and 5,210,427 shares at March 31, 2013 and December 31, 2012, respectively		(349,190)		(312,182)
Treasury stock, at cost - 8,170,066 and 5,210,427 shares						(496,462	)		(312,182	)
Accumulated other comprehensive income		1,976,740		2,108,902		1,182,134			2,108,902

Total stockholders’ equity		6,915,088		6,910,187		5,887,920			6,910,187

Total liabilities and stockholders’ equity	$	40,197,101	$	40,360,438	$	38,790,621		$	40,360,438


					Three months ended June 30,						Six months ended June 30,

	Three months ended March 31,				2013			2012			2013			2012
	2013		2012
Revenues:	(Dollars in thousands, except per share data)				(Dollars in thousands, except per share data)
Net premiums	$	1,979,693	$	1,863,482	$	2,035,156		$	1,950,661		$	4,014,849		$	3,814,143
Investment income, net of related expenses		425,131		340,940		444,234			328,334			869,365			669,274
Investment related gains (losses), net:
Other-than-temporary impairments on fixed maturity securities		(202)		(7,607)		(9,803	)		(1,959	)		(10,005	)		(9,566	)
Other-than-temporary impairments on fixed maturity securities transferred to (from) accumulated other comprehensive income		--		(7,221)		(306	)		162			(306	)		(7,059	)
Other investment related gains (losses), net		94,573		58,348		58,352			25,598			152,925			83,946

Total investment related gains (losses), net		94,371		43,520		48,243			23,801			142,614			67,321
Other revenues		101,907		45,033		63,009			72,957			164,916			117,990

Total revenues		2,601,102		2,292,975		2,590,642			2,375,753			5,191,744			4,668,728


Benefits and Expenses:
Claims and other policy benefits		1,688,910		1,580,149		2,030,574			1,625,446			3,719,484			3,205,595
Interest credited		125,483		88,042		118,345			66,697			243,828			154,739
Policy acquisition costs and other insurance expenses		357,357		307,634		370,505			335,939			727,862			643,573
Other operating expenses		119,501		110,098		113,408			105,541			232,909			215,639
Interest expense		28,486		23,322		29,918			23,360			58,404			46,682
Collateral finance facility expense		2,538		2,967		2,650			2,878			5,188			5,845

Total benefits and expenses		2,322,275		2,112,212		2,665,400			2,159,861			4,987,675			4,272,073


Income before income taxes		278,827		180,763
Income (loss) before income taxes						(74,758	)		215,892			204,069			396,655
Provision for income taxes		93,292		57,445		(25,146	)		74,781			68,146			132,226

Net income	$	185,535	$	123,318

Net income (loss)					$	(49,612	)	$	141,111		$	135,923		$	264,429

Earnings per share:
Basic earnings per share	$	2.51	$	1.68	$	(0.69	)	$	1.91		$	1.86		$	3.59
Diluted earnings per share	$	2.49	$	1.67	$	(0.69	)	$	1.91		$	1.85		$	3.57

Dividends declared per share	$	0.24	$	0.18	$	0.24		$	0.18		$	0.48		$	0.36


	Three months ended
	March 31,				Three months ended June 30,					Six months ended June 30,
	2013		2012		2013			2012		2013		2012
Earnings:
Net income (numerator for basic and diluted calculations)	$	185,535	$	123,318
Net income (loss) (numerator for basic and diluted calculations)					$	(49,612	)	$	141,111	$	135,923	$	264,429
Shares:
Weighted average outstanding shares (denominator for basic calculation)		73,838		73,575		72,350			73,718		73,089		73,646
Equivalent shares from outstanding stock options		551		468		—			336		484		402

Denominator for diluted calculation		74,389		74,043		72,350			74,054		73,573		74,048

Earnings per share:
Basic	$	2.51	$	1.68	$	(0.69	)	$	1.91	$	1.86	$	3.59
Diluted	$	2.49	$	1.67	$	(0.69	)	$	1.91	$	1.85	$	3.57


	Accumulated Other Comprehensive Income (Loss), Net of Income Tax
	Accumulated Currency Translation Adjustments		Unrealized Appreciation (Depreciation) of Investments⁽¹⁾		Pension and Postretirement Benefits		Total
Balance, December 31, 2012	$	267,475	$	1,877,657	$	(36,230)	$	2,108,902
Other comprehensive income (loss) before reclassifications		(14,105)		(112,711)		99		(126,717)
Amounts reclassified from AOCI		--		(6,171)		726		(5,445)

Net current-period other comprehensive income (loss)		(14,105)		(118,882)		825		(132,162)

Balance, March 31, 2013	$	253,370	$	1,758,775	$	(35,405)	$	1,976,740


~~Details about AOCI Components~~	~~Amount~~ ~~Reclassified~~ ~~from AOCI~~		~~Affected Line Item in Statement of Income~~
~~Unrealized gains and losses on available-for-sale securities~~	$	~~10,348~~	~~Investment related gains (losses), net~~
~~Gains and losses on cash flow hedge - interest rate swap~~		~~305~~	~~Investment income~~
~~Deferred policy acquisition costs attributed to unrealized gains and losses~~⁽¹⁾		~~(1,548)~~

		~~9,105~~	~~Total before tax~~
		~~(2,934)~~	~~Tax expense~~

	$	~~6,171~~	~~Net of tax~~


~~Amortization of unrealized pension and postretirement benefits:~~
~~Prior service cost~~⁽²⁾	$	~~(94)~~
~~Actuarial gains/(losses)~~⁽²⁾		~~(1,023)~~

		~~(1,117)~~	~~Total before tax~~
		~~391~~	~~Tax benefit~~

	$	~~(726)~~	~~Net of tax~~


~~Total reclassifications for the period~~	$	~~5,445~~	~~Net of tax~~


	Amount Reclassified from AOCI
Details about AOCI Components	Three months ended June 30, 2013			Six months ended June 30, 2013			Affected Line Item in Statement of Income
Unrealized gains and losses on available-for-sale securities	$	13,510		$	23,858		Investment related gains (losses), net
Gains and losses on cash flow hedge - interest rate swap		201			506		Investment income
Deferred policy acquisition costs attributed to unrealized gains and losses⁽¹⁾		(13,283	)		(14,831	)

		428			9,533		Total before tax
		(87	)		(3,021	)	Tax expense

	$	341		$	6,512		Net of tax

Amortization of unrealized pension and postretirement benefits:
Prior service cost⁽²⁾	$	(213	)	$	(307	)
Actuarial gains/(losses)⁽²⁾		(968	)		(1,991	)

		(1,181	)		(2,298	)	Total before tax
		413			804		Tax benefit

	$	(768	)	$	(1,494	)	Net of tax


Total reclassifications for the period	$	(427	)	$	5,018		Net of tax


	~~At Date of~~
	~~Acquisition~~
~~Contractually required payments (including interest)~~	$	~~91,863~~
~~Cash flows expected to be collected~~⁽¹⁾	$	~~72,940~~
~~Fair value of investments acquired~~	$	~~50,874~~


	At Date of Acquisition
Contractually required payments (including interest)	$	109,931
Cash flows expected to be collected⁽¹⁾		88,422
Fair value of investments acquired		58,471


	~~Three months ended~~ ~~March 31, 2013~~
~~Balance, beginning of period~~	$	~~39,239~~
~~Investments purchased~~		~~22,066~~
~~Accretion~~		~~(1,943)~~
~~Reclassification to nonaccretable difference~~		~~553~~

~~Balance, end of period~~	$	~~59,915~~


	Three months ended June 30, 2013			Six months ended June 30, 2013
Balance, beginning of period	$	59,915		$	39,239
Investments purchased		7,885			29,951
Accretion		(1,879	)		(3,822	)
Disposals		(832	)		(832	)
Reclassification from nonaccretable difference		1,180			1,733

Balance, end of period	$	66,269		$	66,269


	June 30, 2013		December 31, 2012
31-60 days past due	$	20,563	$	7,504
61-90 days past due		—		—
Greater than 90 days		7,930		16,886

Total past due		28,493		24,390
Current		2,356,656		2,287,777

Total	$	2,385,149	$	2,312,167


							Gross Amounts Not Offset in the Balance Sheet
			Gross Amounts		Net Amounts				Cash Collateral
	Gross Amounts		Offset in the		Presented in the		Financial		Pledged/
	Recognized		Balance Sheet		Balance Sheet		Instruments		Received		Net Amount

March 31, 2013:

Derivative assets	$	175,236	$	(23,475)	$	151,761	$	(17,664)	$	(126,329)	$	7,768
Derivative liabilities		42,079		(23,475)		18,604		(14,118)		(6,250)		(1,764)

December 31, 2012:

Derivative assets	$	190,634	$	(22,426)	$	168,208	$	(22,458)	$	(136,414)	$	9,336
Derivative liabilities		54,078		(22,426)		31,652		(1,565)		(27,867)		2,220


								Gross Amounts Not Offset in the Balance Sheet
	Gross Amounts Recognized		Gross Amounts Offset in the Balance Sheet			Net Amounts Presented in the Balance Sheet		Financial Instruments			Cash Collateral Pledged/ Received			Net Amount
June 30, 2013:
Derivative assets	$	146,572	$	(27,781	)	$	118,791	$	(17,010	)	$	(89,829	)	$	11,952
Derivative liabilities		40,900		(27,781	)		13,119		(2,722	)		(6,950	)		3,447
December 31, 2012:
Derivative assets	$	190,634	$	(22,426	)	$	168,208	$	(22,458	)	$	(136,414	)	$	9,336
Derivative liabilities		54,078		(22,426	)		31,652		(1,565	)		(27,867	)		2,220


~~Level 1~~		Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities. Active markets are defined as having the following characteristics for the measured asset/liability: (i) many transactions, (ii) current prices, (iii) price quotes not varying substantially among market makers, (iv) narrow bid/ask spreads and (v) most information publicly available. The Company’s Level 1 assets and liabilities include investment securities that are traded in exchange markets.

~~Level 2~~		Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or market standard valuation techniques and assumptions with significant inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Such observable inputs include benchmarking prices for similar assets in active, liquid markets, quoted prices in markets that are not active and observable yields and spreads in the market. The Company’s Level 2 assets and liabilities include investment securities with quoted prices that are traded less frequently than exchange-traded instruments and derivative contracts whose values are determined using market standard valuation techniques. This category primarily includes corporate securities, Canadian and Canadian provincial government securities, and residential and commercial mortgage-backed securities, among others. Level 2 valuations are generally obtained from third party pricing services for identical or comparable assets or liabilities or through the use of valuation methodologies using observable market inputs. Prices from services are validated through analytical reviews and assessment of current market activity.

~~Level 3~~		Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the related assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using market standard valuation techniques described above. When observable inputs are not available, the market standard techniques for determining the estimated fair value of certain securities that trade infrequently, and therefore have little transparency, rely on inputs that are significant to the estimated fair value and that are not observable in the market or cannot be derived principally from or corroborated by observable market data. These unobservable inputs can be based in large part on management judgment or estimation and cannot be supported by reference to market activity. Even though unobservable, management believes these inputs are based on assumptions deemed appropriate given the circumstances and consistent with what other market participants would use when pricing similar assets and liabilities. For the Company’s invested assets, this category generally includes corporate securities (primarily private placements and bank loans), asset-backed securities (including those with exposure to subprime mortgages), and to a lesser extent, certain residential and commercial mortgage-backed securities, among others. Prices are determined using valuation methodologies such as discounted cash flow models and other similar techniques. Non-binding broker quotes, which are utilized when pricing service information is not available, are reviewed for reasonableness based on the following characteristics for the measured asset/liability: (i) many transactions, (ii) current prices, (iii) price quotes not varying substantially among market makers, (iv) narrow bid/ask spreads and (v) most information publicly available. The Company’s Level 1 assets and liabilities include investment securities that are traded in exchange markets. Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or market standard valuation techniques and assumptions with significant inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Such observable inputs include benchmarking prices for similar assets in active, liquid markets, quoted prices in markets that are not active and observable yields and spreads in the market. The Company’s Level 2 assets and liabilities include investment securities with quoted prices that are traded less frequently than exchange-traded instruments and derivative contracts whose values are determined using market standard valuation techniques. This category primarily includes corporate securities, Canadian and Canadian provincial government securities, and residential and commercial mortgage-backed securities, among others. Level 2 valuations are generally obtained from third party pricing services for identical or comparable assets or liabilities or through the use of valuation methodologies using observable market inputs. Prices from services are validated through analytical reviews and assessment of current market activity. Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the related assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using market standard valuation techniques described above. When observable inputs are not available, the market standard techniques for determining the estimated fair value of certain securities that trade infrequently, and therefore have little transparency, rely on inputs that are significant to the estimated fair value and that are not observable in the market or cannot be derived principally from or corroborated by observable market data. These unobservable inputs can be based in large part on management judgment or estimation and cannot be supported by reference to market activity. Even though unobservable, management believes these inputs are based on assumptions deemed appropriate given the circumstances and consistent with what other market participants would use when pricing similar assets and liabilities. For the Company’s invested assets, this category generally includes corporate securities (primarily private placements and bank loans), asset-backed securities (including those with exposure to subprime mortgages), and to a lesser extent, certain residential and commercial mortgage-backed securities, among others. Prices are determined using valuation methodologies such as discounted cash flow models and other similar techniques. Non-binding broker quotes, which are utilized when pricing service information is not available, are reviewed for reasonableness based on the Company’s understanding of the market, and are generally considered Level 3. Under certain circumstances, based on its observations of transactions in active markets, the Company may conclude the prices received from independent third party pricing services or brokers are not reasonable or reflective of market activity. In those instances, the Company would apply internally developed valuation techniques to the related assets or liabilities. Additionally, the Company’s embedded derivatives, all of which are associated with reinsurance treaties, are classified in Level 3 since their values include significant unobservable inputs.


		Amount Utilized⁽¹⁾
Facility Capacity	Maturity Date	March 31, 2013		December 31, 2012		Basis of Fees
$850.0	December 2015	$	140.0	$	402.9	Senior unsecured long-term debt rating
$200.0	September 2019		200.0		200.0	Fixed
$120.0	May 2016		100.0		100.0	Fixed
$270.0	November 2017		270.0		--	Fixed


Commitment Period	Maximum Potential Obligation
2033	$	350.0
2035		560.0


(dollars in thousands)	For the three months ended June 30,				For the six months ended June 30,
	2013		2012		2013		2012
Revenues:
Net premiums	$	239,633	$	221,167	$	482,904	$	439,377
Investment income, net of related expenses		51,642		46,242		102,197		95,142
Investment related gains (losses), net:
Other-than-temporary impairments on fixed maturity securities		—		—		—		—
Other-than-temporary impairments on fixed maturity securities transferred to (from) accumulated other comprehensive income		—		—		—		—
Other investment related gains (losses), net		3,748		5,625		6,803		14,168

Total investment related gains (losses), net		3,748		5,625		6,803		14,168
Other revenues		302		3,205		510		3,175

Total revenues		295,325		276,239		592,414		551,862

Benefits and expenses:
Claims and other policy benefits		196,584		184,857		386,282		345,482
Interest credited		6		—		18		—
Policy acquisition costs and other insurance expenses		52,134		47,476		112,966		97,761
Other operating expenses		10,942		8,876		21,181		18,526

Total benefits and expenses		259,666		241,209		520,447		461,769

Income before income taxes	$	35,659	$	35,030	$	71,967	$	90,093


	March 31,		December 31,
	2013		2012
Sector:
Corporate securities		38.3 %		30.4 %
Canadian and Canada provincial governments		0.9		0.1
Residential mortgage-backed securities		3.3		2.8
Asset-backed securities		15.6		21.6
Commercial mortgage-backed securities		34.2		38.8
State and political subdivisions		4.7		4.3
U.S. government and agencies		0.1		--
Other foreign government supranational and foreign government-sponsored enterprises		2.9		2.0

Total		100.0 %		100.0 %


Industry:
Finance		16.7 %		18.0 %
Asset-backed		15.6		21.6
Industrial		17.0		9.0
Mortgage-backed		37.6		41.6
Government		8.6		6.4
Utility		4.5		3.4

Total		100.0 %		100.0 %


	Total Number of Shares Purchased (1)		Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)		Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plan or Program

February 1, 2013 - February 28, 2013		96,735	$	57.64		96,724	$	194,424,790

March 1, 2013 - March 31, 2013		718,311	$	58.56		718,287	$	152,359,595


	Total Number of Shares Purchased (1)		Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)		Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plan or Program
April 1, 2013 - April 30, 2013		892,047	$	58.70		892,047	$	200,000,037
May 1, 2013 - May 31, 2013		548,101	$	65.00		424,083	$	172,309,776
June 1, 2013 - June 30, 2013		1,549,081	$	66.34		1,549,002	$	69,543,044


		Reinsurance Group of America, Incorporated

Date: ~~May 6,~~August 5, 2013	~~By:~~	By:	/s/ A. Greig Woodring
			A. Greig Woodring
			President & Chief Executive Officer
			(Principal Executive Officer)

Date: ~~May 6,~~August 5, 2013	~~By:~~	By:	/s/ Jack B. Lay
			Jack B. Lay
			Senior Executive Vice President & Chief Financial Officer
			(Principal Financial and Accounting Officer)


Exhibit Number		Description

3.1		Amended and Restated Articles of Incorporation, incorporated by reference to Exhibit 3.1 of Current Report on Form 8-K filed November 25, 2008.

3.2		Amended and Restated Bylaws, incorporated by reference to Exhibit 3.2 of Current Report on Form 8-K filed November 25, 2008.

10.1		RGA Flexible Stock Plan as amended and restated effective July 1, 1998 and as further amended by Amendment on March 16, 2000, Second Amendment on May 28, 2003, Third Amendment on May 26, 2004, Fourth Amendment on May 23, 2007, Fifth Amendment on May 21, 2008, Sixth Amendment on May 8, 2011, Seventh Amendment on May 18, 2011 and Eighth Amendment on May 15, 2013.

10.2		Form of Officer and Director Indemnification Agreement.

31.1		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document